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Summary
The thesis reports the successful synthesis o f many new acridinium esters and the 
investigation o f their chemiluminescent and stability properties. Such compounds 
were designed to have potential utility as biological probes.
In Chapter 1, a review on chemiluminescence, especially about acridinium derivatives, 
is given; and the background o f the project is discussed.
In Chapter 2, synthesis o f 6  acridine derivatives is reported. Each o f  them bears a
2.6-dibromophenoxy ring as a leaving group. They differ only in the groups bonded to 
the nitrogen atom o f the acridine rings. Compounds 1 and 2 have a dodecyl group 
and methyl group, respectively, i.e. the compounds are 
9-(2,6-dibromophenoxycarbonyl)-10-dodecylacridinium triflate (1) and
9-(2,6-dibromophenoxycarbonyl)-10- methylacridinium triflate (2); both compounds 
3 and 4 have a 3-succinimidyloxycarbonylpropyl group at 10 position, but 3 has an 
iodide counter anion and 4 has a triflate counter anion. Compounds 5 and 6 have a 
5-succinimidyloxycarbonylpentyl group and a 10-succinimidyloxycarbonyldecyl 
group, respectively, at position 1 0 .
In Chapter 3, synthesis o f 13 acridinium derivatives is reported. They are classified 
into 4 groups. Compounds 7-11 have an unsubstituted phenoxy group as leaving 
group and at position 10 have a methyl, dodecyl, 3-succinimidyloxycarbonylpropyl, 
5-succinimidyloxycarbonylpentyl or 10-succinimidyloxycarbonyldecyl group, 
respectively. Compounds 12-15 have a 2,5-dimethylphenoxy group as leaving group, 
and at position 10 have a methyl, 3-succinimidyloxycarbonylpropyl,
5-succinimidyloxycarbonylpentyl or 10-succinimidyloxycarbonyldecyl group, 
respectively. Compounds 16-17 have a 2,6-bis(trifluoromethyl)phenoxy group as 
leaving group, and at position 1 0  have a methyl or 1 0 -succinimidyloxycarbonyldecyl 
group. Finally, compounds 18-19 have a 2,6-dinitrophenoxy group as leaving group, 
and at position 1 0  have a methyl or 1 0 -succinimidyloxycarbonyldecyl group.
In Chapter 4, compounds with substituents on the acridinium ring, which are expected 
to emit chemiluminescence at different wavelengths, were synthesized. They are
2.6-dibromophenyl l,3-dimethylacridine-9-carboxylate (20); 9-(2,6- 
dibromophenoxycarbonyl)-2 -(succinimidyloxycarboxyethyl)-1 0 -methylacridinium 
triflate (21); and 9-(4-(2-succinimidylyoxycarbonylethyl)phenoxy)-2,7-dimethoxy-10- 
methylacridinium trifluoromethansulfonate (2 2 ).
In Chapter 5, the chemiluminescence o f compounds 1-2, 4-19, and 21-22, and the 
storage stabilities were tested.
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Introduction
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1.1 W hat is chemiluminescence (CL)?
Luminescence is a term used to describe the emission o f light, which occurs when a 
molecule in an excited state relaxes to the ground state. The various types o f  
luminescence differ in the source o f energy used to obtain the excited state. This 
energy can be supplied by electromagnetic radiation (photoluminescence; also 
termed as fluorescence or phosphorescence), by heat (pyroluminescence), by 
frictional forces (triboluminescence), by electron impact (electroluminescence) or by 
crystallization (crystalloluminescence). In chemiluminescence (CL), the energy is 
produced by a chemical reaction . 1 Chemiluminescence, which is the phenomenon 
observed when an excited product o f an exoergic reaction relaxes to its ground state 
with emission o f  photons, can be defined in simplistic terms: chemiluminescence 
results when chemical reactions emit light . 1 The chemical reaction produces energy 
in sufficient amount (approximately 300 kJmol' 1 for blue light emission and 150 kJ 
mol’ 1 for red light emission) to induce the transition o f an electron from its ground 
state to an excited electronic state. In organic molecules, transitions from a n bonding 
to a n* anti-bonding orbital (n—* n*) or from a non-bonding to an anti-bonding 
orbital (n—> n*) are most frequently encountered, but it is important to note that 
luminescence does not only refer to the emission o f visible light, but electromagnetic 
radiation in general. Return o f the electron to the ground state with emission o f a 
photon is thus called luminescence.
1.2 Categories o f chemiluminescence
1.2.1 Direct chemiluminescence
A direct chemiluminescent reaction takes place in two steps, which can be simplified 
as follows:
Excitation reaction: A + B ->  C*
De-excitation reaction: C*-» C + hv
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The excited molecule C* can be either the final or an intermediate product o f the 
reaction. The excited molecule can also relax to its ground state via dark routes by 
undergoing chemical reactions, collisional deactivation, internal conversion or inter­
system crossing. These non-radiative processes are undesirable from an analytical 
point o f view when they compete with chemiluminescence. The fraction of
molecules emitting a photon on return to the ground state is the quantum yield ( 4 > 
cl ) . It is the product o f three ratios:
^ 01=  4>c • * $ f
where <1> c is the fraction o f  reacting molecules giving a molecule o f  the appropriate
type which relates to the yield o f the chemical reaction; e is the fraction o f such 
molecules formed in an electronically excited state and relates to the efficiency o f  the 
energy transfer process; and <t> f is the fraction o f these excited molecules that return 
to the ground state by emitting a photon. The total efficiency, 4> ci, o f a 
chemiluminescent reaction usually lies in the range o f 1 -2 0 %, but very often can be 
much less than 1 %, while bioluminogenic reactions may have efficiencies o f up to 
100%. The poor efficiency o f chemiluminescent reactions, in most cases, is due to 
low yields o f the chemical reactions or to poor energy transfer, but in some instances, 
the excited molecule is a poor emitter.
1.2.2 Energy transfer chemiluminescence
The addition to the system o f an efficient fluorophore may result in a non-radiative 
energy transfer to the fluorophore which then emits intense light.
Energy transfer step: C* + F —> C + F*
De-excitation reaction: F* -»  F + hv
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The molecule F is a fluorophore, which can also be excited by absorption o f radiation 
(photoluminescence). I f  a molecule does not have the ability to participate in a 
chemiluminescent reaction, it may still be converted into another molecule, which 
does have this property. Alternatively, the molecule can be converted into a 
fluorophore by derivatization. The fluorophore can then be chemi-excited. The 
general requirements for energy transfer chemiluminescence are as follows . 2  (1) The 
molecule C should be capable o f receiving the energy released from the reaction to 
form C* and the efficiency o f this process should be sufficiently high. (2) C* should 
be capable o f luminescing under the conditions of the reaction and the intensity o f 
the radiation should be sufficiently high, and a suitable acceptor molecule, F, capable 
o f accepting energy should be available for accepting the chemi-excitation energy 
and subsequently emitting the radiation. (3) The energy required for excitation must 
be supplied by the reaction in one step, if  possible. In a multi-step reaction, the 
necessary energy must be released in a single step since the excitation step should 
occur instantaneously. (4) The energy required for luminescence in the visible region 
lies between 44 and 71 kcal m ol'1. Hence, a minimum requirement for CL is that the 
reaction produces 44 kcal mol' 1 o f energy . 3 A variety o f organic compounds meet this 
requirement and, in some instances, their chemiluminescent properties have been 
thoroughly studied during redox reactions . 4
The emission characteristic o f the chemiluminescent process is then determined by 
the sensitizer and the efficiency o f the transfer complies with the Forster Law 5
E  =  d '6/  ( d 6 +  Ro)
Where E is the efficiency, d represents the distance between the centres o f the donor 
and acceptor molecules and Ro is given by the equation:
Ro = 9700 (J K2 <i> C| n-4) 1'6
Where J is the spectral overlap integral between donor emission and acceptor 
absorption spectra, K is the orientation factor for dipole-dipole interaction (2/3 for
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random orientation), $  cj is the quantum yield o f the chemiluminescent reaction o f
the energy donor in the absence o f the acceptor, and n is the refractive index o f the 
medium between the donor and the acceptor . 6
1.3 Chemiluminescence systems
There are five classes o f compounds currently used: acylhydrazides (luminol & 
isoluminol), acridinium derivatives, dioxetanes, coelenterazines and peroxyoxalic 
derivatives. Each o f them has advantages well balanced by some drawbacks, with the 
result that none can be definitively preferred to the others in all circumstances.
1.3.1 Luminol, isoluminol and their derivatives
OH
ligh t +
OOH
a -h yd roxyp erox id e
OH
Figure 1.1, the mechanism of CL of luminol and its derivatives
The chemiluminescent mechanism o f luminol derivatives follows the scheme shown 
in figure 1.1. The key intermediate is a a-hydroxyperoxide obtained by oxidation o f 
the heterocyclic ring. The decomposition o f this intermediate depends only on the pH 
of the system and leads to the excited state and light emission. In contrast, the first 
step is strongly dependent on the composition o f the m edium . 7 In aprotic media 
(DMF, DMSO), only oxygen and a strong base are required for chemiluminescence. 
In protic media (water, alcohol) various oxygen derivatives (molecular oxygen, 
peroxides, superoxide anion) can oxidize luminol derivatives but catalysis by an
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enzyme or a mineral catalyst is required . 9  This reaction may be used for 
determination o f all compounds and ions that catalyse the reaction or alter the action 
o f catalysts or produce hydrogen peroxide during a reaction.
The quantum yield o f  luminol does not exceed 5% in D M SO 10 and 1-1.5% in
jj j2
aqueous systems. ’ Isoluminol is far less efficient ( 4> c\ = 0.1%). Attempts to
improve the efficiency have been made in different ways.
It has been shown that structural modifications o f the heterocyclic ring lead to a
2  j 2
complete loss o f  the chemiluminescent properties o f both compounds. ’ On the 
contrary, analogues with substituents in the non-heterocyclic ring are luminogenic. 
Electron-donating substituents are better tolerated in position 5 or 8  than in position 6  
or 7, while electron-withdrawing substituents result in a loss o f the
2 12 13chemiluminescence. ’ ’ Coupling diazoluminol is also unfavourable. Alkylation o f 
the amino group o f  luminol drastically decreases the efficiency, but the same 
modification is favourable for isoluminol (1-2 in figure 1.2). Different chain lengths 
and coupling arms have been investigated . 1 , 14
NHNHNH
NHNHNH
H2N NH
NH2 O
1-2 1-3 1-4
Figure 1.2, structure o f luminol (1-1), isoluminol (1-2), 7V-4-aminobutyl-7V- 
ethylnaphthalhydrazide (1-3), and O-methyluminol (1-4)
Replacement o f the phenyl ring by naphthalene or benzoperylene rings leads to 
interesting series o f molecules. A-4-Aminobutyl-Af-ethylnaphthalhydrazide (1-3 in 
figure 1.2) is about 4 times more chemiluminescent than the corresponding 
derivative o f isoluminol and emits at longer wavelengths (515 nm rather than 420 nm) 
which may prevent quenching or interference from other fluorophores. However, it is 
easily oxidized by air oxygen at the surface o f the solution . 8 , 1 4 , 15 The benzoperylene
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derivative is twice as efficient as the former owing to a remarkable value o f 4>e
The luminol derivative 1-4, which is an imino ether analogue, shown in figure 1.2, is
luminol derivative could release luminol on light irradiation, which would enable it 
to be utilized for novel CL assays. A luminol derivative that releases luminol upon 
light irradiation can measure light power. Luminol-O-2-nitrobenzylate (1-5 in figure 
1.3) has been reported, and its CL characteristics on light irradiation have been 
investigated using an ultra high-pressure mercury lamp. Furthermore, it has been
17applied to measure light power.
not chem ilum inescent . 16 This means that a non-chemiluminescent but photosensitive
o 2n1-5 HO
O
NH2 O
L u m in ol
Figure 1.3, possible photosensitive luminol release mechanism.
1.3.2 Coelenterazine and synthetic derivatives
The structure o f coelenterazine (Rj = J9 -CH 2 C6H4 OH, R 2  = R 3 = R4  = R 5 = H) is 
given in figure 1.4. Coelenterazine, which is the prosthetic group o f  a coelenterate
• 1 8  19 21protein, has been synthesized by several different methods.
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Figure 1.4, the structure o f  coelenterazines
The chemiluminescence o f coelenterazine is triggered by superoxide anion. In 
contrast with luminol, the reaction is very specific and there is no need for catalytic 
removal o f hydrogen peroxide before its determination. Consequently, coelenterazine 
has been proposed as a sensitive and selective chemiluminescent probe for the study
99o f reactive oxygen metabolites released by neutrophiles.
Several synthetic coelenterazine analogues have been prepared . 2 3 , 2 4  CLA (2-methyl-
6-phenyl-3,7-dihydroimidazo[l,2-a]pyrazin-3-one), (figure 1.4, Ri= CH 3 , R2  = R 3 = 
R4  = R 5 = H), and especially the more efficient MCLA probe (2-methyl-6-(4- 
methoxyphenyl)-3,7-dihydroimidazo[l,2-a]pyrazin-3-one) (figure 1.4, R] = CH 3 , R2
9 S 98= R3 = R 5 = H, R4  = OCH 3 ) have been used up to now for monitoring superoxide. 
Some other analogues have been obtained recently. The old and new ones have been 
screened in a comparative study for their superoxide dependent chemiluminescent 
intensity . 2 9  Alkyl substitution at position 5 o f the imidazopyrazinone ring results in a 
decrease o f the luminescence intensity whereas the addition o f a dimethylene bridge 
between position 5 and the phenyl ring bound to position 6  dramatically increases the 
light emission, indicating the potential usefulness o f this type o f compound as a 
probe for superoxide anion. M odification o f the substituent in position 2 has little 
effect on luminescence. Particularly, the introduction o f a propionyl or a 
propanamido group does not affect significantly the chemiluminescence intensity but 
hinders deleterious interactions with bovine serum albumin (BSA) and allows the 
covalent binding o f the compound.
Conjugates to a -  or P-cyclodextrins are water-soluble and the latter is rather 
insensitive to matrix effects. In contrast with the other analogues, its luminescence is
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not increased by hexadecyltrimethyl ammonium bromide (CTAB), probably owing 
to .the inclusion o f the chromophore in the hydrophobic cage o f the cyclodextrin.
Although coelenterazine and its analogues have been widely used for superoxide 
monitoring, the main application o f  these compounds is undoubtedly their use as 
prosthetic groups o f  different photoproteins such as aequorin, obelin, mnemiopsin, 
beroverin and phialidin sensitive to calcium and several other inorganic ions
* • in(lanthanides, barium and strontium but not magnesium). Among these 
photoproteins, aequorin is the best known for immunoassay applications and 
intracellular calcium measurements ’ but these uses are beyond the scope o f  this 
review (bioluminescence).
1.3.3 Dioxetanes
In bioluminescent reactions, 1,2-dioxetanes are well known to be involved as 
intermediates for efficient emission o f light, due to the potentially large energy o f the 
high torsional strain o f the four-membered ring system, its structure is shown in 
figure 1.5. The dioxetanes decompose thermally, chemically, or enzymatically into
IT
two carbonylic compounds, one o f which is in the excited state. There are two 
distinct modes (figure 1.5). The diradical mechanism mainly occurs during thermal 
decomposition. Very high yields o f excited states are obtained but, unfortunately, 
often the predominant are in the Ti state, which is rapidly quenched in aqueous 
solutions and, therefore, o f poor utility in diagnostic applications. Enzymatic or 
chemical decomposition is achieved through a chemically initiated electron exchange 
chemiluminescence (CIEEL) mechanism: a concerted concomitant two-bond 
breaking process leads to an electron redistribution and the formation o f  the two 
carbonylic products. Large Si versus Tj ratios are generally obtained, which makes 
this reaction much more efficient in aqueous solutions. Although these two 
mechanisms seem rather simple, several aspects are still discussed, especially those 
dealing with the rate determining step . 34
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T,
Figure 1.5, the two modes of decomposition of 1, 2-dioxetanes: 1) the diradical mechanism 
and 2) the chemically initiated electron exchange chemiluminescence (CIEEL). The diradical 
mechanism most often generates triplet excited (Ti) while CIEEL generally results in singlet 
states (Si).
1.3.4 Peroxyoxalic derivatives
Several oxalate derivatives are oxidized by hydrogen peroxide giving high-energy 
intermediates. A gaseous intermediate has been isolated from the reaction mixture o f 
oxalate and hydrogen peroxide and used subsequently to produce emission in the 
prescence o f  a fluorescent acceptor molecule. The proposed intermediate is 
dioxetanedione. In contrast with the chemiluminescent compounds cited above, the 
high-energy intermediate produced in this reaction is not fluorescent and, therefore, 
cannot emit light by itself. Light emission occurs through energy transfer to a 
fluorescer, which is excited in a Si state. As for several dioxetanes, a chemically 
initiated electron exchange chemiluminescence (CIEEL) mechanism is involved in the 
luminescent process . 1
Figure 1.6, the structure o f  peroxyoxalic derivatives
From the reaction mechanism, it is evident that the oxalate and the fluorescent 
sensitizer can be chosen independently. This offers flexibility because each partner 
o f the chemiluminescent reaction can be selected either to maximize cpc (oxalate 
derivatives) or to increase (pe and cpf (fluorescer) or to meet the requirements o f the 
assay (aqueous or non-aqueous medium, buffer composition, pH, wavelength o f the 
emitted light, conjugate synthesis). Energy can also be transferred to near infrared 
fluorescent acceptors.
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By coupling the more efficient partners, overall efficiencies as high as 34% have 
been reported. Unfortunately, these results are obtained in non-aqueous solvents 
while the efficiency falls in water or water-solvent mixtures to values typical for 
acridinium or enhanced luminol chemiluminescence. The reaction can be carried out 
even in acidic media but the optimum pH is close to neutrality. Organic acids impair 
the reaction in contrast with weak bases, especially imidazole, which is reported to
• * ^  Shave a catalytic effect through the formation o f 1 , 1 -oxalydiimidazole. y -  
Cyclodextrins are proposed to preserve a minimal efficiency in water by encaging
'Xfsthe reagents in a low polarity microenvironment.
High background is frequently observed in peroxyoxalate chemiluminescence. The 
formation and decomposition o f  chemiluminescent intermediates seems to be 
responsible for this background. This luminescence can be distinguished kinetically 
from fluorophor-induced chemiluminescence and is reduced at high hydrogen 
peroxide-oxalate ratios. Continuous reagent addition has been proposed for 
suppressing background emission.
1.3.5 Acridinium derivatives
The mechanism o f chemiluminescence o f acridinium derivatives has been studied in 
detail by McCapra. ’ The most widely accepted mechanism is presented at figure 
1.7. All intermediates, except the dioxetanone, have been isolated and
TOcharacterized. No catalyst is involved in these reactions. According to the proposed 
mechanism, reversible nucleophilic addition o f the hydrogen peroxide anion to the 
acridinium ester at the 9 position o f the acridine ring is followed by cyclisation with 
cleavage o f the leaving group, which is the rate determining step o f  the reaction 
mechanism. This intermediate then decomposes to produce carbon dioxide and N- 
methylacridone in the excited state. Only hydrogen peroxide and a strong base are 
needed for the chemiluminescence o f acridinium derivatives.
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Probable mechanism
H v-^B
O
Alternative route 1
Alternative route 2 
Figure 1.7, the possible mechanism o f  CL o f  acridinium derivatives
Arylmethylene vV-methyl dihydroacridines have epoxides and open alkylperoxides as 
intermediates in place o f  a dioxetanone 4 1 , 4 2  Lucigenin reacts with peroxide to form a 
dioxetane derivative . 1 Except for lucigenin and arylmethylene iV-methyl
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dihydroacridines, most chemiluminescent acridinium derivatives are constituted o f 
two parts: the acridinium heterocycle and a leaving group X (figure 1.7). Each part 
plays a major role in the light emission. The acridinium heterocycle, after oxidation, 
generates the fluorescer: the excited TV-methylacridone. Unsubstituted N-
methylacridone emits blue light while methoxy substituted N-methylacridone emits 
green light . 4 3  Ring substitution as well as replacement o f the A^-methyl group by an 
alkyl chain terminated by a carbonylmethyl group has little effect on either the 
quantum yield or the chemical stability, but when the carbonylmethyl group is used 
for binding to an analyte, the light emitting entity will remain attached to the
1.3.5.1 Effect o f pH on the chemiluminescence
In the first step o f the reaction mechanism, an equilibrium exists between the 
hydroperoxide anion and the acridinium ester and the first intermediate. Therefore a 
high concentration o f the hydroperoxide anion will encourage the formation o f the 
intermediate. Hydrogen peroxide and the hydroperoxide anion exist in equilibrium
The pKa o f hydrogen peroxide is 12; therefore the reaction medium should have a pH 
higher than 1 2  to maximize formation o f the hydroperoxide anion.
analyte
H 2 0 2 + HOO"
N.
+ OH- RO' O
2
RO' O
Figure 1.8, the dark reactions o f  10-methylacridinium esters:
1, formation o f a pseudobase; 2, base catalysed hydrolysis o f  the ester bond.
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However, The ester bond is prone to hydrolysis at high pH. The acridinium 
derivatives are also in equilibrium with a non-chemiluminescent pseudobase formed 
by hydroxide addition at the 9 position o f the heterocycle, which prevents attack 
form the HCV (figure 1.8). This equilibrium is displaced toward the pseudobase in 
an alkaline medium. Kinetic data related to the pseudobase equilibrium are given by 
Littig: the half life for pseudobase formation is 26 s at pH 9, 8  s at pH 11 and only Is 
at pH 13.40 These are what are known as dark reactions, as they prevent the 
acridinium ester from following the chemiluminescent reaction pathway. This rapid 
conversion o f  acridinium esters to pseudobase requires that care be taken to 
minimize the reagent mixing time prior to observation o f chemiluminescence 
emission. To avoid this reduction in chemiluminescent quantum yield, it is common 
practice to trigger the acridinium chemiluminescence by sequential addition o f a 
solution o f hydrogen peroxide in acidic medium and then a strong base, which 
rapidly increases the pH o f the mixture, initiating the chemiluminescence.
1.3.5.2 Effect o f the leaving group on the chemiluminescence
The pKa o f the conjugate acid o f the leaving group has a determining influence on 
both the chemiluminescence efficiency and the chemical stability. The leaving group 
must have a pKa less than that o f H2 O2 for high yields. Below that critical value, 
light intensity correlates with the pKa o f the leaving group, but very low pKa leads 
to faster hydrolysis . 421 Phenols, thiols, sulfonamides, fluoroalcohols, heterocyclic 
endocyclic amines, hydroxamic and sulfohydroxamic acids, thiolamines as well as 
0-esterfied oximes and chloroximes can be used as leaving groups. Some examples 
are shown in figure 1.9 43, 4 6 0 0  From these compounds, those having a 
sulphohydroxamic acid as leaving group are probably the most chemiluminescent 
acridium derivatives presently known, but the poor synthesis yields (down to 0 .0 1 % 
overall yield) and the complex synthesis and purification process, especially for 
those bearing bulky groups, limit their use in practice . 4 6
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H 3C  h ^CI Jl
c= o c= o c= o
1-18  1 -1 9  1-20
Figure 1.9, structures o f acridinium derivatives bearing leaving groups based on alcohols or 
phenols (1-6), thiols (1-7), sulfonamides (1-8), heterocyclic amines (1-9), hydroxamic acids 
(1-10), sulfohydroxamic acids (1-11), thiolamines (1-12), oximes (1-13) and chloroximes (1- 
14). AE-NHS (1-15), DMAE-NHS (1-16, 1-18), an acridinium derivative giving a long life 
chemilum inescence (1-17), DOMAE-NHS (1-19), DBrAE-NHS (1-20).
A.M. Holland has prepared a series o f acridinium esters with different substituents 
on the leaving group, and reported the effect o f the pKa o f the conjugate acid o f the 
leaving group on the chemiluminescence in his Ph.D thesis . 51 It was shown that the 
quantum yield o f chemiluminescence decreased, as the pKa o f the alcohol or phenol 
leaving group increased. Table 1.1 shows the pKa, chemiluminescent yield and 
reaction rate o f various acridinium esters.
The comparison also showed that the rate o f reaction increased as pKa decreased, 
because the ease o f forming RO’ anion resulting in the ease o f formation o f cyclic 
intermediate (figure 1.7) increased. The increase in pKa also weakens the bond 
between RO and the carbon atom.
These arguments obviously apply to the quantum yield as well as the rate. As the 
product is formed more easily, a greater proportion o f the reactants will form; the 
product and the quantum yield o f reaction will be higher, which will in turn increase 
the overall quantum efficiency o f the chemiluminescence. The quantum efficiency o f 
emission and chemical excitation should not be affected as the excited state product 
is generated in the next step, and therefore would not be influenced by the leaving 
group.
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Table 1.1, the relationship o f  pKa with chemiluminescent yield and rate constant for 
reactions o f various acridinium esters (from reference 51).
Leaving group (ROH) pKa o f ROH <*>c l ( % ) k ( s ' )
4-acetylphenol 8.05 7.74 5.91
4-chlorophenol 9.38 5.85 6.39
2 -naphthol 9.63 5.87 3.16
2-H-perfluoropropan-2-ol 9.30 5.69 2.06
4-methoxyphenol 1 0 . 2 1 4.29 0.17
phenol 1 0 . 0 0 4.82 0 . 6 6
2 ,2 ,2 -trifluoroethanol 12.37 1.25 4.31 xlO ' 3
2 ,2 -dichloroethanol 12.89 0 . 1 0 3 .4 5 x l0 ' 3
2  -methoxy ethanol 14.82 6.48x10'3 3.43x10 ' 3
methanol 15.49 2.85x10'3 3.56xl0~3
The phenoxy leaving groups had no substituents at the ortho positions o f the ring, 
therefore, the attack at the 9 position in each aryl 10-methylacridinium ester had the 
same degree o f  shielding, and only the pKa o f the leaving group was changing. 
Substituents in the ortho position would not only affect the pKa, but would also 
hinder attack at the 9 position, which would affect the rate and probably the quantum 
yield o f the reaction . 51
1.4 History and development
Luminous animals have been known since the ancient Greek civilization, but many 
o f  these are not widely understood, and progress in gaining understanding is not easy 
due to the problems o f collecting sufficient organisms, the low amounts o f material 
and the complexity o f  the molecules. Although most bioluminescence occurs in 
marine organisms, the best known example o f bioluminescence is the firefly, which 
is actually a beetle. Artificial chemiluminescence was first described in 1877 by 
Radziszewski, who observed yellow light emission when oxygen was bubbled into
• • • 52an alkaline ethanolic solution o f 2,4,5-triphenylimidazole (lophine). Fifty years 
later, Albrecht reported the luminescent properties o f 5-amino-2,3-
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dihydrophthalazine-l,4-dione (luminol). Acridinium derivatives were known as 
chemiluminescent molecules since Gleu and Petsch, in 1935, described the blue or 
green light emission o f  bis(A-methylacridinium) nitrate (lucigenin ) . 54 After McCapra, 
in 1964, proposed a mechanism based on the formation o f a dioxetanone cycle for 
explaining the chemiluminescence o f acridinium salts , 55 derivatives o f  dioxetane and 
dioxetanedione (peroxyoxalate) have been prepared and investigated. ’
1.4.1, Luminol, isoluminol and their derivatives
Since the beginning, many catalysts have been proposed for luminol oxidization: 
enzymes such as microperoxidase, myeloperoxidase, horseradish peroxidase, 
catalase and xanthine oxidase; metaloproteins such as cytochrome c, haemoglobin 
especially haptoglobin and deuterohemin; and mineral catalysts such as molecular 
ozone and halogens or persulfate anion or Fe(III), Co(III) and Cu(II) cations as well 
as their complexes. More recently, the bacterial peroxidase from Arthromyces 
ramosus, characterized by a very high turn-over, has been proposed and a hundred 
times increase in sensitivity is claimed. Moreover, many enzymes or enzyme 
mixtures that produce oxygen derivatives as by-products have been involved in 
chemiluminescent detection. Alkaline phosphatase, p-D-galactosidase and p- 
glucosidase in the presence o f indoxyl conjugates as substrates, lactate oxidase, 
acylCoA synthetase and acylCoA oxidase or diamine oxidase produce hydrogen 
peroxide; 3-a hydroxy steroid dehydrogenase or glucose-6 -phosphate dehydrogenase 
release NADH which reduces, in the presence o f  l-methoxy-5-methylphenazinium 
methylsulfate, molecular oxygen to hydrogen peroxide which generates light in the 
luminol microperoxidase system.
Enzyme cycling is another way to increase the light emission. Although the 
chemiluminescence efficiency o f the system and the light intensity are not modified, 
more light is emitted after a long time because the enzyme substrates are 
continuously recycled. Malate dehydrogenase and alcohol dehydrogenase are cycling 
enzymes for NADH while hexokinase and pyruvate kinase have been proposed for 
ATP.
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Nevertheless, the most attractive mode for increasing the sensitivity is certainly the 
use o f chemical enhancers proposed for the improvement o f luminescence catalysed 
by horseradish peroxidase, xanthine oxidase or Co (II).
Carbonate and bicarbonate containing media are more effective for the detection o f 
low peroxidase concentrations . 5 9  The horseradish peroxidase catalysed reaction is 
also enhanced by several phenols, namely 6 -hydroxybenzothiazole derivatives also 
called “synthetic luciferins” or /?ara-substituted phenols (e.g. jp-iodophenol, p- 
hydroxycinnamic acid, /?-phenylphenol, ^-hydroxybiphenyl) . 6 0 "62  Recently, a new 
class o f  enhancers has been proposed: for example, 4-phenylboronic acid is more 
effective than the basic isoenzyme o f horseradish peroxidase (type VI A). It will be 
noted that this last enhancer has been found synergistic with p-iodophenol. 6 4  The 
mechanism o f horseradish peroxidase enhanced chemiluminescence using phenol 
derivatives has been studied by several authors . 6 5 ' 69 Horseradish peroxidase (HRP) 
reacts with hydrogen peroxide to form an oxidized HRP (HRP I) that reacts with the 
anion o f luminol to form a half reduced enzyme (HRP II) and a radical o f luminol. 
The enzyme returns to the reduced form (HRP) by reaction with a second molecule 
o f  luminol. It is suggested that catalytic phenols preferentially form phenoxy radicals 
in contact with horseradish peroxidase and act as electron-transfer mediators to 
increase the efficiency o f luminol radical formation. From chromatographic data, 
Jansen and van den Berg confirmed the increase in rate o f reaction with the enzyme 
but, based on the product formation, they concluded that the mechanism o f
70enhancement is probably different for the various enhancers. Recently, Navas Diaz 
has given an electrochemical explanation o f  the phenomenon: only phenoxy radicals 
having a reduction potential greater than the redox potential o f luminol at pH 8.5 (+
0.8 V) can act as enhancers. They have also correlated the Hammett coefficients o f 
substituents on the phenyl to inhibitory or enhancing effects. Such correlations are o f
71course o f predictive value for development o f new enhancers. Fluorescein has also
77been proposed but acts via a completely different mechanism (energy transfer).
The xanthine oxidase reaction is enhanced by mineral or organic compounds. 
Sodium dithionite increases the emitted light by an unknown mechanism. With 
complexes o f Fe (III) with ethylenediaminetetraacetic acid (EDTA) or better 
HEDTA (V-(2-hydroxyethyl)ethylenediamine-V,V,A/'-triacetic acid), a tremendous
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increase in light emission is observed in buffered solutions containing sodium 
perborate. This increase, due to the formation o f hydroxyl radicals, is unfortunately 
matrix sensitive and consequently o f little practical value, especially in homogeneous
7T 7Simmunoassays. ’ Indeed, the signal is completely lost upon addition o f  urine or 
serum to a final concentration o f 1 %.
Penicillins have been reported to enhance the lum inol-hydrogen peroxide-Co (II) 
system. Owing to a complexation mechanism, the P-lactam antibiotic extends the 
lifetime o f the superoxide anion by a few orders o f magnitude allowing for more
1ftefficient oxidation o f luminol.
Protein Cu (II) complexes have recently been found to be more efficient than Cu (II) 
alone for triggering the luminol peroxide luminescence. The enhancement 
mechanism is not yet elucidated . 77
Surface-active agents generally impair the light emitted by enzyme mediated luminol 
reactions although, at selected concentrations, anionic surfactants can increase the
70 *7Q
rate o f horse radish peroxidase reactions. ’ Nevertheless, the non-peroxidase 
luminol-metal porphyrin chemiluminescence reaction is enhanced by non-ionic or
on
negatively charged detergents.
1.4.2 Dioxetanes
0-0 0 -0OMe
2
1 -221 -21
Figure 1.10 a model 1,2-dioxetanes AMPPD (1-21); adamantyIideneadamantane-1,2-
dioxetane (1-22).
1,2-Dioxetanes, in their earliest developments (1969), were characterized by several 
unpleasant properties: their thermal instability, the quenching o f  the luminescence in 
aqueous solutions and the difficulty o f controlling the luminescence process make 
them rather unsuitable for diagnostic applications but the great dependence o f the Si
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versus T i ratios and the half-life on the molecule substituents prompted researchers
Q I
to look for more stable dioxetanes. " In 1972, Wynberg described the synthesis o f 
the very stable adam antylideneadamantly-l,2 -dioxetane (figure 1.10), characterized 
by a decomposition temperature higher than 160°C and a half-life o f 21 years at
or
25°C. It has been suggested that steric effects could explain the exceptional 
stability o f this derivative. Nevertheless, other large substituents, such as spirobiaryl 
groups destabilize the dioxetane, so no conclusive theory on the role o f steric effects
o 1
is available yet. A few years later, in 1977, McCapra prepared the first 
asymmetrical and sufficiently stable dioxetane: the 9-(2-adamantylidene)-7V- 
methylacridan-1 ,2 -dioxetane (figure 1.11) still emits light —  through the excited 
singlet state o f  A-methylacridone —  after thermal decomposition, and opens the way 
to a new class o f asymmetrical dioxetanes whose luminescence is triggered by 
chemical or enzymatic removal o f a protecting group o f the stable state o f the 
dioxetane.
Sup p ort to  s ta b iliz e  the d io x eta n e
1-23
1—Q
Support to s ta b iliz e  th e  d io x e ta n e  ring
T rigger  and link er part
1 -24
Figure 1.11, the structure o f  substituted dioxetanes.
(3-(2'-Spiroadamantane)-4-methoxy-4-(3"-phosphoryloxy)phenyl-l,2-dioxetane 
(AMPPD, figure 1.10) and (3-(2,-spiroadamantane)-4-methoxy-4-(3"-P-D- 
galactopyrano-yloxy)phenyl-l,2-dioxetane (AMPGD) prepared by Bronstein have 
been widely used. These compounds are substrates o f high turn-over enzymes 
currently used in immunoassays, alkaline phosphatase and P-D-galactosidase 
respectively . 81
Another advance is the introduction o f 4-methoxy-3-spiro(l,2-dioxetane-3,2'-(5'- 
chlorotricyclo-[3.3.1.1.3,7]decan)-4-yl)phenylphosphate disodium salt (CSPD), a 
derivative o f AM PPD . 8 6 , 87
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AMPPD is stable in water solution: its half-life is one year in slightly alkaline 
medium at room temperature. The light emission is simultaneously controlled by the 
kinetics o f the enzymatic deprotection and the destabilized dioxetane decomposition 
with a finite half-life. The result o f  this two-step process is a delay preceding the 
steady-state chemiluminescence which is proportional to the alkaline phosphatase 
concentration. The pH influences the velocity o f both reactions and the maximum 
light emission occurs at pH 9. The chemiluminescence-emitting moiety is the excited
O 1
state o f the methyl 3-hydroxybenzoate anion that emits a glow at 470 nm. CSPD 
and AMPPD react similarly but a higher light intensity and a shorter delay to reach 
the steady-state are claimed using CSPD. The chlorination o f the adamantane moiety 
o f AMPPD, which minimizes the aggregation o f CSPD and its dephosphorylated 
anion by altering their amphiphilic nature, could explain the best properties o f  this 
new molecule . 86
AMPGD has the same behavior as AMPPD except for the deprotection that is carried 
out at lower pH 7.5. At this pH, the phenol is in the protonated form (pKa o f  the 
phenol = 9) and, therefore, is a slow emitter: raising the pH above 10 produces light. 
It will be noted that it is possible to switch the light on and o ff by shifting the pH in 
the range 7— 12. 81 ’ 88
As for the other chemiluminescent emitters, dioxetanes and especially emitters based 
on the (3-(2'-spiroadamantane)-4-methoxy-4-(3"-hydroxyphenyl)-l ,2-dioxetane
anion (AMPPD and AM PGD) and its chlorinated derivative (CSPD) are more 
efficient (3-400 times) when they are protected from proton quenching in solutions 
containing large proteins (BSA) or surfactants (CTAB ) . 8 1 ’ 88
Indirect chemiluminescence is also possible with the dioxetanes. A very hydrophobic 
derivative o f a fluorescer (5A-tetradecanoylaminofluoresceine) can be included in the 
micelles o f  the surfactant CTAB (Lumi-Phos™ ) or the fluorescer itself can be 
conjugated to the AM PPD analogues by substituting the methoxy at the 4 position on 
the dioxetane ring . 88
The decomposition o f adam antylideneadamantyl-l,2-dioxetane has been induced by 
a photo-excited rare earth m etal . 89
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M cCapra reported that thermal decomposition o f the dioxetane 1-23 produced 10- 
methylacridone with light emission, but dioxetane 1-23, was too unstable to be 
practically handled . 9 0  Hoshino in 1997 91 synthesized the compound, dioxetane 1-24, 
shown in figure 1.11, which has an acridane structure as an excellent luminophore 
moiety, the adamantyl and acetate groups as stabilizer o f the dioxetane ring, and the 
acetate as a trigger for smooth decomposition o f the dioxetane by rapid generation o f 
the acetate anion on alkaline treatment. The thermal stabilities and chemiluminescent 
properties o f dioxetanes 1-24 having various substituents (R) were also described.
1.4.3 Acridine derivatives
The first compound that drew attention to the chemiluminescence o f acridinium 
compounds was lucigenin, 10,10,-dimethyl-9,9’-biacridinium nitrate, which in 1935 
was reported to react with alkaline peroxide to emit blue green light . 54  A mechanism 
was proposed for this reaction which is similar to the one for the chemiluminescent 
reaction o f the acridinium esters, and is shown in figure 1.12.
HOO,
Figure 1.12, the mechanism for chemiluminescent reaction o f lucigenin
In the 1960’s, further attention was given to acridinium compounds, and several 
additional compounds were reported to be chemiluminescent, which included 9- 
cyano-10-methylacridinium nitrate and 9-cyano-10-methylacridan. In the following 
years, other chemiluminescent reactions o f acridinium compounds were reported,
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which included 9-chlorocarbonyl-10-methylacridinium chloride, 9-benzoyl-10- 
methylacridinium methanesulfonate and 9-carbonylmethoxy-10-methylacridinium 
iodide. All the compounds reacted to form 10-methylacridone as the emitter in the 
chemiluminescent reaction. In the 1970’s, substituted phenyl 10-methylacridinium 
esters were synthesized, but little further research was carried out on this group o f 
chemiluminescent compounds until analytical applications were developed.
Figure 1.13, the mechanism o f  chemiluminescence o f 9-cyano-l O-methylacridinium nitrate
and 9-cyano-10-methylacridan
The first acridinium ester label, which has a succinimidyl moiety as the reactive 
group for coupling to proteins reported was the 9-(4-(2-succinimidyl- 
oxycarbonylethylphenoxy)-l O-methylacridinium triflate (AE-NHS, 1-15), shown in
Q9figure 1.9. AE-NHS does not show the best quantum yield and is not very stable, 
especially at room temperature, although its stability is increased after coupling to an 
analyte. More efficient compounds have been found in the thiol, sulfonamide, 
hydroxamic acid, oxime and chloroxime series . 4 6 - 4 7  Thiol and sulfonamide
QTderivatives are often five times more luminogenic than AE-NHS. A remarkable 
characteristic o f  sulfonamide derivatives is that the improvement in efficiency is not 
associated with a loss o f  stability: on the contrary, several compounds are much more 
stable than AE-NHS. No significant loss o f efficiency has been observed even after
4 8one year at room temperature. Compounds combining stability and efficiency were
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also found in the oxime and chloroxime series. Some oxime derivatives have 
intrinsic stability while, up to now, chloroxime derivatives are only stable after 
coupling .4 6 , 4 7  Attempts to improve the stability in the phenol family have led to the 
development o f analogues o f AE-NHS with the leaving group substituted by 2,6- 
dimethyl, 2,6-dimethoxy, and 2,6-dibromo groups (2-18, 1-19, 1-20 respectively) 
shown in figure 1.9.50, 9 4  Recently, Santelli-Rouvier prepared 9-acridinyl sulfur 
derivatives: sulfides, sulfoxides and sulfones, 23 compounds in total and their 
structure are shown in figure 1.14.95 And Miyashita9 6  reported oxiranes having an 
acridane structure as a novel chemiluminescent precursor, shown in figure 1.15.
R'-
s—R
su lfid es
?(0)„
-R"
R'- T— R"
su lfo x id e s  and su lfo n e s
Figure 1.14 the structures o f 9-acridinyl sulfer derivatives
Figure 1.15, a chemiluminescent precursor
Generally, acridinium derivatives emit light as a short flash within 5 seconds or less 
after triggering the chemical reaction. Nevertheless, slower or faster emission rates 
have been observed after modification o f the acridinium ring as well as after 
substitution o f the leaving group. In the phenol series, methylation o f the acridinium 
ring slows the kinetics o f light emission. Electron-withdrawing groups introduced 
into the phenyl ring increase both efficiencies and reaction rates while electron 
donating groups have the opposite effect. Hydrolysis rates are also affected by 
substituents o f both the phenyl and acridinium rings. A parallelism is often observed 
between the effects on hydrolysis and chemiluminescent reactions because both 
involve nucleophilic attack, the sites o f which are only one carbon apart. 
Nevertheless, the relative magnitude o f  the effects can differ greatly from one
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compound to another and, in some cases, increased stabilities can be associated with 
fast emission properties. Steric hindrance could explain these characteristics since 
most o f the compounds exhibiting this stability are substituted in the ortho position 
o f the phenol by bulky groups (methyl) or atoms (Br) while the same substitution in 
another position is not efficient from this point o f view . 9 7  Recently, substitution of 
the phenyl ring by alkylcarboxamido groups has led to unexpected results: the 
luminescence efficiency is unaffected but the kinetics o f the emission and the rate o f 
hydrolysis are strongly dependent on the position o f the substituent. To our 
knowledge, the para  substituted alkylcarboxamido derivatives are the slowest 
emitters described up to now in the acridinium series (duration ^  60 s) . 9 8
Large excesses o f  various nucleophilic reagents (hydroxide, thiolate and sulfite ions) 
attack acridinium carboxylate derivatives at the carbon bearing the carboxy group. 
The adducts formed with thiols or sulfite are more stable than the corresponding 
native compound but the chemiluminescent properties are lost. The 
chemiluminescence is slowly recovered after dilution with water (sulfite) or after 
reagent removal by 2,2'-dipyridyldisulfide (thiols). Formation o f adducts has been 
proposed for long term storage o f unstable acridinium conjugates . 9 9  By reaction with 
hydroxide ion, a non-luminogenic pseudobase is reversibly obtained. Before 
triggering the chemiluminescence, the equilibrium has to be displaced to the 
acridinium by reaction with an acid (HNO 3 , HC1) . 9 9 ’ 100
Epinephrine in cationic surfactant micelles containing periodate has been reported to 
increase the luminescent signal o f lucigenin . 101 A patent has described methods for 
enhancing the chemiluminescent signal o f an acridinium ester, in a chemiluminescent 
reaction in the presence o f an enhancer selected from the group consisting of: (a) a 
cationic surfactant; (b) a nonionic surfactant; and (c) a sulfated primary alcohol (d)
1 A-}
zwitterionic surfactants, and (e) anionic surfactants.
1.5 Applications
In the last few years, several papers dealing with new chemiluminescent compounds 
and more than 1500 per year dealing with applications in immunoassay and
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biomedical research have been published. Although significant improvements o f 
noise and sensitivity, new developments in multi-analyte analysis and homogeneous 
immunoassays, advances in selectivity o f coupling and triggers are expected in the 
near future, chemiluminescence has already become an essential tool in routine 
analysis.
Acylhydrazides like (iso)luminol are still the most frequently used chemiluminescent 
compounds in immunoassays and in oxygen metabolism studies partly because they 
can be used for different kinds o f assays, but they need a catalyst for light emission 
and an enhancer to be competitive in terms o f sensitivity. This can result in higher 
background signals.
Acridinium derivatives have high quantum yields even after easy coupling to 
proteins. As they do not need catalysts, background signals are low and high 
sensitivities are frequently obtained. The instantaneous light emission, which has 
been considered in the past as a disadvantage (measuring problems), allows high 
rates in automated analyzers.
The dioxetanes used for diagnostic applications are enzyme triggered dioxetanes. As 
for acridinium derivatives, low background signals are observed. Moreover, 
dioxetanes exhibit a prolonged light emission but they need a rather long period o f 
time before reaching a constant signal. This last feature represents an unwelcome 
added incubation time in immunoassays.
Coelenterazine and its analogues are essentially used in association with catalytic 
proteins such as apoaequorin. Used alone, it is a specific luminogenic reagent for 
superoxide anion.
In the presence o f  a fluorescer, oxalate derivatives are the most efficient non- 
biological emitters. Fluorescers and oxalates are chosen independently. Efficiency 
and flexibility are therefore the main advantages o f this system. Non-resolved 
problems o f water solubility and stability added to a loss o f efficiency in water 
certainly explain the little success o f peroxyoxalate chemiluminescence in 
immunoassays and biomedical applications.
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1.5.1 Applications in immunoassay
Immunoassay takes advantage o f the properties o f a group o f molecules called 
antibodies that are involved in the acquired immune system o f mammals. In response 
to the invasion o f a substance that is alien to the system, the 5-lym phocytes produce 
antibodies. This alien material is termed the antigen, as its presence initiates the 
production o f antibodies. An antibody will specifically bind to one antigen. A 
labelled antigen (Ag*) is introduced into the sample, which competes with the 
antigen in the sample for the antibody, and the amount o f antigen-antibody complex 
is related directly to the amount present in the blood. Or, the antibody is labelled, and 
the complex, which is now labelled, can be separated and assayed. This is an area in 
which chemiluminescent compounds provide many advantages over the existing 
radioactive compounds that are currently used.
Immunoassay has a wide range o f applications, as an antigen can be a range o f 
substances, such as hormones, therapeutic drugs, illegal drugs (e.g. heroin or an 
anabolic steroid) and pathogens (e.g. salmonella, HIV). Therefore it can provide 
information o f direct value to doctors, such as the identification and location o f 
tumors or the identification o f infections, and it can also be used to follow drug 
therapy. It can be used in veterinary medicine, agriculture, forensic medicine and the 
food industry.
There are two classes o f assays that use this principle: immunoassay and 
immunometric assay. The first immunoassay used radioactive iotopes, such as I, 
so the classes were referred to as radioimmunoassay and immunoradiometric assay, 
but fluorescent and chemiluminescent assays are also used, which are naturally 
called fluorescent immunoassay and chemiluminescent immunoassay respectively.
The first class, radioimmunoassay (RJA), conventionally uses a labelled antigen and 
unlabelled antibody, usually at a concentration that will produce about 50% binding 
o f the labelled antigen. Unlabelled antigen will also bind to the antibody, and will 
compete, as there is a limited amount o f antibody. As the amount o f unlabelled 
antigen increases, the amount o f free unlabelled antigen will increase. The bound
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antigen is separated from the free antigen, and a standard curve can then be produced, 
plotting counts against concentration.
After reaching the equilibrium in the immunoassay, it is necessary to separate the 
free antigen from the antigen-antibody complex. This can be achieved by attaching 
the antibody to a surface, such as the surface o f the tube the reaction takes place in, 
or glass or plastic beads, and a variety o f other complexes. After the reaction, the free 
antigen can be removed by washing.
The second class, immunoradiometric assay (IMRI), always uses labelled antibodies, 
and is a non-competitive assay. Large amounts o f the labelled antibodies are used to 
push the equilibrium over to the right, then the excess free antibody is removed, and 
the remaining bound antibody is measured.
Addition o f  a solid phase antigen can be used to separate the free antibody from the 
complex, and either the activity o f the complex or the free antibody can be measured. 
IMRA is a lot more sensitive than RIA, and can used to cover a wide range o f 
analyte concentrations (pM  o f marker proteins and drugs to pM o f free hormones), 
but RIA is still used.
Luminol, isoluminol and their analogues have been extensively applied in 
immunoassays. Because the oxidation o f luminol derivatives has to be catalysed, 
antigen or antibody labelling with either the catalyst or the luminogenic substrate has 
been investigated and heterogeneous immunoassays in various formats (direct or 
indirect detection in competitive or non competitive mode) as well as homogeneous 
immunoassays have been proposed. In an excellent review, Rongen have listed more
] 03than 60 immunoassays from different classes. Recently Kricka has given a review 
of chemiluminescence in clinical application . 104 In recent years, enzyme labelled 
immunoassays using enhanced luminol detection have been proposed for the 
detection or the determination o f fentanyl, 105 DDT (1,1,1 -trichloro-2,2-bis(p- 
chlorphenyl)ethane, one o f the most widely used organochlorine pesticides) and 
related compounds , 106 human serum albumin , 107 immunoglobulin E serum levels , 108 
2,4-dichlorophenoxyacetic acid , 109 ferrocene and eleven o f  its derivatives , 1 10
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prostaglandin E2 (p-iodophenol enhancer) , 111 endothelin , 112 antibodies 113, proinsulin 
114, human chorionic gonadotrophine |3-subunit in broad range using 
microsampling , 115 and free thyroxine . 1 16 A sensitive non-enhanced chemiluminescent 
assay based on glucose oxidase for human granulocyte colony stimulating factor (G- 
CSF) is also described . 117
Acridinium esters and their analogues are widely used in immunoassay as well as
luminol and its derivatives. Recently, detections o f vitellogenin have been described 
118 120by Fukada and Soh ' in five salmonid species and in fish meal. Silvaieh has 
developed an enantioselective sequential-injection chemiluminescence immunoassay 
for a-am ino acids, 3,3',5-triiodothyronine (T3 ) and thyroxine (T4 ) .121' 123 Leidy 
described the detection o f somatostatin in unextracted rat plasm a , 124 and rat growth
1 1 ^
hormone-releasing hormone. A ’ In Schmidt-Gayk’ s group, competitive 
immunoassay has been used for immunoglobulin A 127 and lysozyme in faeces . 128  
Other immunoassays have been reported for detection o f human cardiac troponin 
I , 129 for glucose oxidase activity and alkaline phosphatase amplification cascade , 130
1 3 1for estradiol based on hapten heterology, for intact human proinsulin and its
137conversion intermediates, for studying the kinetics o f production and consumption
] 33or degradation o f human interferon-y, for the sensitive measurement o f 
apolipoprotein B 1 0 0 , 134 and so on.
In the acridinium series, only lucigenin has been used for non-immunoassay 
applications, namely for specific quantification o f  cellular superoxide anion response
135 117after oxidative stress. " Although chemiluminescent isomers o f acridinium and 
related heterocycles (phenanthridinium and isoquinolinium) have been claimed more 
than 1 0  years ago, no applications have been found in the medical literature . 138
1.5.2 Applications in nucleic acid assay
Acridinium compounds reveal their best capabilities in labelling DNA strands to 
produce chemiluminescent DNA probes. Indeed, after inclusion into the groove o f a 
DNA double helix, acridinium labels show increased stability toward hydrolysis and 
no more reactivity with nucleophilic thiols and sulfites. Various non-separative
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determinations are based on these properties, which have also been exploited for 
the very accurate determination o f hybridization rate constants and thermodynamic 
affinities o f oligonucleotide probes binding to simple synthetic targets as well as to
1 OQ
complex biological targets. Multianalyte determinations based on different decay 
kinetics o f several acridinium derivatives have been made using DNA probes, 
although these methods could probably be applied for labelled antibody based 
assays . 1 40 In 1989, Arnold developed several hybridization assay formats involving 
acridinium ester labelled DNA probes , 141 in which target sequences in the 10' 16 to 10’ 
17 mol L ' 1 range can be detected; when rRNA is the target, this translates to 3000 to 
300 bacterial organisms. The entire assay can be carried out in < 30 min. This is the 
first homogeneous DNA probe to be o f practical use in the clinical laboratory, and it 
represents a major simplification o f hybridization formats. This enhances assay 
sensitivity about 10-fold, to a range o f 10’ 17 to 10’ 18 mol L"1 o f  target. Highly 
sensitive hepatitis C virus RNA detection methods have been described by Sarrazin, 
in which RNA amplicons are detected by a hybridization protection assay with 
amplicon-specific acridinium ester labelled DNA probes . 142 The acridinium ester 
labelled oligonucleotides hybridize to the RNA amplicons. As the RNA amplicons 
are not immobilized within the reaction tube, unhybridized acridinium ester labelled 
probes cannot be easily washed out but have to be deactivated. This is performed by 
addition o f alkaline reagent. The unhybridized acridinium ester labelled probes are 
hydrolyzed at high pH, while the hybridized probes are protected from degradation 
and thereby retain the chemiluminescent label.
1.6 Advantages o f acridinium esters as chemiluminescent labels
There are various problems associated with radioactive isotopes, and therefore 
chemiluminescent compounds were developed as an alternative. There are several 
important features o f  this system.
1 When a sample containing a typical acridinium ester bound to an antibody is 
reacted with hydrogen peroxide and base, the acridinium ester detaches itself from 
the antibody and forms excited A-methylacridone. Therefore the chemiluminescence 
should not be affected. If the acridinium compound were bound to the antibody via 
another route, for example via the nitrogen o f the acridinium ring, the antibody
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would remain attached during chemiluminescence and this might affect the 
chemiluminescence. However, with the Woodhead-Weeks label, the nature o f  the 
biological molecule does not interfere with the chemiluminescence, since attachment 
is via the phenolic part o f the phenolic ester.
2 With the modifications that have been made to the phenoxy component o f the label, 
the stability o f  some labels is greater than that o f  labels that use radioactive isotopes.
1 9 <
I is often used as the radioactive isotope and it releases high-energy particles that 
can damage the antibodies, and therefore reduce the shelf life o f the label. The 
chemiluminescent labels however can be stored for a long time without a loss in 
sensitivity.
3 There are also health hazards presented by using radioactive isotopes. Iodine 
accumulates in the thyroid gland, and a high concentration o f radioactive isotopes 
increases the risk o f cancer. Although the acridinium esters are suspected to be 
carcinogenic, they pose a much lower risk than radioactive isotopes.
4 The acridinium ester chemiluminescent labels are very sensitive (detection limit o f 
1 - 1 0  amol -  10' 17 -  10' 18 mol L '1), being more sensitive than 3H isotope and as 
sensitive as l25I isotope . 143
5 Radioactive isotopes are expensive to use. The health hazards dictate that 
expensive safety standards have to be met, and the isotopes are costly to buy. 
Acridinium esters, in the small quantities that are required, are very cheap.
1.7 Improvements to the model label
Generally, a typical model acridinium ester label is composed o f three parts, emitter, 
spacer and linker, illustrated in figure 1.16. There are several problems that this 
model label presents, and there are areas in which improvements could be made.
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Figure 1.16, a model acridinium ester lab e l92
1.7.1 Changes to the phenol ring50,51,94
The simple model acridinium ester, shown in figure 1.16, is susceptible to hydrolysis, 
reducing the stability o f the label in solution. This makes the label unsuitable for 
some commercial applications, but there have been modifications made to the label 
that have improved its stability. The introduction o f substituents at the ortho position 
on the phenyl ring provides shielding from hydrolysis.50, 51 In addition to labels 
derived from 2 ,6 -dimethyl phenol, which are sufficiently stable for more commercial 
uses, a variety o f other ortho substituted phenol derivatives have been produced.
The chemiluminescence reaction is carried out at high pH, which can present a 
problem when using some biological molecules, as they are not stable at high pH. By 
substitution o f electron-withdrawing groups to decrease the pKa o f the leaving group, 
the reaction rate can be improved so that the reaction can be carried out at lower 
pH . 51
1.7.2 Changes to the acridinium ring94, 144, 145,146
The emitter in the chemiluminescent reaction is 10-methylacridone, and the only 
changes that will affect the wavelength o f the emitted light are changes to the 
acridinium ring. I f  acridinium ester based systems could be developed which emitted 
light at different frequencies, multi-analyte systems could be developed. However,
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substituents on the acridinium ring can also affect the kinetics and stability o f  the 
acridinium ester, in a similar way to modifications to the phenoxy ring.
2,7-Dimethoxy acridium derivative was prepared by Li, and also l,8-dichloro-2,7- 
dimethoxy acridinium compound was produced . 9 4  They have reduced efficiency, 
possibly due to the heavy atom effect. Additionally, fluorophores could be linked to 
the acridinium ring via the nitrogen or at other parts o f the ring. This would allow the 
energy to be transferred to the fluorophore, producing light o f  different wavelengths.
1.7.3 Changes to the spacer and the positions of the linkers
Patel described the use o f energy transfer for detecting antibody and antigen.147An 
antigen was labelled with a chemiluminescent compound (a luminol analogue), and 
its corresponding antibody with a fluorescent molecule (a fluorescin analogue). In 
the absence o f  binding to antibody, the emission detected in a luminometer 
corresponds to a wavelength characteristic o f the chemiluminescent molecule. Upon 
immune complex formation between the antigen and the antibody, the doner/acceptor 
pair is sufficiently close for energy transfer, and the emission characteristics o f the 
fluorescent acceptor were seen.
The energy transfer occurs between chemiluminescent emitter (labels) and energy 
acceptor (quencher) labels as means o f monitoring complementary nucleic acid 
binding reactions. Typically, efficient quenching occurs when the distance between 
the emitter and the quencher is o f the order o f 1 0  nm or less, so the spacer may have 
some effect on the quenching possibly.
In this thesis, a series o f AEs possessing a linker and spacer bonded to the N atom 
(position 1 0 ) o f the acridinium ring, instead o f  to the leaving group, have been 
reported. Their stabilities and chemiluminescent kinetics have been investigated.
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Chapter 2
Synthesis of 9-(dibromophenyl) 
10-methyl, 10-dodecyl and 10-(co- 
succinimidyloxycarbonylalkyl)- 
acridinium carboxylates
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2.1 Introduction
9-(2,6-Dibromophenoxycarbonyl)-10-(3-succinimidyloxycarbonylpropyl)acridinium 
iodide (figure 2.1, n = 3, Y = I) was synthesized successfully by Li in Smith’s group, 
and has been called LiAE for short, in honour o f L i’s excellent work. LiAE has 
shown interestingly properties with potentially useful applications. When it attaches 
to an oligonucleotide fragment via a linker group bonded to the acridinium nitrogen 
atom, and then takes part in a chemiluminescent reaction, the luminescent moiety 
remains attached to the oligonucleotide and doesn’t drift into solution. Consequently, 
energy transfer from the luminescent moiety to a quencher that was itself associated 
with the oligonucleotide should be more reliable than with a similar label linked via 
the phenolic moiety. This could result in both a higher quantum yield o f energy 
transfer and a lower background luminescence from the doner A-alkylacridinium 
moiety.
However, as reported by Li, the synthesis o f  LiAE is both tedious and low yielding, 
giving a yield o f less than 3% overall. Furthermore, it is possible that the relatively 
short spacer group between the linker moiety and the luminescent moiety might 
result in oligonucleotide-bound products having diminishing luminescent 
performance. For these reasons, it was o f interest to synthesize the range o f novel 
labels with different lengths o f spacers (figure 2.1, n = 3, 5, 10).
Y -  (C H 2)nC - 0 - N
Figure 2.1, the structure o f LiAE and desirable novel labels with aN H S  linker group
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A new compound (figure 2.1, n = 3, Y = CF3 SO3 ) was designed, which differs from 
LiAE only in the nature o f the counter anion Y \ This is not expected to have any 
significant effect on the properties o f the luminescence. However, it would be 
derived from an alkyl triflate rather than the corresponding iodide, and the triflate is 
expected to be a more reactive electrophile. Therefore it may be easier to obtain
9-(2,6-dibromophenoxycarbonyl)-10-(3-succinimidyloxycarbonylpropyl)acridinium 
trifluoromethanesulfonate in a better yield than had proved to be the case for 
synthesis o f the corresponding iodide derivative. Another 2 compounds (figure 2.1, n 
= 5 or 10 respectively, Y = CF3 SO3 ) were designed so that the effects o f different 
lengths o f  spacer groups can be investigated.
It was clear that the synthesis o f novel labels with a NHS linker group, would require 
the expenditure o f considerable time and effort. However, it was possible that the 
expected benefits might not be realizable, either because the alkyl triflates did not 
react as expected with AE or because the presence o f a long chain alkyl group on the 
nitrogen might adversely affect the luminescent properties o f the product. Therefore 
before attempting the syntheses o f derivatives with a linker and a spacer (figure 2.1), 
it was decided to investigate the synthesis o f a simple model compound without a 
linker (figure 2.2), w hich would show up any difficulties o f the types listed. The 
dodecyl derivative (9-(2,6-dibromophenoxycarbonyl)-10-dodecylacridinium triflate 
was chosen because it has only one functional group, without the distractions from 
other functional groups, and it has a relative molecular mass similar to the 
succinimidyloxycarbonylpropyl group (figure 2.1, n = 3), and a length o f carbon 
chain similar to succinimidyloxycarbonyldecyl group (figure 2.1, n = 10). The 
availability o f  dodecyl derivative (9-(2,6-dibromophenoxycarbonyl)-10- 
dodecylacridinium triflate, would also allow a comparison between it and the simple 
methyl compound, 10-methyl AE (section 2.2.2). Therefore, the first compound to be 
synthesized would be dodecylated AE, and the experience gained was intended to be 
applied in the synthesis o f  other derivatives shown in figure 2.1 (n = 3, 5, 10, Y = 
CF3SO3).
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2.2 Results and discussion
2.2.1 The scheme for synthesis o f 9-(2,6-dibromophenoxycarbonyl)-10- 
dodecylacridinium trifluoromethanesulfonate (1)
There are 4 steps involved in the synthesis o f  9-(2,6-dibormophenoxycarbonyl)-
1 0 -dodecylacridinium trifluoromethanesulfonate (1 ): (i) substitution o f dodecyl 
iodide with silver triflate to form dodecyl triflate (la); (ii) conversion o f 
acridine-9-carboxylic acid to the corresponding acid chloride (lb )  with SOCb; (iii) 
coupling o f lb  with 2 ,6 -dibromophenol to give 2 ,6 -dibromophenyl 
acridine-9-carboxylate (lc); (iv) coupling o f la  with lc  to give compound 1.
lb
lc
OH
I(CH2)„ C H 3 + A gS 03CF3 ------   CF3S 0 3(CH2)] ,CH3
la
1
Figure 2.2, the synthetic pathway for compound 1
2.2.1.1 Synthesis o f dodecyl triflate1 (la )
The proposed synthesis o f dodecyl triflate is illustrated in figure 2.3. Silver triflate
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does not dissolve in DCM or other common solvents except for benzene and toluene. 
According to the literature, the reaction o f dodecyl iodide with silver triflate was 
accomplished by stirring in benzene for 23 h . 1 Therefore the reaction was carried out 
under similar conditions, and its progress was checked by TLC. A by-product, a 
yellow precipitate o f  A gl, was produced, and its precipitation may have helped drive 
the reaction to completion. The resulting mixture was extracted with DCM and then 
chromatographed on a silica column to remove the triflic acid produced by 
hydrolysis. The purified product obtained showed a triplet peak at 4.57 ppm in the 
*HNMR spectrum, which was attributed to the CH2  protons next to the 
trifluoromethanesufonyloxy group. If the dodecyl triflate was hydrolyzed, the typical 
peak at 4.57 ppm disappeared, and in its place, a new triplet at 3.42 ppm appeared. 
By monitoring these two peaks, the percentage o f decomposition could be calculated. 
The percentage o f decomposition during the reaction and chromatography are shown 
in table 2.1 (note: Five parallel reactions were conducted under the same conditions 
and then chromatographed on different solid phases and with different eluents 
separately). Due to the toxicity o f benzene, the reaction was tried in toluene instead 
and a similar result and yield was obtained, so toluene could be an alternative 
solvent.
B enzene or toluene
I(C H 7) ,,C H 3 +  A g S 0 3C F 3 ------------------ ► C F 3S 0 3(C H 2) )1C H 3
r.t., 18 h
la
Figure 2.3, the synthesis o f  dodecyl triflate ( la )
From the results in table 2.1, it is clear that chromatography on silica, eluted with 
DCM provided material o f reasonable purity. Therefore this method was used to 
produce a sample o f compound la  for use in the later stages o f  the synthesis o f 
compound 1.
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Table 2.1, the percentage o f  decomposed triflate on the column chromatography.
Solid phase / mobile phase Hexane Hexane+ether (2:1) ether DCM
Neutral alumina 1 0 0 % 60.8% 62.0% 15.6%
Silica gel Less than 10%
2.2.1.2 Synthesis o f acridine-9-carboxyIic acid chloride (lb )
The acridine-9-carboxylic acid chloride (lb ) was synthesized according to a 
procedure (Figure 2.4) in the literature . 2 - 4  Acridine-9-carboxylic acid hydrate was 
suspended in excess thionyl chloride and refluxed. About 1 h later, the mixture 
turned clear, after which, the reflux was maintained for a further 1 h. The mixture 
was stripped o f  excess thionyl chloride to provide a bright yellow solid. IR revealed 
the absence o f  a band at 3500 cm"1. The yield should be more than 90% according to 
the literature, but the amount obtained was not recorded. Instead the compound lb  
was used in the next step without further purification.
SOCI2
Reflux, 2 h
OH
lb
Figure 2.4, the synthesis o f acridine-9-carboxyIic acid chloride (lb)
2.2.1.3 The synthesis of 2,6-dibromophenyl acridine-9-carboxylate (lc )
The 2,6-dibromophenyl acridine-9-carboxylate was synthesized by using 
acridine-9-carboxylic acid chloride and 2,6-dibromophenol suspended in pyridine, 
according to a literature procedure . 2 "7 The temperature was raised to 70 °C to dissolve 
the starting materials. And then the mixture was stirred vigorously at room 
temperature for 20 h (figure 2.5). The resulting mixture was chromatographed on
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silica, eluted with toluene (Tol) + EtOAC = 4:1. The fractions with R f = 0.49 were 
combined, and the solvents were evaporated under vacuum to give a pale yellow 
solid which was re-dissolved in DCM and washed with aqueous NaOH (O.lmol L '1) 
solution to remove the 2,6-dibromophenol (R f value 0.43). The pure product was 
obtained in 54% yield. Its 'HN M R spectrum showed 3 doublets and 3 triplets in the
1 3aromatic region, integrating in a ratio 2:2:2:2:2:1. In the CNMR spectrum, there 
were 12 peaks, while the starting material (lb) has only 8  different carbon atoms. A 
peak in the IR spectrum at 1747 cm’1, which was typical for such an ester, and in the
70  RImass spectrum, a molecular ion for the product at m/z 457 ( Br Br isotope peak) 
corroborated the product structure.
Pyridine
r.t, overnight
lc
OH
Figure 2.5, the synthesis o f 2,6-dibromophenyl acridine-9-carboxylate (lc)
2.2.1.4 Synthesis of 9-(2,6-dibromophenoxycarbonyl)-10-dodecylacridinium  
trifluoromethanesulfonate8 (1)
In order to investigate the best conditions for synthesis o f
9-(2,6-dibromophenoxycarbonyl)-10-dodecylacridinium trifluoromethanesulfonate 
(1), the reaction shown in figure 2.6 was carried out separately in toluene and 
1,2-dichloroethane (DCE) at different temperatures for different lengths o f reaction 
time. Then volatiles were evaporated under vacuum and the resulting mixtures were 
separately extracted with chloroform-d for recording a ’HNMR spectrum to calculate 
the crude yield in each case. The crude yield was obtained by using the ratio o f  peak 
integrals in the ]HNM R spectrum at 5.58 ppm and 8 >= 7.40 ppm, then multiplying 
by 11/2 and 100 to give the result as a percentage. The crude product was purified by
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the method developed by Dr. Li for synthesis o f LiAE , 4 involving removal o f the 
solvent, dissolving the product in DCM, precipitating with diethyl ether, removing 
the solvent with a pipette, and then repeating the re-dissolving and re-precipitating 
procedure again and again until a pure product was obtained. The results are shown 
in table 2.2. Reflux in DCE for 30 h afforded the best yield. Although the crude yield 
calculated by the 'HNM R spectrum, was as high as 31%, the pure product obtained 
was far less, just 19%.
solvent, reflux
+ CF3S 0 3(CH2) 1 ,CH3
1
Figure 2.6, the synthesis o f 9-(2,6-dibromophenoxycarbonyl)-10-dodecylacridinium
trifluoromethanesulfonate ( 1)
Table 2.2 the results o f  synthesis o f  compound 1 in different conditions
Solvent Reaction
time
The amount o f reactant 1 The amount of 
dodecyl triflate
Yield, / 
crude
Toluene 3 h 52.5mg, 0.115mmol 50mg, 0.157mmol 8.0%
DCE 10.5 h 83.0mg, 0.182mmol lOOmg, 0.314mmol 12.0%
DCE 31 h 119mg, 0.260mmol 70mg, 0.220mmol 31.0%
DCE 31.5 h 74.8mg, 0.164mmol 80mg, 0.252mmol 30.6%
In the 'HNM R spectrum o f the product, the 3 doublets and 3 triplets in the aromatic 
region integrating for 1 1  protons were at lower field compared with those in the 
'HNM R spectrum o f 2,6-dibromophenyl acridine-9-carboxylate (lc). There was a 
typical peak at 5.58 ppm attributed to the 2 protons o f the CEL group next to the N 
atom and 25 protons in the aliphatic region in total were found. The mass spectrum 
showed one cation at m/z 626 ([M-CF3 S0 3 ]+ for 7 9 Br81Br isotope peak), another at
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m/z 392 (figure 2.7), and an anion at m/z 149 ([CF3 SO3 ]'). In the 13CNMR spectrum, 
a peak at 53.0 ppm attributed to the CH 2 group close to the acridinium ring further 
corroborated the structure o f the product.
(CH2),,C H 3
(CH ,)„CH
m/z, 392
m/z, 626, 79Br8lBr peak
Figure 2.7, MS fragments for compound 1
2.2.2 Synthesis o f 9-(2,6-dibromophenoxycarbonyI)-10-methyIacridinium  
trifluoromethanesulfonate (2)
The synthesis o f compound 2 was performed by stirring 2,6-dibromophenyl 
acridine-9-carboxylate ( lc ) and methyl triflate in dried DCM at room temperature for
2 73 h, as illustrated in figure 2.8. ' Because the product has a poor solubility in DCM, 
while the solubility o f the starting material is good, the product could be isolated by 
filtration and followed by washing with diethyl ether. In the 1FINMR spectrum, the 3 
doublets and 3 triplets in the aromatic region integrating for 11 protons and a singlet 
at 6.05 ppm integrating to 3 protons attributed to the methyl group bonded on the N
1 o
atom were found. In the CNMR spectrum, a peak at 162.8 ppm for the carbonyl 
group and 40.9 ppm for the carbon atom o f the methyl group were found. In the 
19FNMR spectrum, a peak at -79.3 ppm showed the presence o f CF3 SO3 ' group. The 
IR spectrum showed a strong absorption at 1760 cm"1. The mass spectrum showed 
cations at m/z, 472 ([M-CF3 SC>3]+ for 7 9Br81Br isotope peak) and 193 (figure 2.9), 
and an anion at m/z 149 ([CF3 SO3]’).
Chapter 2 51
CH-.
CF-SO
DCM, r. t
+ CF,SO,CH,
3 h, N 2
Figure 2.8, synthesis o f 9-(2,6-dibromophenoxycarbonyl)-10-methylacridinium
trifluoromethanesulfonate (2)
CFU
m/z, 472 (79Br81 Br peak)
m/z, 193
Figure 2.9, MS fragments for compound 2
2.2.3 The scheme for synthesis o f 9-(2,6-dibromophenoxycarbonyI)-10- 
(3-succinimidyIoxycarbonyIpropyl)acridinium iodide (LiAE, 3)
Compound 3 (LiAE) was synthesized successfully by Li. 4 In order to improve the 
yield, the reaction was conducted by using 2 ,6 -dibromophenyl 
acridine-9-carboxylate ( lc ) and succinimidyl 4-iodobutanoate (compound 3a) under 
different conditions. Compound 3a was in turn synthesized by condensing 
4-iodobutyric acid and Af-hydroxysuccinimide using the dehydrating agent 
dicyclohexylcarbodiimide (DCC).
2.2.3.1 Synthesis o f succinimidyl 4-iodobutanoate (3a)
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The succinimidyl 4-iodobutanoate (3a) was synthesized by using
dicyclohexylcarbodiimide (DCC), as illustrated in figure 2.10.2"4 The reaction
in dry THF at 0 °C for 3 h, followed by continued stirring at room temperature 
overnight. Some white precipitate, dicyclohexylurea (DCU), was produced. The 
precipitate was removed by filtration, and the filtrate was evaporated and then 
chromatographed on a silica column, eluted with Tol + EtOAC. The fractions with R f 
= 0.48 were combined and evaporated to give a yellow solid in 84% yield.
The 'HN M R spectrum showed 2 triplets, 1 quintet and 1 singlet integrating to a ratio 
o f 2:2:2:4. In the 13CNMR spectrum, two peaks at 169.4 and 168.0 ppm were found 
for the 3 carbons o f  the ester and amide carbonyl groups. The IR spectrum showed 
absorptions at 1739 (ester) and 1657 cm ' 1 (amide). The mass spectrum showed the 
molecular ion peak at m/z 311 and another ion at m/z 197.
/V-hydroxysuccinimide and 4-iodobutyric acid together with
mechanism was thought to be as shown in Figure 2.11. The reaction was performed
o o
I— (CH2)3C— o — N
r. t., overnight, N2
OO 3a
Figure 2.10, synthesis o f succinimidyl 4-iodobutanoate (3a)
R'A oh+ 0 - n=C=n< 3
NHIc= o
NH
Figure 2.11, the mechanism o f  esterification by DCC dehydration
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2.2.3.2 Synthesis of 9-(2,6-dibromophenoxycarbonyI)-10-
(3-succinimidyloxycarbonylpropyI)acridmium iodide (LiAE, 3)
Different attempts at the synthesis o f LiAE were performed by heating compounds 
3a and lc  in different solvents, at different temperatures and for different lengths o f 
time, separately. Firstly, the starting materials were heated at 120 °C in nitrobenzene 
for 2 h under N 2 . TLC showed a spot different from the starting materials, and a 
chemiluminescent test o f  the mixture gave out a quick and strong greenish blue flash, 
which proved the presence o f the acridinium salt (desired product), because the
2,6-dibromophenyl acridine-9-carboxylate itself emits chemiluminescence too slowly 
to be seen by the naked eye. To the resulting mixture, diethyl ether and petroleum 
ether were added to precipitate the product. Some dark brown oil precipitated, but 
unfortunately, TLC showed that it was a mixture. Because o f the small scale o f the 
reaction and low yield, no pure product was obtained. Nitrobenzene maybe is a 
suitable solvent for the reaction, but its removal was difficult because o f its high 
boiling point (210-212 °C), thus, limiting some ways for purification. The reaction 
was also tried in DMF and in diethylene glycol diethyl ether (DGDE), however, no 
pure product was obtained in either case, for the same reasons. Under Dr. L i’s 
guidance, the reaction was tried with the two starting materials without solvent at 
150 °C for 0.5 h under nitrogen. The pathway is illustrated in figure 2.12. The 
mixture turned dark brown after heating. The product was extracted from the 
resulting mixture with acetonitrile, and then precipitated with diethyl ether. The 
precipitate was washed with ethyl acetate again and again, until TLC showed 
absence o f  starting materials, to give a brown-red product. The whole synthesis and 
purification procedure is illustrated in figure 2.13.
The.residue after separation o f the LiAE was evaporated under vacuum. It could be 
reused for the same reaction. The synthesis o f LiAE using the recycled starting 
materials gave a result similar to the original reaction. After this recycling, a yield 
(3%) in total was obtained. The 1HNMR spectrum o f the LiAE looked good, but the
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product had a deeper dark colour than the previous sample, and its solubility in 
acetonitrile decreased. Possibly, other side reactions occurred under the prolonged 
high temperature conditions, and the side product had a bad solubility and a dark 
colour. It was tedious to purify LiAE by washing with solvent many times and part o f 
the product was washed away in the process. Therefore, column chromatography was 
used to purify LiAE. The extract with acetonitrile was loaded onto a mini silica gel 
column for chromatography. A gradient mobile phase was assumed. First, Tol + 
EtOAc (4:1) was used to wash through the starting materials, 2,6-dibromophenyl 
acridine-9-carboxylate (R f = 0.49) and succinimidyl 4-iodobutanoate (R f = 0.48); 
and then EtOAc + CH 3 CN (2:1) was employed to wash out a bright yellow band. The 
'HN M R spectrum showed that it was not the desired LiAE, but its isomer, as 
reported by Dr. Chen. There is an equilibrium between LiAE and its isomer, shown 
in figure 2.14. Due to the loss o f  the positive charge, the acridine ring protons 
resonated at high field in the ’HNMR spectrum.
0 .5  h
lc
3
I— (CH2)3C— o — N
Figure 2.12, synthesis o f  LiAE (3)
In the ’HNM R spectrum, 3 doublets and 3 triplets in the aromatic region and 4 
peaks in the aliphatic region integrating in a ratio o f 2:2:2:2:2:1:2:2:2:4 were found. 
A typical triplet at 5.33 ppm was attributed to the CH 2 group bonded to the N atom 
and a singlet at 2.69 ppm was attributed to the 4 protons o f the succinimidyloxy 
moiety. Due to the low yield and small scale, the amount o f product was not big
1 Tenough for a CNM R spectrum; and no IR spectrum or mass spectrum were
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recorded either.
150°C 0.5h, N :
extracted with CELCN
solution precipitate
for recycle
precipitate with EtOEt
solutionprecipitate
washed with EtOAC or DCM repeatedly
solid
s t a r t i n g  m a t e r i a l s
s o l u t i o n
Starting materials
L i A E .  s t a r t i n g  m a t e r i a l s
resulting mixture
and s ma l l  a m o u n t  o f  L i A E
Figure 2.13, outline for synthesis and purification o f LiAE (3)
Figure 2.14, the suggested equilibrium between LiAE and its isomer
2.2.4 The scheme for synthesis o f 9-(2,6-dibromophenoxycarbonyl)-10- 
(3-succinimidyIoxycarbonylpropyl)acridinium trifluoromethanesulfonate (4)
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Alkyl triflates are expected to be more reactive than the corresponding iodides for 
attacking the N atom o f the acridine ring. Therefore, compound 4 (figure 2.1, n = 3, 
Y = CF3SO3) was designed. The steps involved in the synthesis o f compound 4 
included substitution o f succinimidyl 4-iodobutanoate (3a) to form the succinimidyl 
4-(trifluoromethanesulfonyloxy)butanoate (4b). Compound 4b was coupled with lc  
to give the product, compound 4.
2.2.4.1 Synthesis of succinimidyl 4-(trifluoromethanesulfonyloxy)butanoate1 
(4b)
The succinimidyl 4-(trifluoromethanesulfonyloxy)butanoate (4b) was synthesized by 
stirring silver triflate and succinimidyl 4-iodobutanoate (3a) in benzene under 
nitrogen for 23 h, as illustrated in figure 2.15. Upon the contact o f the starting 
materials at room temperature, a yellow precipitate appeared immediately. 
Succinimidyl 4-(trifluoromethanesulfonyloxy)butanoate was purified according to 
the method used for purifying dodecyl triflate (la )  (section 2.2.1.1). The resulting 
mixture was stripped o f solvent, taken up in DCM, and chromatographed to remove 
the precipitate (Agl) and triflic acid produced by hydrolysis o f silver triflate. The 
fractions with R f = 0.25 were combined and evaporated under vacuum to leave a 
white solid in 47% yield. In the 'HN M R spectrum, a typical triplet at 4.57 ppm was 
attributed to the protons next to the trifluoromethanesulfonyloxy group, while the 
corresponding protons next to iodide for compound 3a resonated at 3.22 ppm. In the
1 o
CNMR spectrum, the peak at 75.3 ppm was attributed to the carbon next to the 
trifluoromethanesulfonyloxy group, while the corresponding carbon o f compound 
3a gave a peak at 42.4 ppm. Although the mass spectrum did not show any desired 
peak in a good abundance, the successful use o f the product in the next step proved it 
was the desired compound.
Chapter 2 57
Q
Benzene
+ CF3S 0 3Ag
r. t, 23 h
O'
4b
O'
Figure 2.15, the synthesis o f succinimidyl 4-(trifluoromethanesulfonyloxy)butanoate (4b)
10-(3-succinimidyIoxycarbonylpropyI)acridinium trifluoromethanesulfonate
LiAE’ (4) was synthesized by using 2,6-dibromophenyl acridine-9-carboxylate and 
succinimidyl 4-(trifluoromethanesulfonyloxy)butanoate under different conditions, 
as illustrated in figure 2.16. The product was isolated by the same method used for 
isolating LiAE. Firstly the conditions for synthesis o f  compound 1 (A-dodecyl 
derivative) were applied to synthesis o f  LiAE’; the starting materials were refluxed 
in 1,2-dichloroethane (DCE) for 23 h under N 2 . However, the product was obtained 
in less than 1% yield. Compound 4b is not so reactive as compound la  as expected, 
the reaction temperature should therefore be raised, and the solvent should be 
changed. The reaction was therefore conducted in nitrobenzene and DGDE 
separately. Unfortunately, due to the high boiling points and high viscosity o f these 
solvents, the purification method used for LiAE did not work very well in these cases. 
When the reaction was performed in /?-xylene, however, a good yield was obtained. 
Although the ]HNM R spectrum showed the proton integrals were in a good ratio, the 
product had a black color and bad solubility in acetonitrile, possibly because the 
product was not pure and the impurity had a black colour and did not dissolve in 
acetonitrile. The solvents used for syntheses o f compounds 1 and 2 were both chloro 
substituted, so the reaction was carried out in 1,1,2,2-tetrachloroethane (TCE), which 
has a boiling point as high as 147 °C, but not so high that it can not easily be 
removed under vacuum. The starting materials were heated in TCE at 140 °C for 4 h 
under N 2 . Then the product was isolated in a way similar to that used to purify LiAE.
2.2.4.2 Synthesis of 9-(2,6-dibromophenoxycarbonyI)-
(LiAE’, 4)
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LiAE’ was obtained in 7% yield with an expected yellow color and a better solubility 
in acetonitrile. The results are listed in Table 2.3. Compound 4 was characterized by
1 ITHNMR, IR and mass spectrometry, but not by CNMR because o f the limited 
amount. Because the product differs from LiAE only in the counter anion, it gave a 
same 'HN M R spectrum as LiAE (3).
?
f3 C 0 3 s —  (CH2)3C- o — n  
4b
lc
c f 3s o :  (c h 2)3c - o - n .
solvent
4
Figure 2.16, the pathway o f synthesis o f LiAE’ (4)
Table 2.3, the results o f synthesis o f LiAE’ (4) under different conditions.
Solvents Reaction time & 
temperature
The amount of 
compound lc
The amount of 
compound 4b
Yield
(isolated)
p-xylene 4 h, reflux 126 mg, 0.28 mmol 140 mg, 0.42 mmol 6.0%
p-xylene 6.75 h, reflux 91 mg, 0.20 mmol 81 mg, 0.24 mmol 5.0%,
DCE 23 h, reflux 101 mg, 0.22 mmol 106 mg, 0.32 mmol 0.9%,
nitrobenzene 3.5 h, 150 °C 75 mg, 0.25 mmol 84 mg, 0.25 mmol 2.4%
DGDE 4 h, 150 °C 56 mg, 0.12 mmol 41 mg, 0.12 mmol Nearly 0
TCE 2 h, 140 °C 62 mg, 0.14 mmol 57 mg, 0.17 mmol 7%
2.2.5 The scheme o f synthesis of 9-(2,6-dibromophenoxycarbonyI)-
10-(5-succinimidyloxycarbonylpentyl)acridinium trifluoromethanesulfonate (5)
The synthesis o f 9-(2,6-dibromophenoxycarbonyl)-10-
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(5-succinimidyloxycarbonylpentyl)acridinium trifluoromethanesulfonate (5) was 
carried out in a synthetic pathway similar to that used for compound 1 by using 
compound lc  and succinimidyl 6 -(trifluoromethanesulfonyloxy)hexanoate (5c). The 
synthetic pathway is illustrated in figure 2.17. However, unlike in the analogous 
synthetic pathway to compound 4, the iodo compound, 6 -iodohexanoic acid (5a), 
was not commercially available, so a step for synthesis o f 6 -iodohexanoic acid (5a) 
was added. Condensing compound 5a with 7V-hydroxysuccinimide gave 
succinimidyl 6 -iodohexanoate (5b). Compound 5b was converted into the 
corresponding triflate, compound 5c, which would couple with lc , affording the 
final product.
Br(CH2)5COOH ](CH2)5COOH
5a
l(CH2)5C— O N
5b
CF3S 0 3(CH2)5C— O N
5c
c f 3s o 3 (CH2)5C - 0 - N
5
Figure 2.17, the synthetic pathway for 9-(2,6-dibromophenoxycarbonyl)-10- 
(5-succinimidyloxycarbonylpentyl)acridinium trifluoromethanesulfonate (5)
2.2.5.1 Synthesis of 6-iodohexanoic acid (5a)
The synthesis o f 6 -iodohexanoic acid (5a) was achieved by stirring 6 -bromohexanoic 
acid and sodium iodide in dry acetone under N 2  overnight, as illustrated in figure 
2.18. The starting material Nal is soluble in acetone, but the by-product NaBr is not, 
so the reaction would be driven to completion. The resulting mixture (brown solution 
with white precipitate) was poured into water, and extracted with diethyl ether. The 
combined extracts were washed with saturated Na2 S2 C>3 to remove the yellow colour,
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dried over MgSC>4 , filtered and evaporated. The crude product was chromatographed, 
eluted with ether + hexane + formic acid ( 1 :1 :0 .0 1 ) according to a method in the
Q
literature. The fractions with R f = 0.38 were pooled and evaporated to give 
snow-white flakes, the product could be purified further by recrystallization in 
hexane: ether (9:1). When the reaction was not protected by N 2 , the saturated 
Na2 S2 C>3 couldn’t remove the yellow colour completely. However, although the 
product obtained had a yellow colour, the 'HNM R spectrum did not give any peaks 
o f the yellow impurities. In the lHNMR spectrum, the typical triplet at 3.12 ppm 
attributed to the protons next to the iodide was found, while for the corresponding 
protons o f the starting material, 6 -bromohexanoic acid, the chemical shift was 3.45
1 "3ppm. No peak for the carbonyl group was found in the CNMR spectrum because 
the signal was too weak, but in the IR spectrum, a strong absorption at 1703 cm '1, 
attributed to the carbonyl group, was found. In the negative ion mass spectrum (ES"), 
an anion at m/z 483 for the dimer o f the product having lost 1 proton, and another at 
m/z 241 for the molecular anion having lost 1 proton were found.
A cetone, N 7
Br (CH2)5COOH + Nal ---------------^  I (CH2)5COOH + NaBr
overnight, r.t.
5a
Figure 2.18, the synthesis o f 6-iodohexanoic acid (5a)
2 72 .1 .5.2 Synthesis of succinimidyl 6-iodohexanoate ' (5b)
The synthesis o f succinimidyl 6 -iodohexanoate was performed by using DCC as 
dehydration initiator, as shown in figure 2.19; the mechanism is shown in figure 
2.11 in section 2.2.3.I. The procedure was carried out in a way similar to that used 
for synthesis o f compound 3a. Compound 3a (section 2.2.3.1) could be purified by 
chromatography, but this was not the case for succinimidyl 6 -iodohexanoate (5b). 
The ’HNMR spectrum o f the product after chromatography showed that there were 
extra peaks in the high field region, attributed to DCU. The product was therefore 
further purified by recrystallisation. In its 'HNM R spectrum, there were 2 triplets, 1 
singlet and 3 multiplets integrating in a ratio 2:4:2:2:2:2. A triplet at 3.13 ppm was
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attributed to the CH 2 group next to the iodide, another one at 2.57 ppm was attributed 
to the CH2 group next to the ester bond; a singlet at 2.78 ppm was attributed to the 
succinimidyloxy moiety, where there was not such a peak in the ’HNM R spectrum o f 
com pound 5a. The I3CNMR spectrum showed peaks at 169.5 and 168.8 ppm 
attributed to the 3 carbons o f the carbonyl groups, 26.0 ppm for the carbons o f the 2 
CH 2 groups o f the succinimidyloxy moiety and another 5 peaks for the other 5 
carbons o f the 5 different CH2 groups. The IR spectrum showed an absorption at 
1738 cm"1. The Cl mass spectrum showed a desired peak at m/z 357 for the cation 
resulting from the whole molecule plus ammonium.
0  THF, 0 °C, 3 h
I— (CH2)5C O H  + HO— | ------------------ ► 1— (CH2)5C O -N
r. t., overnight, N2
5b O
Figure 2.19, the synthesis o f succinimidyl 6-iodohexanoate (5b)
o
THF, 0°C , 3 h
Br(CH2)5COOH + H O ~N  |  ** Br— (CH2)5C - 0 - N
r. t., overnight, N2
n0  5b'
0 ,
O
Acetone, Nal ||
-----------------► 1— (CH2)5C - 0 - N
4 h, N 2
Figure 2.20, an alternative synthetic pathway for succinimidyl 6-iodohexanoate (5b).
Compound 5b could be synthesized via an alternative route, as shown in figure 2.20. 
Succinimidyl 6 -bromohexanoate (5b’) was synthesized by condensing 
6 -bromohexanoic acid and 7V-hydroxysuccinimide, and then the bromo atom was 
substituted with iodide, which was accomplished by stirring in acetone with Nal. 
Reasonable proton positions and perfect proton integrals in the ]HNM R spectrum
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verified the structures o f succinimidyl 6 -bromohexanoate and succinimidyl 
6 -iodohexanoate.
2.2.5.3 Synthesis o f succinimidyl 6-(trifluoromethanesulfonyloxy)hexanoate1 (5c)
The synthesis o f succinimidyl 6 -(trifluoromethanesulfonyloxy)hexanoate (5c) was 
firstly tried by using succinimidyl 6 -bromohexanoate (5b’) and silver triflate, as 
illustrated in figure 2.21, because if  the Br atom o f 5b’ could be substituted with the 
CF3 SO3 group, 1 step (section 2.2.5.1) for synthesis o f 5c would be saved. The 
reaction was carried out under similar conditions as for synthesis o f compound 4b. 
The resulting mixture was passed through a silica column to remove the triflic acid. 
The 'HN M R spectrum showed that the desired triplet at 4.57 ppm attributed to the 
protons next to the CF3 SO3 group was very small, but showed a strong triplet at 3.45 
ppm which was attributed to the protons next to the bromo atom o f the starting 
material. Based on the proton integrals at 4.57 and 3.45 ppm in the 'HNM R spectrum, 
the crude yield was calculated. Only 1% o f the starting material was converted to the 
desired product. The bromo substituted compound is not so reactive for this type o f 
reaction as the corresponding iodo compound, because the iodide is a better leaving 
group than bromide during the substitution.
Br— (CH2)5C— O—N
Q.
CF3S 0 3Ag, Benzene ||
---------------------------► CF3S 0 3(CH2)5C— o — N
r. t, 18 h
5c
X
Figure 2.21, an attempt to convert compound 5b’ to 5c
Succinimidyl 6 -iodohexanoate (5b) was used for the synthesis o f 5c. Compound 5b 
and silver triflate were stirred in benzene under nitrogen for 18 h, under similar 
conditions to those for synthesis o f  la  and 4b (section 2.2.4.2), as illustrated in 
figure 2.22. The resulting mixture was chromatographed (silica, eluted with DCM).
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The fractions with R f = 0.28 were combined and evaporated under vacuum to give a 
white gel. The presence o f  a small amount o f impurities with R f = 0.38 changed the 
colour o f the product to brown, and made the gel a liquid. So when the product 
became liquid on standing, or became brown in colour, it was passed through a silica 
column again; otherwise, the impurity would affect the synthesis at the next stage. 
The freshly prepared triflate (5c) was more reactive than after standing for 1 or 2 
days. In the 'H N M R spectrum, the triplet for the protons next to the CF3 SO3 group 
was found at 4.45 ppm, and the integrations for all protons were in good ratio, 
2:4:2:2:2:2. In the l3CNMR spectrum, 2 peaks at 169.5 ppm and 168.6 ppm were 
attributed to the 3 carbons o f the 2 different carbonyl groups and a peak at 77.4 ppm 
for the carbon atom next to the CF3 SO3 group was found. The IR spectrum showed 
the strong absorption o f the carbonyl group at 1736 cm '1. However the mass 
spectrum did not show the expected molecular ion. Nevertheless, the successful use 
o f the compound in the next step proved it was the desired compound.
Figure 2.22, synthesis o f  succinimidyl 6-(trifluoromethanesulfonyloxy)hexanoate (5c) 
2.2.5.4 Synthesis of 9-(2,6-dibromophenoxycarbonyl)-10-(5-succinimidyl-
o
oxycarbonylpentyl)acridinium trifluoromethanesulfonate (5)
Compound 5 was synthesized under conditions similar to those used for compound 
1 (section 2.2.1.4), by refluxing 2,6-dibromophenyl acridine-9-carboxylate (lc )  and 
succinimidyl 6 -(trifluoromethanesulfonyloxy)hexanoate (5c) in redistilled DCE for
21.5 h, as illustrated in figure 2.23. The product was then separated by the same 
method used for purifying LiAE.
In the 'H N M R spectrum, 3 doublets and 3 triplets were found in the aromatic region 
and 5 peaks in the aliphatic region, integrating in a ratio o f 2:2:2:2:2:1:2:4:2:2:4. A
+ CFjSOjAg CF3S 0 3(CH2)5C— O— N
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triplet at 5.70 ppm was attributed to the protons o f the CH 2  group linked to the N 
atom, while a singlet at 2.88 ppm was attributed to the succinimidyloxy moiety. The 
peaks for the acridinium ring appeared from 9.07 ppm to 8.13 ppm, while the 
chemical shifts for the acridine ring o f compound lc  were at a relatively high field, 
from 8.73 to 7.61 ppm. In the I3CNMR spectrum, 3 peaks at 169.8, 168.9 and 161.5 
ppm were attributed to the 4 carbons o f the 3 different carbonyl groups; there were 
peaks in the aromatic region, and a typical peak at 52.6 ppm for the carbon o f the 
CH 2 group linked to the N atom, and a peak at 26.0 ppm for the succinimidyloxy 
moiety. The IR spectrum showed a strong absorption at 1734 cm"1, which was lower 
than typical signals for comparable ester carbonyl groups (for compound lc , the IR 
signal o f the ester carbonyL group was at 1754 cm"1); and higher than typical signals 
for comparable amide carbonyl groups. It seemed that the IR signals o f the 3 
carbonyl groups partly overlapped and showed only one strong absorption. The mass 
spectrum showed cations at m/z 669 ([M-CF3 S0 3 ]+ for the 7 9Br81Br isotope peak) 
(figure 2.24), and an anion at m/z 149 ([CF3 SO3]"), corroborating the structure o f the 
product.
O '^ ^ O  + CF3S 0 3(CH2)5C— o — N
5
Figure 2.23 the synthesis of 9-(2,6-dibromophenoxycarbonyl)-10- 
(5-succinimidyloxycarbony]pentyl)acridinium trifluoromethanesulfonate (5).
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o o
(CH2)5C— o — t
o
m/z, 669 (79Br8lBr peak)
Figure 2.24, MS fragment for compound 5.
2.2.6 The scheme for synthesis of 9-(2,6-dibromophenoxycarbonyl)-
10-(10-succinimidyloxycarbonyldecyl)acridinium trifluoromethanesulfonate (6)
The synthesis o f compound 6 was carried out in a synthetic pathway similar to that 
used for compound 5 (section 2.2.5). 11 -Bromoundecanoic acid was converted to
1 1 -iodoundecanoic acid (6a), which was esterified with 7V-hydroxysuccinimide to 
form succinimidyl 11-iodoundecanoate (6b). The iodide group o f compound 6b was 
then substituted with a trifluoromethanesulfonyloxy group to provide the 
corresponding triflate, compound 4c, which was coupled with compound lc  to give 
the final product (6 ).
2.2.6.1 Synthesis of 11-iodoundecanoic acid (6a)
The synthesis o f 11-iodoundecanoic acid was carried out by stirring
1 1 -bromoundecanoic acid and sodium iodide in acetone under N 2 overnight, as 
illustrated in figure 2.25, under similar conditions to those used to synthesize 
6 -iodohexanoic acid (5a).9 The resulting mixture was poured into water and extracted 
with diethyl ether, the combined extracts were washed with saturated Na2 S2 C>3 to 
remove the yellow colour, dried over MgSC>4 , filtered and evaporated. The crude 
product was recrystallized in hexane + ether = 9:1. In the 'HNM R spectrum, a typical
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triplet at 3.12 ppm attributed to the CH 2 protons next to the iodide was found, while 
for the corresponding protons o f the starting material, its chemical shift was 3.45 
ppm. Unlike compound 5a, the signal for the carbon o f the carbonyl group at 179.9
1 Tppm was strong enough to be seen in the CNMR spectrum. The IR spectrum 
showed a strong absorption at 1693 cm"1. The Cl mass spectrum showed the desired 
pseudo molecular ions at m/z 313 ([M+H]+) and 330 ([M+NH 4 ]+).
Acetone, N ,
Br (CH2)10COOH + N al I (CH2)i0COOH + NaBr
r.t, overnight
6a
Figure 2.25, the synthesis o f 11-iodoundecanoic acid (6a)
2.2.6.2 Synthesis of succinimidyl 11-iodoundecanoate (6b)
Succinimidyl 11-iodoundecanoate (6b) was synthesized by stirring
11-iodoundecanoic acid and TV-hydroxysuccinimide in dry THF at 0°C for 3 hours,
• 7 7then at room temperature overnight, as illustrated in figure 2.26. " The resulting 
mixture was filtered to remove DCU, and then followed by chromatography and 
recrystallization in a similar way as used for compound 5b in section 2.2.5.2. White 
flakes were obtained in 65% yield. In the ]HNMR spectrum, a singlet at 2.81 ppm for 
the succinimidyloxy group and another 6  peaks integrating in the ratio 4:20 were 
found. In the 13CNMR spectrum, peaks at 169.5 and 169.0 ppm were attributed to the 
3 carbons o f 2 different carbonyl groups. The IR spectrum gave a signal at 1725 cm"1. 
The mass spectrum (Cl) showed a peak at m/z 427 ([M+NR*]*).
o
0  VL THF, 0°C, 3 h, N2 {?
I— (CH2) ,oC -O H  + HO—N I  ► I— (CH2) 10C— o — N
r. t., overnight
6b
Figure 2.26, synthesis o f  succinimidyl 11-iodoundecanoate (6b)
2.2.6.3 Synthesis of succinimidyl ll-(trifluorom ethanesulfonyloxy)undecanoate1 
(6c)
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Succinimidyl 11 -(trifluoromethanesulfonyloxy)undecanoate (6c) was synthesized by 
stirring silver triflate and succinimidyl 1 1 -iodoundecanoate (6b) in benzene under
similar to those used for compound 4b in section 2.2.4.2 and compound 5c (section
2.2.5.3). In the 1HNMR spectrum, a peak at 4.44 ppm for the protons next to the 
triflate group was found, and there were 7 peaks in a proton-integrating ratio o f 
2:4:2:2:2:2:10. In the I3CNMR spectrum, peaks at 169.6 ppm and 169.0 ppm were 
attributed to the 3 carbons o f the two different carbonyl groups. A signal at 78.1 ppm 
for the carbon atom next to the CF3 SO3 group was found, while for the 
corresponding iodide compound (6b), the signal for the corresponding carbon was 
found at 7.6 ppm. The appearance o f only one peak at -74 .8  ppm in the 19FNMR 
spectrum corroborated the structure o f the product. The IR spectrum showed the 
absorption o f carbonyl groups at 1736 cm '1, but the mass spectrum did not show the 
desired molecular ion peak as with other triflates. The instability o f  the triflate group 
was possibly responsible for this. The successful use o f the product in the next step 
proved it was the desired compound.
Figure 2.27, the synthesis o f  succinimidyl 11 -(trifluoromethanesulfonyloxy)undecanoate (6 c)
Compound 6 was synthesized by a pathway similar to that used for compound 5 
(section 2.2.5.4), by refluxing 2,6-dibromophenyl acridine-9-carboxylate (lc )  and 
succinimidyl 10-(trifluoromethanesulfonyloxy)undecanoate (6c) in DCE for 21 h
comparison reasons. The synthesis is illustrated in figure 2.28. The product (6) was
nitrogen for 18 h, as illustrated in figure 2.27.1 the product was purified in a way
benzene, N 2
6c
2.2.6.4 Synthesis o f 9-(2,6-dibromophenoxycarbonyI)-10-
(lO-succinimidyloxycarbonyldecyl)acridinium trifluoromethanesulfonate8 (6)
under N 2 . The reaction was also carried out separately in TCE at 140°C for 4 h for
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separated according to the method developed by Li, washing the crude product with 
DCM and ether. The reaction conducted in TCE at higher temperature gave a slightly 
higher yield. However, the product showed a brown colour, which deepened on 
standing.
DCE, reflux, 21 h
■q + CF3S0 3 (CH2)ioC O— N
or (TCE, 140 °C, 4 h)
6
Figure 2.28, the synthesis o f 9-(2,6-dibromophenoxycarbonyl)-10- 
(lO-succinimidyloxycarbonyldecyl)acridinium trifluoromethanesulfonate (6)
In the 'HNM R spectrum, 3 doublets and 3 triplets in the aromatic region were found 
and 7 peaks in the aliphatic region integrating in a ratio o f 2:2:2:2:2:1:2:4:2:2:2:2:10. 
A triplet at 5.47 ppm was attributed to the protons o f the CH 2 group linked to the N 
atom, while a singlet at 2.65 ppm was attributed to the succinimidyloxy moiety. The 
peaks for the acridinium ring appeared from 8.84 ppm to 7.58 ppm, while the 
chemical shifts for the acridine ring o f compound lc  were at a relatively high field, 
from 8.73 to 7.61 ppm. In the l3CNMR spectrum, 3 peaks at 169.7, 169.1 and 161.5 
ppm were attributed to the 4 carbons o f the 3 different carbonyl groups; there were 
11 peaks in total in the aromatic region, and a typical peak at 52.9 ppm for the carbon 
o f the CH2 group linked to the N  atom, and a peak at 26.0 ppm for the 
succinimidyloxy moiety. The IR spectrum showed a strong absorption at 1728 cm-1, 
which was lower than signals from the ester carbonyl groups and higher than signals 
from the amide carbonyl groups. It seemed that the IR signals o f  the 3 carbonyl 
groups partly overlapped and showed only one strong absorption. The mass spectrum 
showed cations at m/z 793 and 739 ([M-CF3 SO 3] +) (figure 2.29), and an anion at 
m/z 149 ([CF3 SO3]"), corroborating the structure o f the product. 19FNM R gave only
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one peak at -78 .2  ppm.
oo
II
(CH2) 10C - O — n
o'
m/z, 739 (79Br8lBr peak)
Figure 2.29, MS fragment for compound 6
2.3 Experimental section
Melting points (mp) were measured on a Griffin capillary melting point apparatus 
and are not corrected. !HNMR and 13CNMR (400MHz) spectra were obtained on a 
Bruker AV 400 spectrometer. Chemical shifts are reported in 5 units downfield from 
internal tetramethylsilane (Me4 Si). Abbreviations used are: s = singlet; d = doublet; 
dd = double doublet; ddd = double double doublet; dt = double triplet; t = triplet; m = 
multiplet. Coupling constants (J) are expressed in Hz. IR spectra were recorded on a 
Perkin Elmer spectrometer 1 with Universal ATR Sampling accessory. Only strong 
absorptions (e.g. C=0) are reported. Low resolution electron ionisation (El), 
chemical ionisation (Cl) and electrospray (ESI) MS spectra were determined on a 
Micromass Quattro II low resolution triple quadrupole mass spectrometer. The data 
are presented as m/z ratios for the molecular ion and other most abundant ions with 
their percentage relative intensity given in brackets. The dibromo compounds give
7 0  R 1multiple isotop peaks, but only the Br Br are reported.
TLC was performed on W hatman aluminium silica gel plates and visualised by UV 
254 nm; and columns for chromatography were packed with Fisher Chemicals
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Matrex * Silica 60 (35-70) micron).
2.3.1.1 Synthesis of dodecyl triflate (la )
To a dry round bottom flask (5 ml) equipped with a magnetic stirrer bar, silver triflate 
(278 mg, 2.08 mmol) and 12-iodododecane (300 mg, 1.01 mmol) were added. Then 
the flask was flushed with N 2 for 5 minutes. Afterwards, dry benzene (1 ml) was 
introduced with a syringe. The mixture was stirred for 18 h at room temperature. The 
resulting mixture was stripped o f  volatiles over a rotary evaporator, and then 
extracted with DCM (0.6 ml) for loading on a silica column for chromatography, and 
eluted with DCM. The fractions with R f = 0.75 were pooled and evaporated under 
vacuum to give a colourless oil (219 mg, yield, 6 8 %).
13 1 2 3 4 5 6 7 8 9 10 11 12
CF3S0 3 CH2CH2CH2CH2CH2CH2CH2CH2CH2CH2CH2CH3
'HNM R (400 Hz, chloroform-d, 8 , ppm), 4.57 (2H, Hi, t, J = 7 Hz), 1.85 (2H, H2, 
quintet, J = 7 Hz), 1.45 (2H, H n , quintet, J -  7 Hz), 1.39-1.21 (16H, H3, H4, H5, H6, 
H7, H8, H9, H 10 , m), 0.91 (3H, H 12, t, J = 7 Hz).
13CNMR (400 Hz, chloroform-d, 8 , ppm), 119.0 (C 13, splitting into 4 peaks 123.8, 
1 2 0 .6 , 117.5, 114. 3), 78.1 (C,), 33.0, 30.1-29.2, 26.6 (C2, C 3 ,C 4, C5, C6, C7, C8, C9, 
C 10), 25.4 (C „), 14.5 (C 12).
2.3.1.2 Synthesis of acridine-9-carboxylic acid chloride (lb )
In a round bottom flask (50 ml) equipped with a condenser, a stirrer bar and a CaCl2  
drying tube, acridine-9-carboxylic acid (1.88 g, 8.42 mmol) was refluxed in thionyl 
chloride (10 ml). About 1 h later, the suspension turned clear. The heating was 
maintained for a further hour, and the excess o f thionyl chloride was evaporated 
under reduced pressure. The yellow solid obtained was pumped under vacuum
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overnight to provide the material for the next step without further purification.
2.3.1.3 Synthesis of 2,6-dibromophenyl acridine-9-carboxylate (lc )
In a round bottom flask (50 ml) equipped with a CaCl2  drying tube and a magnetic 
stirrer bar, acridine-9-carboxylic acid chloride (2.036g, 8.42 mmol) in pyridine was 
heated to 70 °C. After the solid had dissolved completely, the solution was cooled 
to room temperature, 2,6-dibromophenol (2.325 g, 9.23 mmol) was added and the 
mixture was stirred vigorously overnight. The resulting mixture was stripped o f 
pyridine to leave a brown solid. DCM (10 ml) was used to extract the product and 
the extract was subjected to column chromatography, eluted with Tol + EtOAc (4:1). 
The fractions with R f 0.49 were collected and evaporated to give a pale yellow solid. 
The solid was re-dissolved in DCM (40 ml), washed with dilute NaOH aqueous 
solution (0.1 mol L"1, 5 x 40 ml), dried over M gS04, filtered and evaporated to give a 
pale yellow powder (2.080 g, 54% yield), m.p. 159-160 °C.
15
'HNM R (400 MHz, chloroform-d3, 6 , ppm), 8.73 (2H, H ,, H8, d, J = 8  Hz), 8.27 (2H, 
H4, H5, d, J = 8  Hz), 7.79 (2H, H3, H6, t, J = 8  Hz), 7.66 (2H, H 14, H 16, d, J = 8  Hz), 
7.61 (2H, H2, H7, t, J = 8  Hz), 7.09 (1H, H 15, t, J = 8  Hz).
13CNMR (400 MHz, chloroform-d, 6 , ppm), 163.0 (C]0), 147.7 (Cn ), 145.5 (C4 a/C4£f),
132.8 (C9), 132.0 (C 14/C 16), 129.3 (C4 /C5), 129.1 (C3/C6), 127.9 (C 15), 126.5 (C2 /C7),
124.9 (C ,/C 8), 1 2 2 . 0  (C9 a/C9a>), 116.8 (C I2/C 13).
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IR (u, cm"1), 1754 (C =0)
MS (m/z), El: 457 ([M, 7 9Br8lBr isotope peak]+, 2%), 206 ([M-Br2PhO]+, 100%), 178 
(72%); Cl: 458 ([M+H, 7 9Br8lBr isotope peak]+, 21%).
2.3.1.4 Synthesis of 9-(2,6-dibromophenoxycarbonyl)-10-dodecyIacridinium  
trifluoromethanesulfonate (1)
To a round bottom flask (5 ml) equipped with a stirrer bar and a condenser (25 ml),
2,6-dibromophenyl acridine-9-carboxylate (74.8 mg, 0.16 mmol) was added. The 
flask was flushed with N 2 for 5 min. Then dodecyl triflate (70 mg, 0.22 mmol) and 
DCE were introduced by syringes respectively. The mixture was refluxed for 31 h. 
The solvent was evaporated under vacuum. The product was extracted with DCM 
(0.6 ml). The extract was precipitated with diethyl ether (3 ml), and the upper 
solution was removed with a pipette carefully. The yellow precipitate was 
re-dissolved in DCM (0.6 ml), and re-precipitated with diethyl ether repeatedly (x 6 ) 
to give a greenish yellow solid (11.5 mg, 19.0% yield), m.p. 92-96 °C.
15
'HNM R (400 Hz, chloroform-d, 6 , ppm), 8.79 (2H, H4, H5, d, J = 8  Hz), 8.62 (2H, Hi, 
H8, d, J = 9 Hz), 8.34 (2H, H3, H6, dd, J = 8 , 7 Hz), 7.83 (2H, H2, H7, dd, J = 9, 7 Hz), 
7.53 (2 H, d, H 14, H 16, J = 8  Hz), 6.99 ( 1 H, H 15, t, J = 8  Hz), 5.43 (2H, H I7, t, J = 8
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Hz), 1.98 (2H, H27, m), 1.62-1.48, 1.26-1.16, 1.15-0.95, (4H, 2H, 1 2 H , m , m ,  m, H 18, 
H 19, H20, H21, H22, H23, H24, H25, H26), 0.64 (3H, H28, t, J = 7 Hz).
13CNMR (400 Hz, chloroform-d, 6 , ppm), 161.5 (C i0), 147.1 (Cn ), 145.9 (C9), 141.7 
(C4a), 140.7 (C I4 /C 16), 130.3 (C 15), 133.8, 129.8, 129.3, 119.9 (C ,/C 8 ,C 2/C7, C3/C6, 
C4/C 5 ), 123.9 (C9a), 117.7 (C 12/C j3), 53.0 (C 17), 32.3 (C26), 30.2, 30.1, 30.0 ( 2  lines), 
29.9, 29.8, 29.7 (C 19, C20, C21, C22, C23, C24, C25), 27.1 (C 18), 23.1 (C27), 14.5 (C28). 
C2 9  has not been found.
IR (o, cm’1), 1764 (C =0).
MS (m/z), ES+: 626 ([M-CF3 SO3 , 7 9Br8lBr isotope peak]+, 84%), 414 (25%), 406 
(47%), 392 (100%); ES': 149 ([CF3 S 0 3’], 100%). Acc-MS: calculated mass: 
624.1107 ([M-CF3 SO3 , 7 9Br79Br isotope peak]+); measured mass: 624.1108.
2.3.2 Synthesis of 9-(2,6-dibromophenoxycarbonyI)-10-methylacridinium  
trifluoromethanesulfonate (2)
To a round bottom flask (5 ml), equipped with a stirrer bar, 2,6-dibromophenyl 
acridine-9-carboxylate (89 mg, 0.19 mmol) was added. The flask was flushed with 
nitrogen via a septum for 5min. Afterwards dry dichloromethane (2 ml) and methyl 
triflate (200 ul, 1.75 mmol) were introduced with syringes respectively. The mixture 
was stirred at room temperature for 3 h. The resulting mixture was filtered, the 
precipitate was washed with DCM (1 ml), followed by EtOAC (1 ml) and EtOEt (1 
ml), and a yellow solid (83 mg, 6 8 % yield,) was collected, m.p. 249- 250 °C.
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15
'HN M R (400 Hz, acetonitrile-d3, 5, ppm), 8.87 (2H, H4, H5, d, J = 9 Hz,), 8.53 (2H, 
Hi, H8, d, J = 9 Hz), 8.34 (2H, H3, H6, dd, J = 9, 7 HZ), 7.98 (2H, H2, H 7, dd, J = 9, 7 
Hz), 7.68 (2H, H ,4 , H i6, d, J = 8  Hz), 7.16 (1H, H 1S, t, J = 8  Hz), 4.72 (3H, H 17, s).
13CNMR (400 Hz, acetonitrile-d3, 6 , ppm), 162.8 (Cm), 147.4 (Cn ), 146.3 (C9), 143.3 
(C4a), 140.6 (C i4 /C |6), 131.5(CiS), 134.6, 130.6, 129.3, 120.3 (C ,/C8, C2 /C7, C3 /C6, 
C4/C 5), 124.5 (C9a), 118.0 (C]2/C j3), 40.9 (C]7), C | 8 has not been seen.
19FNMR (400 Hz, acetonitrile-d3, 5, ppm), -79.3.
IR (u, cm '1), 1760 (C=0).
MS (m/z), ES+: 526 (11%), 472 ([M-CF3 S 0 3, 7 9Br81Br isotope peak]+, 31%), 252 
(49%), 193 (100%); ES': 149 ([CF3 S 0 3] \  100%). Acc-MS: calculated mass: 
469.9386 ([M -CF3 S 0 3 , 79Br79Br isotope peak]+); measured mass: 469.9385.
2.3.3.1 Synthesis o f succinimidyl 4-iodobutanoate (3a)
In a flask (25 ml), equipped with a stirrer bar, 4-iodobutyric acid (480 mg, 2.24 
mmol) in dry THF (10 ml), was cooled to 0 °C in an ice bath under N 2. 
A/-Hydroxysuccinimide (247 mg, 2.14 mmol) in THF (2 ml) and DCC (523 mg, 2.53 
mmol) were then added respectively. The mixture was stirred at 0 °C for 3 h, and then 
at room temperature overnight. The resulting mixture was filtered, the filtrate was
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condensed on a rotary evaporator and loaded onto a silica column for 
chromatography, eluted with Tol + EtOAC (4: 1). The fractions with R f = 0.48 were 
combined and evaporated to give a yellow solid (567 mg, 84% yield), m.p. 86-87 °C.
'HNM R (400 MHz, chloroform-d, 8 , ppm), 3.22 (2H, H ,, t, J = 7 Hz), 2.78 (4H, H6, 
H6’, s) , 2.71 (2H, H3, t, J = 7 Hz), 2.18 (2H, H2, quintet, J = 7 Hz).
I3CNMR (400 MHz, chloroform-d, 8 , ppm), 169.4 (C 5/C 5 .), 168.0 (C4), 32.2 (C3),
28.5 (C2), 26.0 (Cf/Cs-), 4.24 (C,).
IR (u, cm '1), 1739 (C =0), 1657 (C =0).
MS (m/z), El: 311 (M+, 1%), 197 ([M-C4 H4N 0 3]+, 100%), 184 ([M-I]+, 29%) 169 
([M- C4 H4N 0 2 -COO]+, 52%); Cl: 329 ([M+NH4]+, 19%), 225 ([M+NH 4 -C4 H4 N 0 3]+, 
38%).
2.3.3.2 Synthesis of LiAE (3)
In a round bottom flask (5 ml), 2,6-dibromophenyl acridine-9-carboxylate (57.2 mg, 
0.13 mmol) and succinimidyl 4-iodobutanoate (51.6 mg, 0.17 mmol) were ground 
and mixed fully. The flask was equipped with a stirrer bar and then flushed with 
nitrogen. The starting materials were heated in an oil bath (150 °C) for 0.5 h. Soon 
after, the mixture turned to dark brown. To the resulting mixture, acetonitrile (0.5 ml) 
was added to extract the product. The crude product was precipitated with diethyl 
ether (2 ml), and washed with ethyl acetate repeatedly (10 x 2 ml or so) until TLC 
showed that all the starting materials were removed. A red powder (1 mg) was
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obtained and identified as LiAE by 'HNM R spectrum. The residue was evaporated 
under vacuum and re-used for the reaction under same conditions, another 1 mg o f 
the product could be obtained. The starting materials could be recycled for 2 times; 
LiAE (3.0 mg) was obtained with 3% yield in total. The ’HNM R and ES+ mass 
spectra are same with those o f compound 4 (see section 2.3.4.2).
2.3.4.1 Synthesis of succinimidyl 4-(trifluoromethanesulfonyloxy)butanoate (4b)
To a round bottom flask (25 ml) equipped with a stirrer bar, succinimidyl 
4-iodobutanoate (145 mg, 0.466 mmol) and silver triflate (163 mg, 0.637 mmol) 
were added, and then the flask was flushed with N 2 for 5 minutes. Dry benzene (2 ml) 
was introduced with a syringe, and the mixture was stirred for 23 h. The resulting 
mixture was passed through a mini silica gel column, eluted by DCM. The fractions 
with R f = 0.25 were pooled and evaporated on a rotary evaporator and then pumped 
overnight to leave a white solid, m.p. 59-60 °C (73 mg, 47% yield).
> AA4 X 6f 3c o js  ' Y '  f t - ° “ N\ L
0  c A
'HNM R (400 MHz, chloroform-d, 5, ppm), 4.47 (2H, H ,, t, J = 7 Hz), 2.67 (4H, H6, 
H6., s ) , 2.63 (2H, H3, t, J = 7 Hz), 2.10 (2H, H2, q u in te t, J = 7 Hz).
I3CNMR (400 MHz, chloroform-d, 6 , ppm), 169.2 (C5/C 5 ), 167.7 (C4), 120.6 (C7, 
splitting into four peaks), 75.3 (Ci), 27.2 (C3 ), 26.0 (C JC v ), 24.9 (C2 ).
IR (t>, cm '1), 1738 (C =0).
2.3.4.2 Synthesis of LiAE’ (4)
To a round bottom flask (5 ml), equipped with a stirrer bar and an air condenser, 
freshly prepared succinimidyl 4-(trifluoromethanesulfonyloxy)butanoate (56.9 mg, 
0.17 mmol) and 2,6-dibromophenyl acridine-9-carboxylate (61.9 mg, 0.14 mmol)
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were added and the flask was flushed with nitrogen. Then TCE (2 ml) was 
introduced with a syringe. The flask was placed into an oil bath (140 °C) for 2 h. The 
resulting mixture was stripped o f solvent on a rotary evaporator, and then treated in 
the similar way for purification o f LiAE. A brown solid (7 mg, 6.3% yield) was 
obtained.
14
'HN M R (400 Hz, acetonitrile-d3, 5, ppm), 8.93 (2H, H„, H5, d, J = 9 Hz), 8.62 (2H, 
H ,, H8, d, J = 8  Hz), 8.40 (2H, H3, H6, t, J = 9 Hz), 8.01 (2H, H2, H7, t, J = 8  Hz); 
7.73 (2H, H l3, H is, d, J = 8  Hz); 7.20 (1H, H,4, t, J = 8  Hz); 5.33 (2H, H I7, t, J = 8  
Hz); 3.02 (2H, H ,9, t, J = 7 Hz); 2.69 (4H, H23, H24, s); 2.45 (2H, H l8, quintet).
IR (o, cm '1), 1746 (C =0).
MS (m/z), ES+: 641 ([M-CF3 S 0 3, 7 9Br8lBr isotope p e a k f , 11%); ES‘: 149 
([CF3 S 0 3] \  100%). Acc-MS: calculated mass: 638.9761 ([M-CF3 S 0 3, 7 9Br79Br 
isotope peak]+); measured mass: 638.9769.
2.3.5.1 Synthesis o f 6 -iodohexanoic acid (5a)
The sodium iodide (3.11 g, 20.7 mmol) in a round bottom flask (100 ml) was dried 
over an oil pump for a while. To the flask, 6 -bromohexanoic acid (1.49 g, 7.64 mmol) 
was added, followed by a stirrer bar. Then the flask was equipped with a septum and 
flushed with N 2 . Redistilled acetone (30 ml) was introduced with a syringe. The
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mixture was stirred for 4 h. The resulting mixture was poured into water (15 ml), and 
the product was extracted with diethyl ether (4X 20  ml). The organic phase was 
washed with saturated N a2 S2 C>3 (20 ml), dried over M gS 04) filtered and evaporated 
over a rotary evaporator. The pale yellow crude product was chromatographed, 
eluted with hexane + EtOEt + formic acid (1:1:0.1%). The fractions with R f = 0.35 
were pooled and stripped o f solvents to give white flakes (1.48 g, 80% yield), m.p. 
40-41 °C (L it.93, 43-43.5 °C).
1 2 3 4 5 6
ICH2CH2CH2CH2CH2COOH
'HNM R (400 MHz, chloroform-d, 5, ppm), 3.12 (2H, H b t, J = 7 Hz), 2.31 (2H, H5, t, 
J = 7 Hz), 1.78 (2H, H2, m, J = 7 Hz), 1.60 (2H, H4, m, J = 7 Hz), 1.40 (2H, H3, m, J 
= 7 Hz). H6 was not been found, due to its chemical shift beyond 11.5 ppm or a too 
broad peak.
I3CNMR (400 MHz, chloroform-d, 8 , ppm), 34.14 (C5), 33.5 (C2), 30.3 (C3), 24.0 
(C4), 6.85 (Ci), the signal for carbonyl group was too weak to be found.
1R(«, cm '1), 1703 (C =0).
MS (m/z), ES': 483 ([2M -H ]\ 100%), 241.1 ([M -H ]\ 19%).
2.3.5.2 Synthesis of succinimidyl 6 -iodohexanoate (5b)
In a round bottom flask (25 ml), equipped with a stirrer bar, flushed with nitrogen, 
6 -iodohexanoic acid (699.9 mg, 2.89 mmol) was dissolved in dry THF (10 ml), and 
cooled to 0°C in an ice bath. 7V-Hydroxysuccinimide (433.8 mg, 3.77 mmol) in THF 
(2 ml) was added, followed by DCC (680.0 mg, 3.30 mmol). The mixture was stirred 
at 0 °C for 3 h, then at room temperature overnight. The resulting mixture was
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filtered, the filtrate was condensed and loaded onto a silica column for 
chromatography, eluted with Tol + EtOAc (4: 1), and the fractions with R f = 0.48 
were combined and evaporated on a rotary evaporator to give a white solid (706 mg). 
The crude product was recrystallized in hexane + EtOEt at 65 °C. White needle 
crystals (448 mg, 46% yield,) were obtained, m.p. 74-75 °C.
'HNM R (400 MHz, chloroform-d, 8 , ppm), 3.13 (2H, H i, t, J = 7 Hz), 2.78 (4H, H8, 
Hg-, d, J = 2 Hz), 2.57 (2H, H 5, t, J = 7 Hz), 1.82 (2H, H2, quintet, J = 7 Hz), 1.71 (2H, 
EE, quintet, J = 7 Hz), 1.46 (2H, H 3 , quintet, J = 7 Hz).
i3CNMR (400 MHz, chloroform-d, 8 , ppm), 169.5 (C 7 /C7-), 168.8 (C6), 33.3 (C2),
31.1 (C5), 30.0 (C3), 26.0 (Cg/Cg-), 23.9 (C4), 6.51 (C,).
IR (o, cm '1), 1737 (C =0), 1653 (C =0).
MS (m/z), El: 225 ([M-C4 H 4N 0 3]+, 18%); Cl: 357 ([M+NH4]+, 13%).
2.3.5.2’ Synthesis of succinimidyl 6 -bromohexanoate (5b’)
In a round bottom flask (25 ml), equipped with a stirrer bar, 6 -bromohexanoic acid 
(318.0 mg, 1.63 mmol) in dry THF (10 ml) was cooled to 0 °C in an ice bath. 
W Hydroxysuccinimide (290.4 mg, 2.52 mmol) in THF (2 ml) was added, followed 
by DCC (372.4 mg, 1.80mmol) in THF (5 ml). The flask was flushed with nitrogen, 
and the mixture was stirred at 0 °C for 3 h, afterwards at room temperature overnight. 
The resulting mixture was filtered, and the filtrate was evaporated to give a white 
solid. The crude product was chromatographed over a silica column, eluted with Tol
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+ EtOAC (4: 1). The fractions with R f = 0.48 were combined and evaporated on a 
rotary evaporator to give a white solid, purified further by recrystallisation (250.4 mg, 
45% yield), m.p. 70-71°C.
C— O— N
'HNM R (400 MHz, chloroform-d, 5, ppm), 3.45 (2H, H ,, t, J = 7 Hz), 2.85 (4H, H8, 
H8-, s), 2.64 (2H, Hs, t, J = 7 Hz), 1.91 (2H, H 2, quintet, J = 7 Hz), 1.78 (2H, H4, 
quintet, J = 7 Hz), 1.57 (2H, H3 , quintet, J = 7 Hz).
°CN M R (400 MHz, chloroform-d, 8 , ppm), 169.53 (C 7/Cr ), 168.8 (C6), 33.6 (C2),
32.6 (C,), 31.2 (C5), 27.7 (C3), 26.0 (C 8/C8-), 24.16 (C4).
IR (n, cm '1), 1736 (C =0).
MS (m/z), El: 177 ([Br(CH 2 )5CO]+, 11%); Cl: 309 ([M+NH4]+, 100%).
2.3.5.3 Synthesis of succinimidyl 6 -(trifluoromethanesulfonyloxy)hexanoate (5c)
To a round bottom flask (5 ml) equipped with a stirrer bar, succinimidyl 
6 -iodohexanoate (109 mg, 0.322 mmol) was added, followed by silver triflate (166 
mg, 0.648 mmol). The flask was flushed with nitrogen for 5min, and then re-distilled 
benzene (2 ml) was introduced with a syringe. The mixture was stirred at room 
temperature for 18 h. The resulting mixture was condensed on a rotary evaporator, 
and chromatographed over a silica column, eluted with DCM. The fractions with R f 
= 0.28 were pooled, evaporated on a rotary evaporator, and then pumped overnight to 
give a white gum (54.8 mg, 47% yield).
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'HNM R (400 MHz, chloroform-d, 5, ppm), 4.45 (2H, Hi, t, J = 7 Hz), 2.75 (4H, Hg, 
H8’, s), 2.56 (2H, H5, t, J = 7 Hz), 1.79 (2H, H2, quintet, J = 7 Hz), 1.73 (2H, H4, 
quintet, J = 7 Hz), 1.48 (2H, H3 , quintet, J = 7 Hz).
I9FNMR (400 MHz, chloroform-d3, 8 , ppm), -74.8.
I3CNMR (400 MHz, chloroform-d, 8 , ppm), 169.5 (C 7/C 7 0, 168.6 (C6), 117.4 (G>, 
splitting into 4 peaks), 77.4 (C ,), 31.0 (C5), 29.2 (C3), 26.0 (Cg/Cr), 24.7 (C4), 24.3 
(C2 ).
IR (u, cm '1), 1736 (C =0).
2.3.5.4 Synthesis of 9-(2,6-dibromophenoxycarbonyl)-10-
(5-succinimidyIoxycarbonylpentyl)acridinium trifluoromethanesulfonate (5)
In a round bottom flask (5 ml), equipped with a stirrer bar and a condenser,
2,6-dibromophenyl acridine-9-carboxylate (82.5 mg, 0.18 mmol) and freshly 
prepared succinimidyl 6 -(trifluoromethanesulfonyloxy)hexanoate (70 mg, 0.19 mmol) 
were added. The flask was flushed with nitrogen, and then dry DCE (2 ml) was 
introduced with a syringe. The mixture was refluxed under N 2 for 21.5 h. The 
resulting mixture was stripped o f solvent on a rotary evaporator, and then was taken 
up in DCM (1 ml). The product was precipitated with diethyl ether (3 ml), the 
precipitate was re-dissolved in DCM, and re-precipitated repeatedly, until TLC 
showed absence o f the starting materials. A yellow solid (17 mg, 12% yield) was 
obtained, m.p. 96-98 °C.
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'HNM R (400 Hz, c h l o r o f o r m - d ,  5, p p m ) :  9.07 (2H, H4, H5, d ,  J = 8  Hz), 8.96 (2H, 
Hi, H8, d ,  J = 8  Hz), 8.64 (2H, H3, H6, t, J = 8  Hz), 8.13 (2H, H2, H 7, d ,  J = 8  Hz), 
7.81 (2H, H i4 , H 16, d ,  J = 8  Hz), 7.30 (1H, H 15, t, J = 8  Hz), 5.70 (2H, H 17, t, J = 8  
Hz), 2.88 (4H, H25, H26, s ) ,  2.71-2.76 (2H, H21, m ) ,  2.42-2.48 (2H, m )  a n d  1.97-2.03 
(4H, m), (H 18,H 19, H20).
i3CNMR (400 Hz, chloroform-d, 6 , ppm), 169.8 (C2 3 /C24), 168.9 (C22), 161.5 (C]0),
147.2 (Cn), 145.8 (C9), 141.7 (C4a), 141.0 (C 14/C ]6), 130.4 (C 15), 133.8, 129.9, 129.2,
119.8 (C ,/C 8 ,C 2/C7, C3 /C6, C4 /C5), 123.9 (C9a), 117.6 (C 12/C 13), 52.6 (C 17), 30.9 (C21),
26.0 (C2 5 /C26), 29.2, 25.5, 24.6 (C 18, C ]9, C20).
IR (u, cm '1), 1734 (C=0).
MS, ES+: 723 (37%), 669 ([M-CF3 S 0 3, 7 9Br81Br isotope peak]+, 100%), 449 (56%), 
79 (44%); ES’: 149 ([CF3 S 0 3]‘, 100%). Acc-MS: calculated mass: 667.0074 
([M-CF3 S 0 3 , 7 9Br79Br isotope peak]+); measured mass: 667.0081.
2.3.6.1 Synthesis of 11-iodoundecanoic acid (6 a)
The sodium iodide (3.04 g, 20.3 mmol) in a round bottom flask (100 ml) was dried 
over an oil pump for a while. Then, 11-bromoundecanoic acid (2.19 g, 8 . 27 mmol)
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was added, followed by a stirrer bar. The flask was flushed with N 2 via a septum. 
Redistilled acetone (20 ml) was added with a syringe. The mixture was stirred for 4 h 
at room temperature. The precipitate was removed by filtration. To the filtrate, dry 
Nal (1.50 g, 10.1 mmol) was added again, the mixture was stirred for further 4 h. The 
resulting mixture was poured into water ( 2 0  ml), and the product was extracted with 
diethyl ether (4 X 25 ml). The organic phase was washed with saturated Na2 S2 0 3 
(20 ml), dried over M gS 04, filtered, and evaporated over a rotary evaporator to give 
a pale pink solid (2.36 g), which was later chromatographed over a silica column and 
eluted with hexane + EtOEt + formic acid (1 :1 : 0.1%). The fractions with R f = 0.35 
were pooled and evaporated to give white flakes (2.23 g, 83% yield), m.p. 62-63 °C 
(L it.9a, 64-65 °C).
1 2 3 4  5 6  7 8 9  10 11
I CH2CH2CH2CH2CH2CH2CH2CH2CH2C H 2C 00H
'HNM R (400 Hz, chloroform-d, 5, ppm), 3.12 (2H, H ,, t, J = 7 Hz), 2.23 (2H, H ]0, t, 
J = 7 Hz), 1.75 (2H, H2, quintet, J = 7 Hz), 1.56 (2H, H9, quintet, J = 7 Hz), 1.28-1.18 
(12H, H4, H5, H6, H 7, H8, H9, m).
,3CNMR (400 Hz, chloroform-d, 5, ppm), 179.9 (C n ), 34.3 (C 10), 33.9 (C2), 30.8 
(C3), 29.7 (C5, C6, C7), 29.4 (C8), 28.9 (C4), 25.0 (C9), 7.53 (C,).
IR (u, cm '1), 1693 (s, CO).
MS (m/z), El: 313 ([M + H]+, 3%); Cl: 330 ([M + NH4]+, 100%).
2.3.6.2 Synthesis o f succinimidyl 11-iodoundecanoate (6 b)
In a round bottom flask (50 ml), equipped with a stirrer bar, 11-iodoundecanoic acid 
(989 mg, 3.17 mmol) in dry THF (10 ml) was cooled to 0 °C in an ice bath.
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/V-Hydroxysuccinimide (655.5 mg, 5.70 mmol) in THF (5 ml) was added with a 
syringe, followed by DCC (760 mg, 3.69 mmol) in THF (5 ml). The flask was 
flushed with nitrogen, and the mixture was stirred at 0 °C for 3 h, then at room 
temperature overnight. The resulting mixture was filtered, and the filtrate was 
condensed for loading onto a silica column for chromatography, eluted with tol + 
EtOAC (4: 1). The fractions with R f = 0.48 were combined and evaporated on a 
rotary evaporator to give a white solid. The crude product was further purified by 
recrystallization in hexane + EtOEt at 65 °C, to give white needle crystals (847 mg, 
65% yield), m.p. 84 °C.
'HNM R, (400 Hz, chloroform-d, 8 , ppm), 3.16 (2H, H ,, t, J = 7 Hz), 2.81 (4H, H i3, 
H ,3 ’, s ) ,  2.57 (2H, H 10, t, J = 7 Hz), 1.79 (2H, H2, quintet, J = 7 Hz), 1.71 (2H, H9, 
quintet, J = 7 Hz), 1.35 (2H, H3, quintet, J = 7 Hz), 1.35-1.23 (10H, H4, H5, H6, H 7, 
H8, m).
13CNMR (400 Hz, chloroform-d, 8 , ppm), 169.5 (Ci2 /C i2-), 169.0 (Cn ), 35.3 (C2), 
33.9 (C3), 31.3 (C 10), 30.8, 29.6, (C 5 , C 7 , two o f them overlapped accidentally),
29.4 (C8), 29.2 (C4), 24.9 (C9), 26.0 (C 13/C 13-), 7.6 (C,).
IR (u, cm’1), 1725 (C =0).
MS (m/z), Cl: 427 ([M+NH4]+, 15%), 301 ([M+NH 4 -I]+ 15%), 225 (16%), 149 
(30%), 132 (100%).
2.3.6.3 Synthesis of succinimidyl ll-(trifluorom ethanesulfonyloxy)undecanoate 
(6 c)
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To a round bottom flask (5 ml) equipped with a stirrer bar, succinimidyl 
11-iodoundecanoate (147 mg, 0.359 mmol) was added, followed by silver triflate 
(266 mg, 1.03 mmol). The flask was flushed with nitrogen for 5min via a septum, 
and then dry benzene (2 ml) was introduced with a syringe. The nitrogen source was 
removed, the septum was sealed with nesco film, and the mixture was stirred at room 
temperature for 18 h. The resulting mixture was condensed on a rotary evaporator for 
chromatography over a silica column, eluted with DCM. The fractions with R f =
0.31 were pooled and evaporated under vacuum to give a white gum (110.4 mg, 71% 
yield).
C—O—N
'HNM R (400 MHz, chloroform-ds, 5, ppm), 4.44 (2H, H h t, J = 7Hz), 2.74 (4H, H ]3, 
H i3’, s ) ,  2.51 (2H, H 10, t, J = 7 Hz), 1.73 (2H, H 2, quintet, J = 7Hz), 1.65 (2H, H9, 
quintet, J = 7 Hz), 1.31 (2H, H3, quintet), 1.27-1.18 (10H, H4, H5, H6, H7, H8, m).
19FNMR (400 MHz, chloroform-d, 6 , ppm), -74.8.
13CNMR (400 MHz, chloroform-d, 5, ppm), 169.6 (C 12/C 12-), 169.0 (C n ), 118.2 (C ,4, 
splitting into 4 peaks), 78.14, (C]), 31.3 (Cio), 29.6, 29.5 (C 5 , C6 , C 7), 29.3, 29.2 (C4, 
C8), 29.1 (C3), 26.0 (C 13/C 1 30, 25.4 (C9), 24.9 (C2).
IR (u, cm '1), 1725 (C=0).
2.3.6.4 Synthesis of 9-(2,6-dibromophenoxycarbonyl)-10-
(lO-succinimidyloxycarbonyldecyl)acridinium trifluoromethanesulfonate (6 )
In a round bottom flask (5 ml), equipped with a stirrer bar and a condenser,
2,6-dibromophenyl acridine-9-carboxylate (93.2 mg, 0.20mmol) and freshly prepared
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succinimidyl 11-(trifluoromethanesulfonyloxy)undecanoate (94.1 mg, 0.22 mmol) 
were added. The flask was flushed with nitrogen, and then redistilled TCE (2 ml) was 
introduced with a syringe. The mixture was heated at 140 °C under N 2 for 4 h. The 
product was isolated in a similar way used for purifying LiAE to give a yellow solid 
(28.0 mg, 15% yield), m.p. 165-166 °C.
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'HNM R (400 Hz, c h l o r o f o r m - d ,  5, p p m ) ,  8.84 (2H, H4, H s, d, J = 8  Hz), 8.59 (2H, H,, 
H8, d, J = 9 Hz), 8.39 (2H, H3, H6, dd, J = 8 , 7 Hz), 7.89 (2H, H2, H 7, dd, J = 9, 7 Hz), 
7.58 (2H, H 13, H ,5 , d, J = 8  Hz), 7.06 (1H, H 14, t, J = 8  Hz), 5.47 (2H, H 17, t, J = 8  
Hz), 2.65 (4H, H30, H3 1 , s), 2.41 (2H, H26, t, J = 7 Hz), 2.07-1.98, (2H, H,g, m), 
1.64-1.49 (4H, H 19, H25, m) 1.31- 1.08 (10H, H20, H21, H22, H23, H24, m).
,3CNMR (400 Hz, chloroform-d, 5, ppm), 169.7 (C2 8 /C29), 169.1 (C27), 161.5 (C 10),
147.1 (C n ), 145.9 (C9), 141.7 (C4a), 140.8 (C 13/C 15), 130.3 (CM), 133.8, 129.9, 129.3,
119.8 (C ,/C 8 ,C 2 /C7, C3 /C6, C4 /C 5), 123.9 (C9a), 117.7 (C I2 /C 16), 52.9 (C 17), 31.3 (C26), 
30.1, 29.6, 29.5 ( 2  lines), 29.3, 29.0, (C 19, C20, C21, C22, C23, C24), 26.9 (C 18), 26.0 
(C3 0/C 3 1), 24.9 (C25).
19FNMR (400 Hz, chloroform-d, 5, ppm), -78.2.
IR (u, cm '1), 1728 (C =0).
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MS, ES+: 793 (48%), 739 ([M-CF3 S 0 3]+, 7 9 Br81Br isotope peak]+, 82%), 519 (100%), 
361 (20%); ES': 149 ([CF3 S 0 3] \  100%). Acc-MS: calculated mass: 737.0856 
([M-CF3 S 0 3 , 7 9Br79Br isotope peak]+); measured mass: 737.0865.
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Chapter 3
Synthesis of 9-(substituted 
phenoxy carbonyl)-l O-substituted 
acridinium derivatives
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3.1 Introduction
Label 2 1 shown in figure 3.1, was reported to be a more stable acridinium ester (AE), 
compared with label 1 , the first AE label reported in 1983. Furthermore it exhibits a 
two-fold improvement in the signal-to-noise ratio when used in solid phase specific 
binding assay and its IgG conjugate also exhibits a three-fold increase in light
• 13emitting efficiency. ’ Steric hindrance could explain these characteristics since most 
o f the compounds exhibiting this stability are substituted in the ortho position o f the 
phenol by bulky groups (methyl) or atoms (Br) while the same substitution in another 
position is not efficient from this point o f view .4 , 5 The presence o f substituents at the 
ortho positions has the effect o f improving the stability towards hydrolysis at the 
ester group, irrespective o f the electronic nature o f the substituents. The electronic 
effects are more important in determining the rate at which the chemiluminescent 
reaction occurs, thereby providing a range o f labels, which are differentiated in the 
time over which light is emitted as well as being relatively stable to hydrolysis. This 
provides opportunities for choosing a label with properties appropriate for a
particular application. Electron-withdrawing groups introduced in the phenyl ring
increase both efficiencies and reaction rates while electron donating groups have the 
opposite effects. The dibromo compound flashes quickly while the dimethyl and 
dimethoxy compounds give off chemiluminescence slowly, as a result o f the relative 
ease o f expulsion o f the corresponding phenoxide anions . 3 ' 7
CFF -  CH3
CF3SO3 | J CF3SO3 |
Figure 3.1, structures o f label 1 and label 2 in literatures1'3
In this chapter, the protons o f the phenoxyl ring are substituted by 2,5-methyl, 2,6- 
bis(trifluoromethyl), 2 ,6 -dinitro groups, which are expected to influence both the
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stability and the chemiluminescent kinetics by a combination o f steric and electronic 
effects from the substituents. Studies o f the chemiluminescent properties o f the 
compounds will, therefore, enable some further understanding o f the importance o f 
such factors and allow multi-analysis, based on different decay kinetics o f several 
acridinium derivatives. Such compounds have been designed for use as DNA probes, 
although these methods could probably also be applied for antibody based assays. In 
order to try to combine the advantages o f an acridinium ester, which has substituents 
on the phenoxy ring and an acridinium ester, which has its linker and spacer moiety 
bonded to the nitrogen atom, several new target compounds were designed (figure 
3.2). AE without linker groups are included in group a, to allow investigation o f the 
chemiluminescent kinetics and stability; and compounds in group b would be used 
to investigate not only chemiluminescent kinetics and stability, but also the 
properties o f their conjugates to oligonucleotides or antibodies.
a b
n = 0, 11
R, =  R2 = R3 = H; R, = R3 = N 0 2, R2 = H;
R2 = R3 = CH3, R, = H; R, = R3 = CF3, R2 = H.
n = 3, 5, 10:
R, = R2 = R3 = H; R, = R3 = N 0 2, R2 = H;
R2 = R3 = C H 3, R,  = H; R,  = R3 = CF3, R2 = H.
Figure 3.2, the target compounds
The specific compounds intended to be made are shown in table 3.1.
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Table 3.1. The structures o f intended targets
Compound
number
Type a or b n Ri r 2 r 3
7 a 0 H H H
8 a 1 1 H H H
9 b 3 H H H
1 0 b 5 H H H
1 1 b 1 0 H H H
1 2 a 0 H c h 3 c h 3
13 b 3 H c h 3 c h 3
14 b 5 H c h 3 c h 3
15 b 1 0 H c h 3 c h 3
16 a 0 c f 3 H c f 3
17 b 1 0 c f 3 H c f 3
18 a 0 n o 2 H n o 2
19 b 1 0 n o 2 H n o 2
23 b 3 n o 2 H n o 2
24 b 5 n o 2 H n o 2
25 b oJ c f 3 H c f 3
26 b 5 c f 3 H c f 3
Note: Attempts to synthesize compounds 23, 24, 25 and 26 were unsuccessful (see text), but 
all other compounds were prepared; and are reported later in this chapter.
The target compounds are classified into several groups according to the properties 
o f the substituted groups on the phenoxy ring. The group o f AEs with 2,6-dibromo 
(weakly electron-withdrawing) substitution on the phenyl ring reported in chapter 2 , 
is expected to have a quicker and stronger chemiluminescence output than the 
corresponding phenyl ring unsubstituted group; the second group, with 2,5-dimethyl 
(electron-donating) substitution, is expected to have the opposite effect; the third 
group, with 2 ,6 -bis(trifluoromethyl) or 2 ,6 -dinitro (strongly electron-withdrawing) 
substitution on the phenyl ring ortho to the ester functionality, is expected to have 
the quickest and strongest chemiluminescence output; the unsubstituted AEs would
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play a role as model compounds against which to test synthetic methods and provide 
a baseline for comparison o f properties.
3.2 Results and discussion
The first requirement was to synthesize a range o f  target compounds. This work is 
described in the following sections.
3.2.1 The scheme for synthesis of 9-(phenoxycarbonyl)-10-methylacridinium  
trifluoromethanesulfonate (7)
9-(Phenoxycarbonyl)-10-methylacridinium trifluoromethanesulfonate (7), would be 
derived from phenyl acridine-9-carboxylate (7a), which would be methylated with 
methyl triflate to afford the product. The first task, therefore, was to synthesize 7a.
3.2.1 . 1  Synthesis of phenyl acridine-9-carboxylate (7a)
Phenyl acridine-9-carboxylate (7a) was synthesized by stirring phenol and acridine- 
9-carboxylic acid chloride (figure 3.3). The synthesis was performed in a similar 
procedure to that used for synthesis o f compound lc . However, after reaction, 
column chromatography followed by pumping overnight was able to provide the 
pure product (63% yield). Phenol was not completely removed by the 
chromatography, but could be pumped away under vacuum, whereas for purification 
of compound lc , the excess 2 ,6 -dibromophenol could not be removed by the oil 
pump due to its high boiling point.
The ]HNMR spectrum o f compound 7a showed 7 peaks in the aromatic region 
integrating in the ratio 2:2:2:2:2:2:1. In the 13CNMR spectrum, a peak at 163.0 ppm, 
attributed to the carbonyl group, and another 1 1  aromatic peaks for 1 1  different 
carbons were found. The IR spectrum showed a peak at 1755 cm ' 1 for the ester bond. 
The mass spectrum gave ions at m/z 229 ([M]+), 206, and 178 (figure 3.4). It was 
therefore clear that compound 7a had been synthesized successfully.
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P yrid in e, r.t,
overnight
7a
Figure 3.3, the synthesis o f phenyl acridine-9-carboxyIate (7a)
m /z , 2 0 6
m /z , 178
3.2.1.2 Synthesis 
trifluoromethanesulfonate (7)
Figure 3.4, MS fragments for compound 7a
9-(phenoxycarbonyl)-10-methyIacridiniumof
8-11
The synthesis o f compound 7 (figure 3.5) was carried out in a way similar to that 
used for compound 2 (section 2.2.2). The starting materials, compound 7a and 
methyl triflate, were stirred at room temperature for 3 h. The precipitate produced 
was filtered and washed with EtOEt to provide the product. In the ]HNMR spectrum, 
there were 7 peaks in the aromatic region and a singlet at 5.33 ppm integrating in a 
ratio o f 2:2:2:2:2:2:1:3. In the 13CNMR spectrum, a peak at 164.9 ppm was attributed 
to the carbonyl group, a signal at 41.1 ppm appeared for a methyl group and another 
11 aromatic carbons were found. The IR spectrum showed absorption at 1760 cm '1. 
The mass spectrum showed cations at m/z 314 ([M-CF3 SC>3 ]+) and 193 (figure 3.6) 
and an anion at m/z 149 ([CF3 SO 3]').
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DCM, r. t.
C C ' X )  + CF3SO3CH3
3 h, N2
CF3SO3
Figure 3.5, synthesis o f  9-(phenoxycarbonyI)-l O-methylacridinium 
trifluoromethanesulfonate (7)
m/z, 193
m/z, 314
Figure 3.6, MS fragments for compound 7
3.2.2 Synthesis of 9-(phenoxycarbonyl)-10-dodecylacridinium  
trifluoromethanesulfonate (8 )
Synthesis o f compound 8  was carried out by using freshly prepared dodecyl triflate 
(la , section 2.2.1.1) and phenyl acridine-9-carboxylate (7a). Such reaction mixtures 
were heated in p-xylene, toluene, nitrobenzene and DCE respectively, at different 
temperatures for different lengths o f  time. The resulting mixtures were evaporated 
under vacuum and dissolved in chloroform-d and submitted for 'HNM R 
spectrometry. The crude yield was calculated in each case from the ratio o f the 
proton integrals at 5 = 5.58 ppm (attributed to the CH 2 group next to the N atom in 
the desired product) and 5>= 7.40 ppm (attributed to all protons in the aromatic 
region o f the starting material and the product) in the ]HNMR spectrum, multiplied 
by 13/2. The crude product was purified by the method used for purifying LiAE to 
give a bright yellow solid . 10 The results for syntheses o f compound 8  under different 
conditions are listed in table 3.2. From table 3.2, refluxing the starting materials in
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DCE for 21.5 h afforded the best crude yield (39%). The crude yield was not 
obtained for the reaction conducted in nitrobenzene because the high boiling point o f 
the solvent rendered it difficult to remove, and thus the 'HNM R spectrum was too 
complicated. A slightly better yield was obtained for the synthesis o f compound 8  
than for compound 1 under similar conditions. Compound 8  was isolated and 
purified in the same way as compound 1  (section 2 .2 .1 .4).
DCE, reflux
+ CF3S 0 3(CH2) ,,C H 3
21.5 h, N2
7a
8
Figure 3.7, the synthesis of 9-(phenoxycarbonyI)-10-dodecylacridinium 
trifluoromethanesulfonate (8 )
In the 'HNM R spectrum, there were 7 peaks in the aromatic region and 6  peaks in 
the aliphatic region, integrating in a ratio o f 2:2:2:2:2:2:1:2:2:4:2:12:3. A peak at 
5.52 ppm was attributed to the CH2 group next to the N atom and one at 0.80 ppm to 
the CH 3 group. The protons on the acridinium ring resonated at lower field, than for
1 3com pound 7a. In the CNMR spectrum, there were a signal at 163.3 ppm attributed 
to carbonyl group, another 1 1  aromatic peaks for the 1 1  different aromatic carbons, a 
peak at 52.6 ppm for the CH 2 group next to the N atom and another 11 peaks in 
aliphatic region. The mass spectrum showed a cation at m/z 468 ([M-CF3 SC>3 ]+), and 
an anion at m/z 149 ([CF3 SO3 ]"), corroborating the structure o f the product.
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Table 3.2. The results o f  attempted synthesis o f 9-(phenoxycarbonyl)-l O-dodecylacridinium 
trifluoromethylsulfonate (8) under different conditions.
Solvent Reaction time 
& temperature
The amount o f
7a
The amount o f
la
Yield / %, 
Crude
DCE 45.5 h (reflux) 83.5 mg, 0.28 mmol 80 mg, 0.25 mmol 38
DCE 21.5 h (reflux) 95.5 mg, 0.32 mmol 80 mg, 0.25 mmol 39
Toluene 9 h (reflux) 74.3 mg, 0.25 mmol 100 mg, 0.31 mmol 8
p-xylene 7 h (reflux) 77.2 mg, 0.26 mmol 90 mg, 0.28 mmol 15
Nitrobenzene 2 h (140°C) 65.0 mg, 0.22 mmol 70 mg, 0.22 mmol No pure
4 h (140°C) 59.5 mg, 0.20 mmol 60 mg, 0.19 mmol
product
The starting materials, compounds 7a (phenyl acridine-9-carboxylate) and la (dodecyl 
triflate) in a ratio o f  from 1.3 to 0.8, were heated in solvent (2 ml) for the stated time at the 
stated temperature respectively.
3.2.3 The scheme for synthesis of 9-(phenoxycarbonyl)-10-(3- 
succinimidyloxycarbonyIpropyl)acridinium trifluoromethanesulfonate (9)
The route for synthesis o f compound 9 is shown in figure 3.8. A mixture o f 
compounds 7a and 4b was heated at reflux in DCE for 22.5 h under nitrogen. The 
product was isolated by the method used for isolating compound 4 (section 2.2.4.2), 
The product was obtained in a 2.7% yield. A similar reaction carried out in re fluxing 
nitrobenzene at higher temperature did not give a better yield. The 'HNM R spectrum 
o f compound 9 showed 7 peaks in the aromatic region and 4 peaks in the aliphatic 
region, integrating in a ratio o f 2:2:2:2:2:2:1:2:2:4:2. A typical signal at 5.63 ppm 
was attributed to the CH2 group next to the N atom and a signal at 2.82 ppm was 
attributed to the protons o f the succinimidyloxy group. The mass spectrum, showing 
cations at m/z 483 ([M-CF3 SO3 ]4)  and 368 (figure 3.9), and an anion at m/z 149
([CF3 SO3 ]'), further corroborated the structure o f  the product. The amount o f the
1 ^product was not enough for a CNMR spectrum.
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o,
o
CF3SO3 (CH2)3C - 0 -N  
N
f3 c o 3 s —  (CH2)3C -  o — n , 
O'
4b
DCE, reflux
Figure 3.8, the synthetic pathway for compound 9
(CH2)3C - 0 - N
m/z, 483
Figure 3.9, MS fragment for compound 9
3.2.4 Synthesis of 9-(phenoxycarbonyl)-10-(5-succinimidyloxycarbonylpentyl)- 
acridinium trifluoromethanesulfonate ( 1 0 )
Compound 10 was synthesized in a pathway similar to that used for compound 5 
(section 2.2.5.4), by refluxing phenyl acridine-9-carboxylate (7a) and freshly 
prepared succinimidyl 5-(trifluoromethanesulfonyloxy)hexanoate (5c) in redistilled 
DCE under nitrogen for 22.5 h (figure 3.10). The resulting mixture was evaporated 
under vacuum, and the residue was subjected to gradient chromatography on a silica 
column, eluted with DCM, then DCM+CH 3 CN (4:1) and finally DCM+CH 3.CN (2:1). 
The fractions with R f = 0.15 developed in DCM+CH 3 CN (4:1) were pooled and 
evaporated to give a bright yellow solid in 9% yield.
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o
■q + CF3S0 3 (CH2)5C—o —]
5c
c
DCE, reflux,
CF3 SO3 |
(CH2 )5 C - 0 — N
O'
7a
10
Figure 3.10, synthesis o f 9-(phenoxycarbonyl)-10-(5-succinimidyloxycarbonylpentyl)- 
acridinium trifluoromethanesulfonate (10).
the aliphatic region integrating in a ratio o f 2:2:2:2:2:2:1:2:4:2:2:4. A triplet at 5.70 
ppm was attributed to the CH 2 group next to the N atom and a singlet at 2.88 ppm 
was attributed to the protons o f the succinimidyloxy moiety. The peaks for the 
protons on the acridinium ring appeared at relatively low field compared to the
170.0 and 164.8 ppm for the 3 different carbonyl groups, a typical peak at 52.6 ppm 
for the carbon next to the N atom, and a signal at 26.0 ppm for the CH 2 groups o f the 
succinimidyloxy moiety were found. The IR spectrum showed absorption at 1734 
cm "1 (C =0), presumably for the 3 overlapped carbonyl groups. The mass spectrum 
showed a cation at m/z 511 ([M-CF3 S0 3 ]+) (figure 3.11) and an anion at m/z 149
In the 'HNM R spectrum, there were 7 peaks in the aromatic region and 6  peaks in
1 o
corresponding starting material. In the CNMR spectrum, 3 signals for at 171.0,
([CF3 SO3 ]").
m/z, 511
Figure 3.11, MS fragment for compound 10
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3.2.5 Synthesis of 9-(phenoxycarbonyI)-10-(10-succinimidyloxycarbonyldecyl)- 
acridinium trifluoromethanesulfonate (1 1 )
Compound 11 was synthesized by a procedure similar to that used for synthesis o f 
compound 6  (section 2.2.6.4), by refluxing phenyl acridine-9-carboxylate (7a) and 
succinimidyl 10-(trifluoromethanesulfonyloxy)undecanoate (6 c) in DCE for 21 h 
under N 2 (figure 3.12). The product was isolated in 41% yield by column 
chromatography (silica), eluted by DCM, then DCM+CH3 CN (4:1), and finally 
DCM+CH3 CN (2:1). The fractions with R f 0.19 (developed in DCM+CH3 CN (2:1)) 
were pooled and evaporated to give a yellow solid.
DCE, reflux,
0 + CF3S03(CH2)ioC O N
21 h, N 2
7a
11
Figure 3.12, the synthesis o f 9-(phenoxycarbony1)-l O-(lO-succinimidyloxycarbonyldecyl)- 
acridinium trifluoromethanesulfonate (11)
In the 'HNM R spectrum o f the product, there were 7 peaks in the aromatic region 
and 7 peaks in the aliphatic region integrating in a ratio o f 
2:2:2:2:2:2:1:2:4:2:2:2:2:10. A typical triplet at 5.47 ppm was attributed to the CH2  
group next to the N atom, and a singlet at 2.65 ppm was for the protons o f the 
succinimidyloxy moiety. The peaks attributed to the acridinium ring appeared at
ITrelatively low field compared with the starting material. In the CNMR spectrum, 
peaks at 169.7, 169.1 and 161.5 ppm were attributed to the 3 different carbonyl 
groups. There were also 11 aromatic peaks for 11 different aromatic carbons, a 
typical peak at 52.6 ppm attributed to the carbon next to the N atom, and a peak at
26.0 ppm attributed to the 2 CH 2 groups o f the succinimidyloxy moiety. The mass 
spectrum showed cations at m/z 581 ([M-CF3 SC>3 ]+) and 506 (figure 3.13), and an 
anion at m/z 149 ([CF3 SO3 ] ).
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o Q
(CH2) 10C - O — N 
,NL ^  O'
m/z, 581
O 0.
(CH2)10C - O - N  
NL O'
+ H
HO
m/z, 506
Figure 3.13, MS fragments for compound 11
3.2.6 The scheme o f synthesis of 9-(2,5-dimethylphenoxycarbonyl)-10- 
methylacridinium trifluoromethanesulfonate ( 1 2 )
There are 2 steps involved in synthesis o f 9-(2,5-dimethylphenoxycarbonyl)-10- 
methyl acridinium trifluoromethanesulfonate (12). Compound 12 would be derived 
from 2,5-dimethylphenyl acridine-9-carboxylate (12a), which would be obtained by 
esterification o f compound lb  with 2,5-dimethylphenol. The synthetic pathway is 
illustrated in figure 3.14.
OH
Pyridine, r. t, overnight DCM, r. t, 3 h, N 2
12a 12
Figure 3.14, the synthesis o f 9-(2,5-dimethylphenoxycarbonyl)-10-methylacridinium
trifluoromethanesulfonate (12)
3.2.6.1 Synthesis of 2,5-dimethylphenyl acridine-9-carboxylate (12a)
Compound 12a was synthesized by stirring acridine-9-carboxylic acid chloride (lb )  
and 2,5-dimethylphenol in pyridine at room temperature overnight, in a similar
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synthetic way as used for compound 7a (section 3.2.1.1). The resulting mixture was 
evaporated under vacuum. The product was purified by column (silica) 
chromatography, eluted with DCM.
In the 'HNM R spectrum o f the product, there were 7 peaks in the aromatic region 
and 2 singlets at 3.39 and 2.29 ppm attributed to the 2 different methyl groups on the
1 3phenoxy group, integrating in a ratio o f 2:2:2:2:1:1:1:3:3. In the CNMR spectrum, a 
peak at 166.3 ppm was attributed to the carbonyl group, another 13 aromatic peaks 
for 13 different aromatic carbons, and 2  peaks in the aliphatic region, were found. 
The IR spectrum showed a peak at 1748 cm ' 1 for the ester bond. The mass spectrum 
gave fragments at m/z 328 ([M+H]+), 327 (M+), 206 (100%) and 178 (82%). The 
mass fragments at m/z 206 and 178 are the same as those from compound lc  and 
compound 7a (figure 3.4).
3.2.6.2 Synthesis of 9-(phenoxycarbonyl)-10-methyIacridinium  
trifluoromethanesulfonate ( 1 2 )
Compound 12 was synthesized by stirring compound 12a and methyl triflate in dry 
DCM at room temperature for 3 h. The precipitate produced was filtered and washed 
with DCM and EtOEt to leave a yellow solid. The !HNMR spectrum showed 7 peaks 
in the aromatic region and 3 peaks in the aliphatic region integrating in a ratio o f 
2:2:2:2:1:1:1:3:3:3. A singlet at 4.99 ppm attributed to the methyl group next to the 
N atom and another 2 singlets at 2.30 and 2.16 ppm attributed to the 2 methyl groups 
on the phenoxy ring were found. The peaks for the protons on the acridinium ring
resonated at relatively low field compared to the corresponding protons o f the
• 1 ^  starting material. In the CNMR spectrum, a peak at 165.1 ppm attributed to the
carbonyl group, another 13 aromatic peaks for the 13 different aromatic carbons, a
peak at 41.2 ppm attributed to the methyl group next to the N atom and 2 peaks at
21.5 ppm and 17.2 ppm attributed to the 2 methyl groups on the phenoxy group,
were found. The IR spectrum showed a peak at 1747 cm ' 1 for the ester bond. The
mass spectrum showed cations at m/z 342 ([M-CF3 SC>3 ]+, 100%) and 193 (6 8 %)
(figure 3.15) and an anion at m/z, 149 ([CF3 SO3 ]').
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m/z, 342
m/z, 193
Figure 3.15, the MS fragments o f compound 12
3.2.7 Synthesis of 9-(2,5-dimethylphenoxycarbonyl)-10-(3-
succinimidyloxycarbonylpropyl)acridinium trifluoromethanesulfonate (13)
Compound 13 was synthesized by using 2,5-dimethylphenyl acridine-9-carboxylate 
(12a) and freshly prepared succinimidyl 4-(trifluoromethanesulfonyloxy)butanoate 
(4b), (figure 3.16). The starting materials were refluxed in DCE for 20 h. The 
resulting mixture was extracted with acetonitrile, and the extract showed three TLC 
spots ( 2  yellow and 1 colourless) was loaded onto a silica column for 
chromatography. The 1st yellow band was eluted with DCM, and then the column 
was eluted with DCM + MeOH (3:1), the fractions with R f = 0.25 (developed in 
DCM + MeOH (3:1)) were pooled and evaporated to give a white solid. The solid 
was obtained in only small amount, but sufficient to get a 'HNM R spectrum. 
'HNM R (400 Hz, chloroform-d, 5, ppm) showed 3 peaks, 9.37 (2H, m), 9.09 (1H, t, J 
= 8  Hz), 8.56 (2H, m). It is clear that this side product does not contain a 2,5- 
dimethylphenoxy moiety, and the succinimidyloxycarbonylpropyl group is not 
present. Furthermore, the white colour suggests that the product does not contain an 
acridine ring. It is possible that the acridine ring has been reduced to an acridan ring, 
but the mechanism for producing such a side product is unknown. The fractions 
containing the 3rd yellow band with R f = 0.15 were pooled and evaporated to give a 
yellow solid. This proved to be the desired product as shown by ]HNMR and mass
13spectrometry. It has not been characterized by CNMR, since there was not enough
i  o
sample to obtain a CNMR spectrum.
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reflux, 2 0  h
13
C F 3S 0 3(C H 2) 3 C - 0 — Nx
1 2 a
Figure 3.16, synthesis o f 9-(2,5-dimethylphenoxycarbonyl)-10-(3- 
succinimidyloxycarbonylpropyl)acridinium trifluoromethanesulfonate (13)
In the 1HNMR spectrum, there were 7 peaks in the aromatic region and 6  peaks in 
the aliphatic region, integrating in a ratio o f 2:2:2:2:1:1:1:2:2:4:2:3:3. A triplet at 
5.83 ppm was attributed to the CH 2 group next to the N atom. A singlet at 3.03 ppm 
attributed to the 2  identical CH 2  groups o f the succinimidyloxy moiety, and 2  singlets 
at 2.59 and 2.46 ppm attributed to the 2 different methyl groups on the phenoxy 
group, were found. The peaks for the protons on the acridinium ring resonated at 
relatively low field compared to the corresponding protons o f  the starting material. 
The cations in the mass spectrum at m/z 511 ([M-CF3 SC>3]+), 414 and 396 (figure 
3.17), and an anion at m/z 149 ([CF3 SO3 ]') further proved it was the desired structure.
m/z, 414m/z, 511
Figure 3.17, the MS fragments for compound 13
3.2.8 Synthesis of 9-(2,5-dimethyIphenoxycarbonyl)-10-(5-
succinimidyloxycarbonylpentyl)acridinium trifluoromethanesulfonate (14)
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Compound 14 was synthesized in a pathway similar to those used for compounds 5 
(section 2.2.5.4) and 10 (section 3.2.4), by refluxing 2,5-dimethylphenyl acridine-9- 
carboxylate (12a) and succinimidyl 5-(trifluoromethanesulfonyloxy)hexanoate (5c) 
in DCE for 21 h, as illustrated in figure 3.18. The resulting mixture was stripped of 
solvents, and subjected to chromatography on a silica column, eluted with DCM+ 
MeOH (3:1). The fractions with R f = 0.18 were pooled and evaporated to give a 
yellow solid.
In the 'HNM R spectrum, there were 7 peaks in the aromatic region and 6  peaks in 
the aliphatic region, integrating in a ratio o f 2:2:2:2:1:1:1:2:4:2:3:3:2:4. A triplet at 
5.39 ppm was attributed to the CH2 group next to the N atom. A singlet at 2.60 ppm 
attributed to the 2  identical CH2  groups o f the succinimidyloxy moiety, and 2  singlets 
at 2.24 and 2.11 ppm attributed to the 2 methyl groups on the phenoxy group, were 
found. The protons on the acridinium ring resonated at the relatively low field 
compared to those corresponding protons o f the starting material. In the l3CNMR 
spectrum, there were 3 peaks at 169.8, 168.9, and 163.2 ppm attributed to the 3 
different carbonyl groups, and another 13 aromatic peaks for the 13 different 
aromatic carbons. A signal at 52.3 ppm was attributed to the CH 2 group next to the N 
atom and a peak at 26.0 ppm was attributed to the 2  CH 2 groups o f the succinimidyl 
moiety. Two peaks at 21.5 and 17.2 ppm for the 2 methyl groups on the phenoxy 
group were found. The cations in the mass spectrum at m/z 539 ([M-CF3 S0 3 ]+), 442 
and 424 (figure 3.19); and an anion at m/z 149 ([CF3 SO 3]') further proved it was the 
desired structure.
CF3S0: (Ch 2)5c — o - n
DCE, N 2
+ CF3 S 0 3 (CH2 )5 C— O— N
reflux, 21 h
12a
14
Figure 3.18, synthesis o f  9-(2,5-dimethylphenoxycarbonyl)-10-(5- 
succinimidyloxycarbonylpentyl)acridinium trifluoromethanesulfonate (14)
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m/z, 539 m/z, 442
Figure 3.19, the MS fragments for compound 14
3.2.9 The synthesis o f 9-(2,5-dimethylphenoxycarbonyl)-10-(10- 
succinimidyloxycarbonyIdecyl)acridinium trifluoromethanesulfonate (15)
Compound 15 was synthesized in a synthetic pathway similar to those used for 
compounds 6  (section 2.2.6.4) and 11 (section 3.2.5), by refluxing 2,5- 
dimethylphenyl acridine-9-carboxylate (12a) and succinimidyl 10- 
(trifluoromethanesulfonyloxy)undecanoate (6 c) in DCE for 20 h (figure 3.20). The 
product was isolated by chromatography in 34% yield.
CF3SO3 (CH2) 10C - O - N
DCE, N2
reflux, 2 0  h
15
+ CF3SO3(CH2) ,0C— o — N
12a
Figure 3.20, synthesis o f  9-(2,5-dimethylphenoxycarbonyl)-10-(10- 
succinimidyloxycarbonyldecyl)acridinium trifluoromethanesulfonate (15)
In the 'HNM R spectrum, there were 7 peaks in the aromatic region and 8  peaks in 
the aliphatic region, integrating in a ratio o f 2:2:2:2:1:1:1:2:4:2:3:3:2:4:10. A triplet
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at 5.59 ppm was attributed to the CH 2 group next to the N atom. A singlet at 2.83 
ppm attributed to the 2  identical CH 2 groups o f the succinimidyloxy moiety and 2  
singlets at 2.44 and 2.31 ppm attributed to the 2 methyl groups on the phenoxy group 
were found. Peaks for the protons on the acridinium ring resonated at the relatively 
lower field than those for the corresponding protons o f the starting material. In the 
13CNMR spectrum, peaks at 169.8, 169.1, and 163.3 ppm attributed to the 3 different 
carbonyl groups, and another 13 aromatic peaks for the 13 aromatic carbons were 
found. A signal at 52.3 ppm for the CH 2 group next to the N atom, a peak at 26.0 
ppm for the 2 CH 2 groups o f the succinimidyloxy moiety and 2 peaks at 21.5 and
17.2 ppm for the 2 methyl groups on the phenoxy moiety, were found. Cations in the 
mass spectrum at m/z 609 ([M-CF3 S0 3 ]+) and 512 (figure 3.21), and an anion at m/z 
149 ([CF3 SO3 ]") further proved it was the desired product.
m/z, 609 m/z, 512
Figure 3.21, the MS fragments for compound 15
3.2.10 The scheme of synthesis of 9-(2,6-bis(trifluoromethyl)phenoxycarbonyl)-
1 0 -methylacridinium trifluoromethanesulfonate (16)
2,6-Bis(trifluoromethyl)phenyl acridine-9-carboxylate (16e) is an essential 
intermediate for compound 16. Compound 16e is an analogue o f  compounds 5c, 
7a, and 12a. Therefore, it could be synthesized by using 2,6-
bis(trifluoromethyl)phenol (16d) and lb  in a synthetic pathway similar to that used 
for its analogues. However, 2,6-bis(trifluoromethyl)phenol (16d) is not commercially 
available. Therefore, 3 extra steps would be needed for the synthesis o f 2,6- 
bis(trifluoromethyl)phenol (16d) from 2-trifluoromethylphenol (16a). The hydroxy
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group o f 2-trifluoromethylphenol (16a) would need to be protected by 3,4- 
dihydropyran to produce 16b, which would be treated with n-BuLi followed by 
iodine in order to attach an iodide atom ortho to the hydroxy group to afford 
compound 16c. Finally, substituting the iodide atom on 16c with a trifluoromethyl 
group would accomplish the synthesis o f 2 ,6 -bis(trifluoromethyl)phenol (16d).
3.2.10.1 Synthesis of 2-(trifluoromethyl)phenol tetrahydropyranyl ether (16b)
2-(Trifluoromethyl)phenol (16a) was refluxed with excess 3,4-dihydropyran (DHP) 
in EtOEt for 18 h, in the presence o f a little jp-toluenesulfonic acid monohydrate as 
catalyst, as shown in figure 3.22. The resulting mixture was poured into saturated 
NaHC 0 3  solution and the product was extracted with EtOEt, dried over MgS0 4  and 
evaporated under vacuum to give the crude product, which was purified by 
chromatography on a silica column. The product was obtained in 89% yield . 1 2 , 13 The
19 ITmechanism ’ is shown in figure 3.23.
The 'HNM R spectrum o f 16b showed 4 peaks in the aromatic region and 6  apparent 
peaks in the aliphatic region, integrating in a reasonable overall ratio, 4:9. It is worth 
noting that an asymmetric center was produced (figure 3.22), so the protons o f the 
CH 2  groups are in principle not identical. However, only those o f the CH2 group next 
to the oxygen atom gave 2 clearly separated signals, at 3.77ppm (apparent dt), and at
3.53 ppm (m).
CF3 DHP, reflux, 18 h
EtOEt, TsOH.H20  
16 a
16 b
Figure 3.22, protection o f hydroxyl group
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0
Figure 3.23, the mechanism o f synthesis o f 2-(trifluoromethyl)phenol tetrahydropyranyl
ether
3.2.10.2 Synthesis of 2-trifluoromethyI-6-iodophenol (16c)
M ethoxy groups are known to direct lithiation to the ortho position o f an aromatic 
ring, so the presence of the ether bond should allow lithiation to occur at the ortho 
position. The lithium could then be replaced by iodine. Compound 16b in THF was 
treated with n-butyllithium at -78 °C. After the mixture was stirred for 30 minutes, a 
solution o f iodine in THF was added and stirred for further 10 minutes before 
allowing the mixture to warm to room temperature. The resulting brown mixture was 
poured into aqueous Na2 SC>3 (2 0 %) solution to remove the excess iodine, causing it 
to turn pale yellow after shaking. The product was extracted with EtOEt, dried over 
M gS 0 4  and evaporated under vacuum to give a yellow oil. In its 1HNMR spectrum, 
three peaks were found in the aromatic region from 7.88 to 6.80 ppm. The lack o f a 
fourth peak indicated that one proton had been exchanged by iodine. The proton 
integrals in the aromatic region and aliphatic regions were in a ratio o f approximately 
3:9 revealing that the product should indeed be 2-(trifluoromethyl)-6-iodophenol 
tetrahydropyranyl ether (16c’). Although the 'HNM R spectrum proved that the 
synthesis o f compound 16c’ was successful, a small amount o f impurities was still 
present. The crude product was purified by short-path distillation using a Kugelrohr 
apparatus, according to the literature (b.p. 70 °C / 0.25 Torr12; b.p. 130 °C / 1 Torr13). 
It is interesting that 2-(trifluoromethyl)-6-iodophenol tetrahydropyranyl ether 
completely decomposed into its corresponding phenol 2 -(trifluoromethyl)-6 - 
iodophenol (16c) during short-path distillation at 130 °C (1 Torr), and decomposed to 
the extent o f about 50% at 120 °C (0.7 Torr). The 'HNM R spectrum o f 16c showed a
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peak at 5.76 ppm, attributed to the proton o f its hydroxyl group. However, there were 
also other peaks in the downfield region, attributed to impurities produced from 
hydrolysis (figure 3.25). The crude sample o f compound 16c would correspond to a 
94% yield, if  it were assumed to be pure, but in reality, it was contaminated by about
15% o f  dihydropyran hydrate. The yield was lower than that reported in the literature
12(97% yield). One possible explanation for this is that smaller quantities o f the 
starting material were used, so loss in transfer and during distillation would be 
greater.
OTHP
1 6 b  1 6 c
Figure 3.24, synthesis o f  2-(trifluoromethyl)-6-iodophenol (16c)
Figure 3.25, the possible hydrolysis o f  2-(trifluoromethyl)-6-iodophenol tetrahydropyranyl
ether
3.2.10.3 Synthesis of 2,6-bis(trifluoromethyI)phenol (16d)
2,6-Bis(trifluoromethyl)phenol (16d) was prepared from 2-(trifluoromethyl)-6- 
iodophenol by using the reactive organometallic compound ‘CuCFs’, which was 
produced by Burton’s methodology , 13' 15 shown in figure 3.26. The mechanism 
proposed for the formation o f CF3 MX and the subsequent reaction to form CF3 CU is 
shown in figure 3.27. A mixture o f cadmium powder in DMF was cooled to 0 °C 
under nitrogen, and CF2 Br2  was introduced by a syringe very slowly. Upon contact o f 
the CF2 Br2 with Cd powder, heat and gas were given off, indicating an exothermic 
reaction. The mixture was diluted with HMPA to stabilize the reactive component, 
and then CuBr was added at 0 °C. The resulting mixture was treated with 2- 
(trifluoromethyl)-6 -iodophenol and heated at 65 °C for 1.5 h. After cooling, the
Chapter 3 110
resulting mixture was poured into a mixture o f HC1 (3 mol L"1) and EtOEt. Solids
were removed by filtration, and the aqueous phase was extracted with EtOEt. The
combined extract was washed with saturated NaCl to remove some o f the DMF,
dried over MgS0 4  and evaporated to give the crude product, which was purified by
short-path distillation at 80 °C / 0.7 Torr (lit., b.p. 130 °C / 1 Torr13and b.p. 70 °C / 
120.25 Torr ), to give a colourless oil which turned to yellow on standing.
In the 'HNM R spectrum o f the product, two peaks at 7.70 ppm and 7.06 ppm were 
found in the aromatic region, integrating in a ratio 2:1. The spectrum also showed the 
peaks o f DMF (corresponding to around 17% o f the mass). The CNMR spectrum 
gave 5 signals at 153.0, 131.0, 123.8 (q due to coupling to 3 F nuclei), 120.3, and
120.0 ppm for 5 different carbons. The mass spectrum showed the molecular ion at 
m/z 230 ([M]+).
The short-path distillation could separate the product from the starting material, but 
DMF possesses a boiling point relatively close to the product, so could not be 
removed completely by this way. Column chromatography after short-path 
distillation was used by Dr. A.M. Holland to purify the product13. However, because 
the DMF would not affect the reaction in the next stage and the amount o f the 
product obtained in this stage was not enough for the luxury o f chromatography, the 
product containing 17% DMF was used for the next stage without further 
purification. The yield (38%) on this stage was low, due to the losses during 
extraction and short-path distillation.
OH
IX ^ 1;^ . C F 3 1. Br2CF2 Cd, DMF
I I  2. CuBr, HMPA
16c
Figure 3.26, synthesis o f  2,6-bis(trifluoromethyl)phenol
Cd + CF2 Br2 -»  Cd+[CF2 Br2]’ ->  [CF2 Br]“ + Br + Cd2+
[CF2 Br]‘ ->  [:CF2] + B f  
[:CF2] + Me2N C H =0 —► CO + M e2NCF2H «-► [Me2N +=C FH ]F
Chapter 3 111
F" + [:CF2] [CF3'] -*  CF3CdBr + (CF3)2Cd + Br"
CF3CdBr + (CF3)2Cd + CuBr -> [CF3 Cu]
Figure 3.27, suggested mechanism for formation o f [CF 3 CU] 1 2 ’ 1 3
3.2.10.4 Synthesis of 2,6-bis(trifluoromethyl)phenyI acridine-9-carboxyIate (16e)
2,6-Bis(trifluoromethyl)phenyl acridine-9-carboxylate (16e) was synthesized in a 
way similar to those used for compounds lc  (section 2.2.1.3), 7a (section 3.2.1.1) 
and 12a (section 3.2.6.1) by stirring 2,6-bis(trifluoromethyl)phenol (16d) and 
acridine-9-carboxylic acid chloride (lb ) in pyridine overnight at room temperature 
(figure 3.28). The product was isolated by chromatography. The ,HNMR spectrum 
o f the product showed 6  peaks in the aromatic region, integrating in a ratio o f 
2:2:2:2:2:1. In the 13CNMR spectrum, a signal at 164.6 ppm attributed to the 
carbonyl group; a peak at 122.8 ppm (q due to coupling to 3 F nuclei) attributed to 
the CF3 group and another 11 aromatic peaks for 11 the different carbons, were 
found, while there were 7 different aromatic carbons for compound lb . The IR 
spectrum showed an absorption at 1758 cm"1. The Cl mass spectrum showed pseudo 
molecular ion peaks at m/z 435 ([M]+) and 436 ([M+H]+), giving the corroboratory 
evidence for the desired product. The other MS fragments were similar to those o f  
compounds lc  and 7a (figure 3.4).
Figure 3.28, synthesis o f  2,6-bis(trifluoromethyl)phenyl acridine-9-carboxylate (16e)
3.2.10.5 Synthesis of 9-(2,6-bis(trifluoromethyI)phenoxycarbonyl)-10- 
mcthylacridinium trifluoromethanesulfonate (16)
Pyridine, r.t, overnight
1 6 e
The synthesis o f compound 16 was carried out by stirring 2,6-
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bis(trifluoromethyl)phenyl acridine-9-carboxylate (16e) and methyl triflate in a way 
similar to that used for compounds 2 (section 2.2.2), 7 (section 3.2.1.2), and 12 
(section 3.2.6.2), as illustrated in figure 3.29. The precipitate in the resulting mixture 
was filtered, and washed with EtOEt to provide the product (16).
16e
20 h
16
Figure 3.29, synthesis o f  9-(2,6-bis(trifluoromethyl)phenoxycarbony])-10-methylacridinium
trifluoromethanesulfonate (16)
In the 'iTNMR spectrum o f the product, there were 6  peaks in the aromatic region 
and another one singlet at 4.95 ppm attributed to the methyl group next to the N atom, 
integrating in a ratio o f  2:2:2:2:2:1:3. Peaks for the protons on the acridinium ring 
resonated at the relatively low field compared to those for the corresponding protons 
o f the starting material. In the 13CNMR spectrum, a peak at 161.7 ppm was attributed 
to the carbonyl group and a peak at 40.1 ppm was attributed to the methyl group next 
to the N atom. Another 11 aromatic peaks for the 11 different aromatic carbons were 
found. However, the signal for CF3 groups was too weak to be seen. The mass 
spectrum showing cations at m/z 450 ([M-CF3 S0 3 ]+), 221 and 193 (figure 3.30), and 
an anion at m/z, 149 ([CF3 SO 3]'), corroborated the structure o f  the product.
Figure 3.30, MS fragments for compound 16
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3.2.11 Synthesis of 9-(2,6-bis(trifluoromethyl)phenoxycarbonyl)-10-(10- 
succinimidyloxycarbonyldecyl)acridinium trifluoromethanesulfonate (17)
Compound 17 was synthesized in a synthetic pathway similar to that used for 
compounds 6  (section 2.2.6.4), 11 (section 3.2.5) and 15 (section 3.2.9), by
refluxing 2,6-bis(trifluoromethyl)phenyl acridine-9-carboxylate (16e) and 
succinimidyl 10-(trifluoromethanesulfonyloxy)undecanoate (6 c) in DCE for 21 h 
under N 2 , as illustrated in figure 3.31. The resulting mixture was evaporated under 
vacuum, then DCM was used to extract the residue, and EtOEt to precipitate the 
product. The procedure o f re-dissolving and re-precipitating was repeated several 
tim es in a way for isolating compounds 3, 4, 5 and 6 . The 'HNM R spectrum showed 
impurities in the aromatic region. This suggested that some side reaction occurred, 
and the side product has similar R f values to those o f compound 17. Therefore 
HPLC (ODS column; mobile phase: CH3CN + H2O (90:10); UV detector) was 
employed to isolate the product. The fractions with Rt (retention time) = 1.79 
minutes or so were collected, condensed and injected back, and only one peak 
appeared as expected. But the ’HNMR showed the signal for the CH2 group close to 
the N atom was not around 5.6 ppm as its other analogues, but at 4.57 ppm, so the 
compound collected from HPLC was not the desired product.
Figure 3.31, synthesis o f 9-(2,6-bis(trifluoromethyI)phenoxycarbonyl)-10-(10- 
succinimidyloxycarbonyldecy])acridinium trifluoromethanesulfonate (17)
Therefore, the crude product was purified by flash chromatography (silica column), 
eluted with DCM, and then DCM + acetonitrile (3:1). The fractions with R f 0.19 
developed in DCM + acetonitrile (3:1), were pooled and evaporated to give a bright 
yellow solid in 11% yield. In the 'iTNMR spectrum o f the product, there were 6
17
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peaks in the aromatic region and 7 peaks in the aliphatic region, integrating in a 
reasonable ratio o f 2:2:2:2:2:1:2:4:2:2:4:10. A triplet at 5.69 ppm was attributed to 
the CH2 group next to the N atom, and a singlet at 2.85 ppm was attributed to the 
protons o f the succinimidyloxy moiety. Peaks for the protons on the acridinium ring 
resonated at the relatively low field compared to the corresponding protons o f the 
starting material. In the I3CNMR spectrum, 3 peaks at 169.7, 169.1 and 161.8 ppm 
were attributed to the 4 carbons o f the 3 different carbonyl groups. Another 11 peaks 
in total in the aromatic region for 11 carbons, and a peak at 53.3 ppm attributed to the 
CH 2 group next to the N atom, were found. A peak at 26.0 ppm was attributed to the 
CH 2 groups o f succinimidyloxy moiety. However, no signal for CF3 groups was 
found. The coupling o f the carbon nucleus with the three F nuclei resulting in 4 split 
peaks possibly accounted for the weakness o f the signal. The 19FNMR spectrum 
showed 2 peaks at -78.4 ppm ([CF3 SO3]') and -59.8 ppm (the 2 CF3 substituents on 
the phenoxy group). The mass spectrum showed a cation at m/z 717 ([M-CF3 SC>3 ]+) 
(figure 3.32), and an anion at m/z 149 ([CF3 SO3 ]').
3.2.12 Attempt to synthesize 9-(2,6-bis(trifluoromethyl)phenoxycarbonyl)-10-(3- 
succinimidyloxycarbonylpropy])acridinium trifluoromethanesulfonate (23)
The attempt to synthesize 9-(2,6-bis(trifluoromethyl)phenoxycarbonyl)-10-(3-
performed by using 2,6-bis(trifluoromethyl)phenyl acridine-9-carboxylate (16e) (53 
mg, 0.12 mmol) and freshly prepared succinimidyl 3-(trifluoromethanesulfonyloxy)-
m/z , 7 1 7
Figure 3.32, the MS fragment for compound 17
succinimidyloxycarbonylpropyl)acridinium trifluoromethanesulfonate was
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butanoate (4b) (36 mg, 0.11 mmol). The starting materials were refluxed in DCE for 
21 h, as illustrated in figure 3.33. Unlike the reaction for compound 17 and other 
analogues, the mixture turned black after heating for a few hours. TLC showed a 
yellow spot possessing an R f value similar to that o f compound 17 and other 
analogues. An attempt was made to separate the product in a way similar to that used 
for LiAE, but no pure product was obtained, possibly due to the yield being too poor 
and side reactions having happened. Due to the strongly electron-withdrawing 
substituents on the phenoxy group, the electron density on the phenoxy moiety 
decreases and electrons flow from the acridine ring to the phenoxy group, resulting 
in the electron density on the acridine ring decreasing too. Therefore, the reactivity o f 
compound 16e toward electrophiles decreases and furthermore compounds 16e and 
4b have several easily broken moieties, so side reactions are more likely. The 
reaction was not tried in TCE at higher temperature because o f the probability o f side 
reactions.
3.2.13 Attempt to synthesize 9-(2,6-bis(trifluoromethyl)phenoxycarbonyl)-10-(5- 
succinimidyloxycarbonylpentyl)acridinium trifluoromethanesulfonate (24)
The attempted synthesis o f 9-(2,6-bis(trifluoromethyl)phenoxycarbonyl)-10-(5- 
succinimidyloxycarbonylpentyl)acridinium trifluoromethanesulfonate was performed 
by refluxing 2,6-bis(trifluoromethyl)phenyl acridine-9-carboxylate (16e) (90 mg, 
0.21 mmol) and freshly prepared succinimidyl 5-
(trifluoromethanesulfonyloxy)hexanoate (5c) (75 mg, 0.21 mmol) in DCE for 21 h 
under N 2 (figure 3.33; n = 5; Rj = R2 = CF3) The mixture turned to black after 0.5 h. 
Although TLC showed a yellow spot with R f = 0.19 (a R f value similar to that o f 
compound 17 and its analogues), when developed in DCM + CH3 CN (3:1), due to a 
very low yield, no pure product was obtained or characterized. The reaction was 
repeated for 4 times, but on no occasion was a pure product isolated due to the same 
reason with for compound 23.
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CF3SO3 (CH2)nC - 0 — N
DCE
+ CF3S 0 3(CH2)nC - 0 - N
reflux, 21 h, N2
n — 3, 5 ] R] — R2  — CF3 , Rj — R2  — N 0 2
Figure 3.33, the reactions for conjunction o f compounds 16e and 18a separately with 4b and
5c
3.2.14 The scheme of synthesis o f 9-(2,6-dinitrophenoxycarbonyI)-10“ 
methylacridinium trifluoromethanesulfonate (18)
There are 2 steps involved in the synthesis o f compound 18, by using methyl triflate 
and 2,6-dinitrophenyl acridine-9-carboxylate (18a). Compound 18a was prepared 
from 2,6-dinitrophenol and acridine-9-carboxylic acid chloride (lb ).
3.2.14.1 Synthesis of 2,6-dinitrophenyl acridine-9-carboxylate (18a)
Compounds lc , 7a, 12a and 16e, synthesized by stirring acridine 9-carboxylic acid 
chloride (lb ) with the corresponding phenols in pyridine for more than 2 0  h, are 
analogous to 18a. Commercial 2,6-dinitrophenol contains 20% water, and stirring 
the commercial material with lb  in pyridine would result in the hydrolysis o f lb  into 
the carboxylic acid la , giving none o f the desired product (18a). Therefore, the 
water should first be removed from 2,6-dinitrophenol. The commercial 2,6- 
dinitrophenol was dissolved in DCM and treated with MgSC>4 followed by filtration 
and evaporation under vacuum. The 2,6-dinitrophenol obtained was used in the next 
stage without further purification.
A mixture o f acridine-9-carboxylic acid chloride (lb )  and dry 2,6-dinitrophenol 
dissolved in pyridine was stirred at room temperature (figure 3.34), during which, 
some yellow solid floated in the upper solution, while the by-product, pyridinium
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chloride, precipitated at the bottom. The product was isolated by chromatography, 
but the yield o f 2,6-dinitrophenyl acridine-9-carboxylate (18a) was only 9%, far 
lower than that o f 2,6-bis(trifluoromethyl)phenyl acridine-9-carboxylate (16e) under 
the same conditions. Therefore, the synthesis was carried out in a different way, by 
using acridine-9-carboxylic acid (la ) and 2,6-dinitrophenol with DCC as dehydrating
• 8 1113initiator in THF. " ’ TLC showed a new spot different from the starting materials, 
but no pure product was isolated after chromatography, due to the yield being too 
poor. The reaction was modified by using compound lb  and 2,6-dinitrophenol, in the 
presence also o f DCC as a dehydrating initiator. This time the product was isolated in 
22% yield. The low yield may have resulted not only from hydrolysis, but also 
possibly as a result o f the steric hindrance o f the two bulky NO 2 groups. It is also 
possible that the difficulties with isolation rather than fundamental problems with the 
reaction itself, resulted in the poor yield. In particular, the product had 
chromatographic characteristics very close to those o f the side product, DCU. The R f 
value o f 18a was lower than those o f its analogues, compounds lc , 7a, 12a and 16e, 
which made it quite difficult to separate cleanly from DCU.
A possible way to improve the yield would be to add the 2,6-dinitrophenol during the 
conversion o f acridine-9-carboxylic acid (la ) to acridine-9-carboxylic acid chloride 
(lb ) by refluxing in SOCI2 , so that the water in 2 ,6 -dinitrophenol could be removed 
by the SOCI2 and hydrolysis would be prevented. In such circumstance, there would 
be no need to have DCC involved in the reaction, and the difficult purification would 
be avoided. However, this idea has not been put into practice, because the product 
obtained was enough for use in the following stages.
In the 'HNMR spectrum of 18a, there were 5 peaks in the aromatic region, 
integrating in a ratio o f 2:2:2:2:3. It seems that two signals overlapped accidentally.
1 'y
In the CNMR spectrum, there was a signal at 163.9 ppm, attributed to the carbonyl 
group; 11 aromatic peaks accounted for 11 different carbons, while there were only 7 
different aromatic carbons for the compound lb . The IR spectrum showed a peak at 
1775 cm"1. The EI/CI mass spectrum showed a molecular ion cluster at m/z 389 
([M]+) and 390 ([M+H]+), giving the corroboratory evidence for the desired product. 
The other MS fragments at m/z 206 and 178 were similar to those o f compounds lc  
and 7a, shown in figure 3.4.
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O H
o 2n  n o 2
n o 2
18a
Figure 3.34, synthesis o f  2,6-dinitrophenyl acridine-9-carboxylate (18a)
3.2.14.2 Synthesis of 9-(2,6-dinitrophenoxycarbonyl)-10-methylacridinium  
trifluoromethanesulfonate (18)
The synthesis o f compound 18 was carried out by refluxing 2,6-dinitrophenyl 
acridine-9-carboxylate (18a) and methyl triflate in DCE, in a way similar to that used 
to prepare compound 2 in section 2.2.2, compound 7 in section 3.2.1.2 and 
compound 12 in section 3.2.6.2, The synthetic pathway is illustrated in figure 3.35. 
The product was isolated by filtration followed by washing with EtOEt to give a 
yellow solid in 46% yield.
n o 2
1 8 a
CF3SO3
C H ,
+  C F 3S O 3C H 3
D C M , r. t, N 2
3 h
n o 2
18
Figure 3.35, synthesis o f  9-(2,6-dinitrophenoxycarbonyl)-10-methylacridinium 
trifluoromethanesulfonate (18)
In the HNMR spectrum, there were 6  peaks in the aromatic region and a singlet at 
4.95 ppm attributed to the methyl group next to the N  atom, integrating in a ratio o f 
2:2:2:2:2:1:3. The peaks for the protons on the acridinium ring resonated at relatively
1 3low field compared to those o f the starting material. In the CNMR spectrum, a peak 
at 160.4 ppm was attributed to the carbonyl group, 11 aromatic peaks was attributed 
to the 11 different aromatic carbons, and a peak at 42.0 ppm was attributed to the
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methyl group next to the N atom. The IR spectrum gave the absorption at 1767 cm '1. 
The mass spectrum showed cations at m/z 404 ([M-CF3 SC>3]+) and 193 (figure 3.36), 
and an anion at m/z 149 ([CF3 SO3 ]').
Figure 3.36, the MS fragments for com pound 18
3.2.15 Synthesis of 9-(2,6-dinitrophenoxycarbonyI)-10-(10-
succinimidyloxycarbonyldecyl)acridinium trifluoromethanesulfonate (19)
Compound 19 was synthesized by a synthetic pathway similar to that used for 
compound 6  in section 2.2.6.4, compound 11 (section 3.2.5), compound 15 
(section 3.2.9) and compound 17 (section 3.2.11) by refluxing 2,6-dinitrophenyl 
acridine-9-carboxylate (18a) and succinimidyl 10-
(trifluoromethanesulfonyloxy)undecanoate (6 c) in DCE for 20 h under N 2 , as 
illustrated in figure 3.37. The product was isolated by chromatography in 14% yield.
+ CF3SO3(CH2) 10C o  n
NO;
18a
DCE, reflux
20 h, N2
CF3S 0 3 (CH2) 10C -O — N,
NO;
19
Figure 3.37, synthesis o f  9-(2,6-dinitrophenoxycarbonyl)-10-(10- 
succinimidyIoxycarbonyldecyl)acridinium trifluoromethanesulfonate (19)
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In the 'HNM R spectrum, there were 5 peaks in the aromatic region, two o f them 
overlapped accidentally, and 6  peaks in the aliphatic region, all integrating in a ratio 
o f 4:2:2:2:1:2:4:2:2:4:10. A triplet at 5.48 ppm and a singlet at 2.69 ppm were 
attributed to the CH 2 group linked to the N atom and the succinimidyloxy moiety, 
respectively. The peaks for the protons on the acridinium ring resonated at relatively
1 3low field compared to those o f the starting material. In the CNMR spectrum, 3 
peaks at 169.7, 169.1 and 161.1 ppm were attributed to the 4 carbons o f the 3 
different carbonyl groups; there were also 1 1  peaks in total in the aromatic region, a 
typical peak at 53.1 ppm for the CH 2 group next to the N atom, and a peak at 26.0 
ppm for the CH2 groups o f succinimidyloxy moiety. The IR spectrum showed one 
overlapped absorption for carbonyl groups at 1735 cm '1. The mass spectrum showed 
a cation at m/z 671 ([M-CF3 S0 3 ]+) (figure 3.38) and an anion at m/z 149 ([CF3 SO3 ]'), 
as expected.
o °^ \
( c h 2) :oc - o - n J
m/z, 671
Figure 3.38, MS fragment for compound 19
3.2.16 Attempts to synthesize 9-(2,6-dinitrophenoxycarbonyl)-10-(3- 
succinimidyloxycarbonylpropyl)acridinium trifluoromethanesulfonate (25) and 
9-(2,6-dinitrophenoxycarbonyl)-10-(5-succinimidyloxycarbonylpentyl)- 
acridinium trifluoromethanesulfonate (26)
2,6-Dinitrophenyl acridine-9-carboxylate (18a) and freshly prepared succinimidyl 5- 
(trifluoromethanesulfonyloxy)hexanoate ester (5c) (33 mg, 0.084 mmol) were 
refluxed in DCE in a round bottom flask (5 ml) under N 2 . The resulting mixture 
turned black after heating for 1 hour or so. The experiment was attempted several 
times and isolation o f the product was tried by chromatography, or by the way used
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to purify LiAE (involving solvent washes), but no pure product was obtained in any 
case, due to the small amount o f the sample and too poor yield. A similar result was 
obtained for the attempted synthesis o f 9-(2,6-dinitrophenoxycarbonyl)-10-(3- 
succinimidyloxycarbonylpropyl)acridinium trifluoromethanesulfonate by using the 
corresponding starting materials. The attempted synthetic route is illustrated in 
figure 3.33 (n = 3 or 5; R\ = R 2  = NO 2 ) in section 3.2.13.
3.3 Experimental details and charaterization
3.3.1.1 Synthesis of phenyl acridine-9-carboxylate (7a)
In a round bottom flask (25 ml) equipped with a CaCl2  drying tube and a magnetic 
stirrer bar, acridine-9-carboxylic acid chloride (290 mg, 1.20 mmol) in pyridine (15 
ml) was heated to 50 °C. After the solid had dissolved completely, the solution was 
cooled to room temperature, phenol (141 mg, 1.50 mmol) was added and the mixture 
was stirred vigorously overnight. The resulting mixture was stripped o f pyridine to 
leave a brown solid. DCM (10 ml) was used to extract the product and the extract 
was subjected to column chromatography, eluted with toluene + EtOAc (4:1). The 
fractions with R f = 0.51 were collected and evaporated to give a pale yellow solid
(226 mg, 63% yield), m.p. 192 - 193 °C (lit.13, 193 °C).
14
HNMR (400 MHz, chloroform-d, 5, ppm), 8.26 (2H, H ,, H8, d, J = 9 Hz), 8.18 (2H, 
H4, H5, d, J = 9 Hz), 7.79 (2H, H3, H6, dd, J = 9, 7 Hz), 7.61 (2H, H2, H7, dd, J = 9, 7 
Hz), 7.49 (2H, H i3, H 15, t, J = 9 Hz), 7.41 (2H, H 12, H 16, d, J = 9 Hz), 7.32 (1H, H 14, t, 
J = 9 Hz).
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I3CNMR (400 MHz, chloroform-d, 6 , ppm), 166.3 (C 10), 150.9 (C n ), 149.0 (C4 a/C 4 a0,
135.6 (C9), 130.9, 130.4, 130.3 (C4 /C5, C3/C6, C ,3 /C ,5), 128.0 (C2 /C 7), 127.1 (Ci/C8),
125.3 (C 14), 1 2 2 . 8  (C9 a/C9 aO, 121.9 (C 12/C 16).
IR (t), cm '1), 1747 (C =0).
MS (m/z), El: 299 (M+, 78%), 206 (97%), 178 (100%).
3.3.1.2 Synthesis of 9-(phenoxycarbonyl)-10-methylacridinium  
trifluoromethanesulfonate (7)
To a round bottom flask (5 ml), equipped with a stirrer bar, phenyl acridine-9- 
carboxylate (65 mg, 0.22 mmol) was added. The flask was flushed with nitrogen. 
Afterwards dry dichloromethane (2 ml) and methyl triflate (90 pi, 130 mg, 0.80 
mmol) were introduced with syringes respectively. The mixture was stirred at room 
temperature for 3 h. The resulting mixture was filtered, and the precipitate was 
washed with DCM (1 ml), EtOAC (1 ml), and then EtOEt (1 ml) to give a yellow 
solid (83 mg, 50% yield), m.p. 234 °C.
14
HNMR (400 MHz, DMSO-d6, 6 , ppm), 9.22 (2H, H4, H5, d, J = 9 Hz), 8.89 (2H, H ,, 
H8, dd, J = 8 , 1 Hz), 8.79 (2H, H3, H6, ddd, J = 9, 7, 1 Hz), 8.41 (2H, H2, H7, dd, J = 8 , 
7 Hz), 7.91 (2H, H 12, H 16, d, J = 8  Hz), 7.81 (2H, H 13, H |5, apparent t, J = 8  Hz), 7.65 
( lH ,H M,t ,  J = 8 Hz).
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13CNMR (400 MHz, DMSO-d6, 5, ppm), 164.9 (C 10), 151.4 (C n ), 149.3 (C9), 143.9 
(C4 a/C4 a’), 140.9, 131.5, 131.2, 129.2 128.9 (C 13/C i5, C4 /C5, C3 /C6, C2 /C7, C ,/C8),
124.2 (C9 a/C 9 aO, 123.2 (C 14), 121.3 (C ,2 /C ,6). 41.1 (Cn).
IR ( d , cm '1), 1760 (C =0).
MS (m/z), ES+: 314 ([M-CF3 S 0 3]+, 100%), 193 (71%); ES': 149 ([CF3 S 0 3] \  100%). 
Acc-MS: calculated mass: 314.1176 ([M-CF3 S 0 3]+); measured mass: 314.1175.
3.3.2 Synthesis o f 9-(phenoxycarbonyI)-10-dodecylacridinium  
trifluoromethanesulfonate (8 )
To a round bottom flask (5 ml) equipped with a stirrer bar and a condenser (25 ml), 
phenyl acridine-9-carboxylate (96 mg, 0.32 mmol) and dodecyl triflate (80 mg, 0.25 
mmol) were added. The flask was flushed with N 2 for 5 min. Then DCE was 
introduced with a syringe. The mixture was gently refluxed for 21.5 h. The volatiles 
were evaporated under vacuum. To the residue, DCM (0.6 ml) was added to extract 
the product. The extract was precipitated with diethyl ether (3 ml), and the upper 
solution was removed with a pipette carefully. The yellow precipitate was re­
dissolved in DCM (0.6 ml), and re-precipitated with diethyl ether repeatedly (x 6 ) to 
give a greenish yellow solid (30.3 mg, 19.5% yield), m.p. 110-111 °C.
14
'HNM R (400 Hz, chloroform-d, 5, ppm), 8.72 (2H, H4, H5, d, J = 9 Hz), 8.47 (2H, H3, 
H6, ddd, J = 9, 7, 1 Hz), 8.34 (2H, H ,, H8, dd, J = 8 , 1 Hz), 8.00 (2H, H2, H7, dd, J = 8 , 
7 Hz), 7.49 (2H, t, H i3, H 15, J = 8  Hz), 7.39 (2H, H 12, H ,6, t, J = 8  Hz), 7.34 (1H, H 14,
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t, J = 8  Hz), 5.52 (2H, H n , t, J = 8  Hz), 2.09 (2H, H27, m), 1.69-1.59 (4H, m), 1.39- 
1.30 (2H, m) and 1.27-1.12 (12H, m), (H 18, H 19, H20, H21, H22, H23, H24, H25, H26), 
0.64 (3H, H28, t, J = 7 Hz).
I3CNMR (400 Hz, chloroform-d, 5, ppm), 163.3 (C ]0), 150.2 (C n ), 148.7 (C9), 141.7 
(C4 a/C4 aO, 140.6, 130.6, 130.1, 128.3, 128.0, (C I3 /C 15, C2 /C7, C4 /C5, Ce/C3, C ,/C8),
123.3 (C9 a/C 9 a0, 121.4 (C 14), 119.9 (C 12/C 16), 52.6 (C 17), 32.3 (C26), 30.1, 30.0 ( 2  
lines), 29.9, 29.8 (2 lines), 29.7 (C 19, C20, C21, C22, C23, C24, C25), 27.0 (C 18), 23.1 
(C27), 14.5 (C28).
IR (u, cm '1), 1771 (C =0).
MS (m/z), ES+: 468.5 ([M-CF3 S 0 3]+, 100%); ES': 149 ([CF3 S 0 3'], 100%). Acc-MS: 
calculated mass: 468.2897 ([M-CF3 S 0 3]+); measured mass: 468.2900.
3.3.3 Synthesis o f 9-(phenoxycarbonyl)-10-(3-succinimidyIoxycarbonyIpropyl) 
acridinium trifluoromethanesulfonate (9)
To a round bottom flask (5 ml), equipped with a stirrer bar and a condenser, freshly 
prepared succinimidyl 4-(trifluoromethanesulfonyloxy)butanoate (51 mg, 0.15 mmol) 
and phenyl acridine-9-carboxylate (78 mg, 0.26 mmol) were added. The flask was 
flushed with nitrogen. Then dry DCE (2 ml) was introduced with a syringe. The 
mixture was gently re fluxed for 22.5 h. The volatiles were evaporated under vacuum. 
DCM (0.6 ml) was added to the residue to extract the product. The extract was 
precipitated with diethyl ether (3 ml), and the upper solution was removed with a 
pipette carefully. The yellow precipitate was re-dissolved in DCM (0.6 ml), and re­
precipitated with diethyl ether repeatedly (x 7) to give a greenish yellow solid (2.6 
mg, 2.7% yield), m.p. 110-111 °C.
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14
'HNM R (400 Hz, acetonitrile-d3, 5, ppm), 9.03 (2H, H4, H5, d, J = 8  Hz), 8.52 (2H, 
H3, H6, ddd, J = 8 , 7, 1 Hz), 8.36 (2H, H ,, H8, dd, J = 8 , 1 Hz), 8.00 (2H, H2, H7, dd, 
J = 8 , 7 Hz), 7.50 (2H, H 13, His, t, J = 8 Hz), 7.38 (2H, H 12, H 16, d, J = 8  Hz), 7.36 
( 1 H, H 14, t, J = 8  Hz), 5.63 (2H, H n , t, J = 8  Hz), 3.24 (2H, H ,9, t, J = 7 Hz), 2.82 
(4H, H23, H2 4 , s ) ,  2.55 (2H, H |8, approx quintet).
IR (u, cm '1), 1734 (C =0).
MS (m/z), ES+: 483 ([M-CF3 S 0 3]+, 100%), 368 ([M-CF3 S 0 3 -C4 H 5N 0 3]+, 25%); ES': 
149 ([CF3 S 0 3]', 100%). Acc-MS: calculated mass: 483.1551 ([M-CF3 S 0 3]+); 
measured mass: 483.1553.
3.3.4 Synthesis of 9-(phenoxycarbonyl)-10-(5-succinimidyloxycarbonylpentyl) 
acridinium trifluoromethanesulfonate ( 1 0 )
To a round bottom flask (5 ml), equipped with a stirrer bar and a condenser, phenyl 
acridine-9-carboxylate (77 mg, 0.26 mmol) and freshly prepared succinimidyl 6 - 
(trifluoromethanesulfonyloxy)hexanoate ( 8 8  mg, 0.25 mmol) were added. The flask 
was flushed with nitrogen, and then dry DCE was introduced with a syringe. The 
mixture was refluxed under N 2  for 22.5 h. The resulting mixture was stripped o f 
solvent on a rotary evaporator to leave a sticky yellow gum, which was 
chromatographed on a silica column, eluted with DCM firstly, then, DCM + CH3CN 
(4:1), and finally DCM + CH3CN (3:1). The fractions with R f = 0.15 developed in
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DCM + CH 3 CN (3:1) were evaporated under vacuum to give a yellow solid (15 mg, 
9% yield) m.p. 201-202 °C.
9a’
14
'HNM R (400 Hz, acetone-d6, 5, ppm): 8 . 8 8  (2H, H4, H s, d, J = 8  Hz), 8.55 (2H, H,, 
H 8, d, J = 8  Hz), 8.46 (2H, H3, H6, dd, J = 8 , 7 Hz), 8.08 (2H, H2, H7, dd, J = 8 , 7 Hz),
7.53 (2H, H 12, H |6 , d, J = 8  Hz), 7.46 (2H, H 13, H 15, apparent t, J = 8  Hz), 7.31 (1H, 
H 14, t, J = 8  Hz), 5.57 (2H, H I7, t, J = 8  Hz), 2.71 (4H, H25, H26, s), 2.55 (2H, H21, t, J 
= 7 Hz), 2.32-2.20 (2H, H 18, m), 1.83-1.71 (4H, H ,9, H20, m).
I3CNMR (400 Hz, acetone-d6, 5, ppm), 171.0 (C2 3 /C24), 170.0 (C22), 164.8 (C 10),
151.4 (C N), 149.8 (C9), 143.2 (C4 a/C 4 a0, 141.2, 131.5, 131.1, 129.5, 128.8, (C 13/C 15, 
C ,/C 8, C3/C6, C4 /C5, C2 /C7), 124.5 (C9 a/C 9a0, 123.0 (C 14), 120.7 (C 12/C 16), 53.0 (C17),
31.4 (C21), 30.0 (C I9), 26.7 (C2 5 /C26), 26.6, 25.5 (C18, C20).
IR (u, cm '1), 1733 (C=0).
MS, ES+: 565 (17%), 511 ([M-CF3 S 0 3]+, 100%); ES': 149 ([CF3 S 0 3]', 100%). Acc- 
MS: calculated mass: 511.1864 ([M-CF3 S 0 3]+); measured mass: 511.1863.
3.3.5 Synthesis of 9-(phenoxycarbonyl)-10-(10-succinimidyloxycarbonyldecyl) 
acridinium trifluoromethanesulfonate (11)
To a round bottom flask (5 ml), equipped with a stirrer bar and a condenser, phenyl 
acridine-9-carboxylate (65 mg, 0.22 mmol) and freshly prepared succinimidyl 11- 
(trifluoromethanesulfonyloxy)undecanoate (43 mg, 0.10 mmol) were added. The
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flask was flushed with nitrogen, and then dry DCE was introduced with a syringe. 
The starting materials were refluxed under N 2 for 21 h. The solvent was evaporated 
on a rotary evaporator to leave a sticky yellow gum, which was chromatographed on 
a silica column, eluted with DCM firstly, and then DCM + CH 3 CN (3:1). The 
fractions with R f = 0.15 developed in DCM + CH 3 CN (4:1) were evaporated under 
vacuum to give a yellow solid (30 mg, 41% yield), m.p. 88-89 °C.
'O
]HNMR (400 Hz, chloroform-d, 5, ppm), 8.78 (2H, H4, H5, d, J = 8  Hz), 8.54 (2H, H3, 
H6, dd, J = 8 , 7 Hz), 8.42 (2H, H 1? H8, d, J = 8  Hz), 8.09 (2H, H2, H7, dd, J = 8 , 7 Hz), 
7.55 (2H, H 13, His, apparent t, J = 8  Hz), 7.46 (2H, H 12, H 16, d, J = 8  Hz), 7.40 (1H, 
H 14, t, J = 8  Hz), 5.58 (2 H, H 17, t, J = 8  Hz), 2.83 (4H, H30, H 3 1 , s), 2.58 (2 H, H26, t, J 
= 7 Hz), 2.21-2.10 (2H, m), 1.77-1.66 (4H, m), 1.46-1.30 (4H, m), 1.33-1.24 (6 H, m),
(h 18, h ,9, h 20, h 21, h 22, h 23, h 24, H25).
13CNMR (400 Hz, chloroform-d, 6 , ppm), 169.7 (C28/C29), 169.1 (C27), 163.4 (C10),
150.1 (Cn), 148.7 (C9), 141.6 (C4a/C4a0, 140.8, 130.6, 130.3, 128.3, 127.9, (C]3/C 15, 
C]/C8, C2/C7, C3/C6, C4/C5), 123.3 (C9a/C9a’), 121.4 (C14), 119.8 (C12/C16), 52.6 (C]7),
31.3 (C26), 30.0, 29.6, 29.5, 29.4, 29.2, 29.0, 26.9, (C]8, CI9, C20, C21, C22, C23, C24),
26.0 (C30/C3,), 24.9 (C25)
19FNMR (400 Hz, chloroform-d, 5, ppm), -78.2.
IR (u, cm '1), 1733 (C=0).
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MS (m/z), ES+: 667 (6 8 %), 635 (58%), 613 (76%), 581 ([M-CF3 S 0 3]+, 100%), 506 
([M-CF3 S 0 3 -Ph+2H]+, 98%); ES': 149 ([CF3 S 0 3] \  100%). Acc-MS: calculated mass: 
581.2646 ([M-CF3 S 0 3]+); measured mass: 581.2645.
3.3.6.1 Synthesis of 2,5-dimethylphenyl acridine-9-carboxylate (12a)
In a round bottom flask (25 ml) equipped with a CaCl2  drying tube and a magnetic 
stirrer bar, acridine-9-carboxylic acid chloride (425 mg, 1.90 mmol) in pyridine was 
heated to 50 °C, after the solid dissolved completely, the solution was cooled to room 
temperature, and then 2,5-dimethylphenol (267 mg, 2.18 mmol) was added. The 
mixture was stirred vigorously at room temperature overnight. The resulting mixture 
was stripped o f pyridine to leave a brown residue. The residue was taken up in DCM 
( 1 0  ml) and filtered, and the filtrate was condensed and loaded onto a column (silica) 
for chromatography, eluted with toluene + EtOAc (4:1). The fractions with R f = 0.51 
were pooled and evaporated under vacuum to give a pale yellow solid (424 mg, 6 8 % 
yield), m.p. 187 °C.
4a' NL 4a
9a'
]HNM R (400 Hz, c h l o r o f o r m - d ,  6 ,  p p m ) ,  8.26, (2H, H ,, H8, d ,  J = 8  Hz), 8.22 (2H, 
H4, H5, d ,  J = 8  Hz), 7.79 (2H, H3, H6, d d ,  J = 8 , 7 Hz), 7.62 (2H, H2, H7, d d ,  J = 8 , 7 
Hz), 7.20 (1H, H 12, s ) ,  7.18 (1H, H 16, d ,  J = 8  Hz), 7.03 (1H, H ,5, d ,  J = 8  Hz), 2.39 
(3H, H 17 o r  H 18, s ) ,  2.29 (3H, H 17 o r  H 18, s ) .
13 CNMR (400 MHz, c h l o r o f o r m - d ,  5 ,  p p m ) ,  166.3 (C 10), 149.4 (Cn ), 149.1 
(C4 a/C4a-), 137.8 (C 14), 136.5 (C9), 131.8 (C ]6), 130.8 (C4 /C5), 130.6 (C3 /C6), 128.0 
(C 15), 127.9 (C2 /C7), 127.1 (C 13), 125.3 (C ,/C8), 122.9 (CgJCg*), 122.7 (C 12), 21.4 
(C I8), 16.9 (C ,7).
IR (u, cm’1), 1748 (C =0).
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MS (m/z), El: 327 ([M]+, 5%), 206 (100%), 178 (82%), 77 (78%); Cl: 328 ([M+H]+, 
52%), 206 (18%), 180 ( 1 0 0 %).
3.3.6.2 Synthesis of 9-(2,5-dimethylphenoxycarbonyI)-10-methyIacridinium  
trifluoromethanesulfonate (12)
To a round bottom flask (5 ml), equipped with a stirrer bar, 2,5-dimethylphenyl 
acridine-9-carboxylate (140 mg, 0.43 mmol) was added. The flask was flushed with 
nitrogen via a septum for 5min, and then dry DCM (2 ml) and methyl triflate (130 ul,
188.5 mg, 1.15 mmol) were introduced with syringes respectively. The mixture was 
stirred at room temperature for 3 h. The resulting mixture was filtered, and the 
precipitate was washed with DCM + EtOEt 3:1 ( 5 x 4  ml) to leave a yellow solid 
(144 mg) in 6 8 % yield, m.p. = 221 °C (oil appeared at 221 °C and turned to black, 
but the compound didn’t melt completely until 229 °C).
_ 19
9a'
'HNM R (400 Hz, chloroform-d, 5, ppm), 8.73 (2H, H4, H5, d, J = 9 Hz), 8.35 (2H, H3, 
H6, dd, J = 9, 7 Hz), 8.32 (2H, H I? H8, d, J = 8  Hz), 7.91 (2H, H2, H7, dd, J = 8 , 7 Hz),
7.11 (1H, H 12, s ) ,  7.08 (1H, H ,6 , d, J = 8  Hz), 6.97 (1H, H ]5, d, J = 8  Hz), 4.99 (3H, 
H |9, s ) ,  2.30 (3H, H,y or H 18, s), 2.16 (3H, H 17 or H 18, s).
,3CNMR (400 MHz, acetonitrile-d3, 8 , ppm), 165.1 (C10), 150.1 (Cn ), 149.1 (C9),
144.0 (C4a/C4aO, 141.3, 131.4, 129.4, 120.9 (Cj/C8, C2/C7, C3/C6, CVC5), 139.6 (C]4),
133.3 129.9, 123.9, (C12, C15, C16,), 128.4 (C9a/C9a0, 124.6 (C13), 41.2 (C19), 21.5 
(C]8), 17.2 (C17).
IR (o, cm '1), 1747 (C =0).
Chapter 3 130
MS (m/z), ES+: 396 (9%), 342 ([M-CF3 S 0 3]+, 100%), 252 (2 1 %), 220 (2 1 %), 193 
(6 8 %); ES': 149 ([CF3 S 0 3] \  100%). Acc-MS: calculated mass: 342.1489 ([M- 
CF3 S 0 3]+); measured mass: 342.1489.
3.3.7 Synthesis of 9-(2,5-dimethylphenoxycarbonyI)-10-(3-succinimidyloxy- 
carbonylpropyl)acridinium trifluoromethanesulfonate (13)
To a round bottom flask (5 ml), equipped with a stirrer bar and a condenser, 2,5- 
dimethylphenyl acridine-9-carboxylate (43.2 mg, 0.13 mmol) and freshly prepared 
succinimidyl 4-(trifluoromethanesulfonyloxy)butanoate (30.0 mg, 0.09 mmol) were 
added. The system was flushed with nitrogen, and then DCE was introduced with a 
syringe. The mixture was refluxed under N 2 for 20 h. The resulting mixture was 
stripped o f solvent on a rotary evaporator to leave a brown residue, which was taken 
up in DCM (1 ml), and then precipitated with diethyl ether (3 ml). The precipitate 
was re-dissolved in DCM, and re-precipitated repeatedly, until TLC showed absence 
o f the starting materials (x 6 ). A yellow solid (1.6 mg, 2.7% yield) was obtained, m.p. 
98-99 °C.
9a1
'HNM R (400 Hz, chloroform-d, 8 , ppm), 9.27 (2H, H4, H5, d, J = 9 Hz), 8.60 (2H, H l; 
Hg, d, J = 9 Hz), 8.75 (2H, H3, H 6 , apparent t, J = 8  Hz), 8.23 (2H, H2 , H 7 , apparent t, 
J = 8  Hz), 7.41 (1H, H 12, s ) ,  7.39 (1H, d, H 15, J = 8  Hz), 7.27 (1H, H 14, d, J = 8  Hz), 
5.90-5.76 (2H, H 17, t, J = 8  Hz), 3.46 (2H, H i9, t, J = 8  Hz), 3.03 (4H, H23, H24, s), 
2.79 (2H, H]g, apparent quintet), 2.59 (3H, H 25 or H2 6 , s), 2.46 (3H, H25 or H2 6 , s).
IR (u, c m 1), 173 7 (0 = 0 ).
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MS (m/z), ES+: 565 (53%), 543 (58%), 511 ([M-CF3 S 0 3]+, 100%), 436 (57%), 414 
(6 8 %); ES': 149 ([CF3 S 0 3]', 100%). Acc-MS: calculated mass: 511.1864 ([M- 
CF3 S 0 3]+); measured mass: 511.1867.
3.3.8 Synthesis of 9-(2,5-dimethylphenoxycarbonyl)-10-(5-
succinimidyloxycarbonylpentyl)acridinium trifluoromethanesulfonate (14)
To a round bottom flask (5 ml), equipped with a stirrer bar and a condenser, 2,5- 
dimethylphenyl acridine-9-carboxylate (36.1 mg, 0.11 mmol) and freshly prepared 
succinimidyl 6 -(trifluoromethanesulfonyloxy)hexanoate (35.6 mg, 0.099 mmol) were 
added. The system was flushed with nitrogen, and then dry DCE was introduced with 
a syringe. The mixture was refluxed under N 2 for 21 h. The resulting mixture was 
stripped o f solvent on a rotary evaporator, and then was taken up in DCM (0.5 ml) 
for loading onto a mini silica (0.8 g) column for chromatography, eluted with DCM 
firstly until TLC showed all starting materials were washed through out o f the 
column, then with DCM + methanol (2:1). The fractions with R f = 0.29 developed in 
DCM + methanol (2 :1 ) were pooled and evaporated to give a bright yellow solid 
(13.4 mg, 2 0 % yield), m.p. 87-88 °C.
'HNM R (400 Hz, chloroform-d, 8 , ppm), 8.67 (2H, H4, Hs, d, J = 9 Hz), 8.36 (2H, H3, 
H6, dd, J = 9, 7, 1 Hz), 8.25 (2H, Hi, H8, dd, J = 9, 1 Hz), 7.89 (2H, H2, H 7, dd, J = 9, 
7 Hz), 7.07 (1H, H |2, s ) ,  7.03 ( 1 H, H ,6, d, J = 8  Hz), 6.90 ( 1 H, H ,5, d, J = 8  Hz), 5.39 
(2H, H |9, t, J = 8  Hz), 2.60 (4H, H27, H28, s), 2.41-2.47 (2H, H23, t, J = 7 Hz), 2.24
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(3H, H , 7  or H 18, s), 2.11 (3H, H ,v or H 18, s), 2.09-2.00 (2H, m ) and 1.69 (4H, m),
( h 20, h 2 1 , h 22).
13 CNMR (400 MHz, chloroform-d, 5, ppm), 169.8 (C2 5 /C26), 168.9 (C24), 163.2 (C]0),
149.1 (C n ), 148.7 (C9), 141.7 (C4 a/C4a’), 140.9, 132.1, 130.2, 128.8, 128.1, 1 2 2 . 1 ,
1 2 0 . 0  (C ,/C8, C2 /C7, C3/C6, C4 /C 5 , C 12, C 15, C 16) 138.3 (C 14), 126.6 (C 13), 123.4 
(C9 a/C 9aO, 52.3 (C 19), 30.9 (C23), 29.2 (C2I), 26.0 (C2 7 /C28), 25.5 (C20), 24.6 (C22),
21.4 (C 18), 16.8 (C 17).
IR (u, cm '1), 1737 (C =0).
MS (m/z), ES+: 593 (32%), 539 ([M-CF3 S 0 3]+, 100%), 464 (33%), 442 (22%), 424 
(14%); ES': 149 ([CF3 S 0 3]', 100%). Acc-MS: calculated mass: 539.2177 ([M- 
CF3 S 0 3]+); measured mass: 539.2180.
3.3.9 Synthesis o f 9-(2,5-dimethyIphenoxycarbonyI)-10-(10-
succinimidyIoxycarbonyldecyl)acridinium trifluoromethanesulfonate (15)
To a round bottom flask (5 ml), equipped with a stirrer bar and a condenser, freshly 
prepared succinimidyl 11-(trifluoromethanesulfonyloxy)undecanoate (76.0 mg, 0.18 
mmol) was added, followed by 2,5-dimethylphenyl acridine-9-carboxylate (80.0 mg, 
0.25 mmol). The flask was flushed with nitrogen, and then dry DCE was introduced 
with a syringe. The mixture was refluxed under N 2 for 20 h. The resulting mixture 
was stripped o f solvent under vacuum to leave an orange gum, which was taken up in 
DCM (1 ml), and then precipitated with EtOEt (3 ml). The upper solution was 
removed with a pipette, the precipitate was re-dissolved in DCM and re-precipitated 
with EtOEt repeatedly ( x6 ), until TLC showed only 1 spot, a bright yellow sticky oil
which solidified on standing was obtained (46 mg, 34% yield), m.p. 56-60 °C.
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9a'
]HNM R (400 Hz, c h l o r o f o r m - d ,  6 , p p m ) ,  8.80 (2H, H4, Hs, d ,  J = 9 Hz), 8.57 (2H, H 1? 
H8, d d ,  J = 9, 1 Hz), 8.47 (2H, H3, H6, d d d ,  J = 9, 7, 1 Hz), 8.12 (2H, H2, H7, d d ,  J = 
9, 7 Hz), 7.29 (1H, H 12, s), 7.23 (1H, H 15, d, J = 8  Hz), 7.11 (1H, H ]4, d, J = 8  Hz), 
5.59 (2 H, H i7, t, J = 8 Hz), 2.83 (4H, H30, H31, s), 2.58 (2H, H26, t, J = 7 Hz), 2.44 
(3H, H 32  o r  H33, s ) ,  2.31 (3H, H 3 2  o r  H33, s), 2.26-2.02 (2H, m ) ,  1.77-1.67 (4H, m )  
a n d  1.49-1.25 (10H, m ) ,  (H I8, H 19, H20, H21, H22, H23, H24, H25).
,3CNMR (400 Hz, chloroform-d, 6 , ppm), 169.8 (C28/C29), 169.1 (C27), 163.3 (C10),
149.0 (Cn), 148.7 (C9), 141.6 (C4a/C4a ), 140.8, 132.1, 130.2, 128.7, 128.2, 122.2,
119.9 (C,/ C8, C2/ C7, C3/ C6, C4/C5, C 12, C 14, C 15), 138.3 (CI3), 126.6 (C16), 123.4 
(C9a/C9a0, 52.6 (C17), 31.3 (C26), 30.0, 29.6, 29.5, 29.4, 29.2, 29.0, 26.9, 24.9 (C!8, 
C 19, C20, C2i, C22, C23, C24, C25), 26.0 (C30/C31), 21.4 (C33), 16.8 (C32).
,9FNMR (400 MHz, chloroform-d, 6 , ppm), -78.2.
IR (i), cm '1), 1734 (C =0).
MS (m/z), ES+: 663 (7%), 609 ([M-CF3 S 0 3]+, 100%), 512 (9%), 481 (10%); ES':
149 ([CF3 S 0 3]", 100%). Acc-MS: calculated mass: 609.2959 ([M-CF3 S 0 3]+); 
measured mass: 609.2965.
3.3.10.1 Synthesis of 2-(trifluoromethyl)phenoI tetrahydropyranyl ether (16b)
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To a round bottom flask (50ml), equipped with a stirrer bar and a condenser, 2- 
trifluoromethylphenol (1.00 g, 6.17 mmol) and 3,4-dihydropyran (2 ml) were added, 
followed by a few crystals o f toluenesulfonic acid monohydrate (TSOH.H2 O). Then 
diethyl ether (25 ml) was introduced, and the mixture was refluxed for 19 h. The 
resulting mixture was poured into saturated NaHCC>3 (20 ml) aqueous solution, the 
aqueous layer was extracted with diethyl ether (25 ml x 3), the combined extracts 
were washed with saturated NaCl, dried over MgSC>4 and stripped o f solvents to 
leave a colourless oil, which was purified by chromatography (silica column, EtOAC 
(5%) + hexane (95%) + Et3N (0.5%)) to afford the product (1.35 g) in 89% yield.
CF-
4
'HNM R (400 Hz, chloroform-d, 5, ppm), 7.50 (1H, H3, d, J = 8  Hz), 7.38 (1H, H5, 
apparent t, J = 8  Hz), 7.18 (1H, H6, d, J = 8  Hz), 6.94 (1H, H4, t, J = 8  Hz), 5.48 (1H, 
H7, dd, J = 5, 2 Hz), 3.77 (1H, H8a, dt, J = 10, 3 Hz), 3.55 (1H, H8b, m), 2.01-1.46 
(6 H, H ,,, H9, H 10, m).
13CNMR (400 Hz, chloroform-d, 5, ppm), 155.5 (C]), 133.8 (C5), 127.5 (C2), 127.4 
(C3), 1 2 1 . 2  (C4), 1 2 0 . 1  (C 12), 116.1 (C6), 96.6 (C7), 62.2 (C8), 30.7 (CH), 25.8 (C9),
20.4 (C ,0).
3.3.10.2 Synthesis of 2-trifluoromethyl-6-iodophenol (16c)
Compound 16b was dissolved in THF (8.5 ml) in a flask (25 ml). The system was 
flushed with nitrogen and then cooled in a acetone-dry ice bath. rc-BuLi (3 ml, 2.5 M) 
was introduced with a syringe. After stirring at -78  °C for 30 min, the reaction 
mixture was treated with a solution o f iodine (2.20 g, 8.67 mmol) in THF (8.5 ml), 
stirred for 10 min, and then allowed it to warm to room temperature. The resulting 
mixture was poured into Na2 S0 3  (2 0 %) aqueous solution and vigorously shaken.
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The aqueous layer was extracted with diethyl ether and the combined extract was 
washed with saturated NaCl, dried over M gS0 4 , filtered, and evaporated to leave a 
yellow-red oil. Its 'HNM R spectrum showed the oil was 2-(trifluoromethyl)-6- 
iodophenol tetrahydropyranyl ether (compound 16c’). The oil was subjected to 
short-path distillation, during which, the tetrahydropyranyl ether decomposed, giving 
the product, 2-(trifluoromethyl)-6-iodophenol (1.67 g, 94% yield if  assumed to be 
pure, but in reality contaminated by about 15% o f dihydropyran hydrate).
4
'HNM R (400 Hz, chloroform-d, 5, ppm), 7.88 (1H, H5, dd, J = 8 , 1 Hz), 7.46 (1H, H3, 
d, J = 8 , 1 Hz), 6.80 (1H, H4, apparent t, J = 8  Hz), 5.25 (1H, H7, dd, J = 5, 2 Hz),
4.04 (1H, H8a, m), 3.43 (1H, Hgb, m), 2.01-1.42 (6 H, m, H9, Hio, H u).
7
HO
4
'HNM R (400 Hz, chloroform-d, 5, ppm), 7.77 (1H, H5, d, J = 8  Hz), 7.47 (1H, H3, d, 
J = 8  Hz), 6.70 (1H, H4, apparent t, J = 8  Hz), 5.85 (1H, H7, s).
3.3.10.3 The synthesis of 2,6-bis(trifluoromethyI)phenol (16d)
To a round bottom flask (50 ml) equipped with a stirrer bar, Cd powder (3.057 g,
27.2 mmol) and dimethyl formamide (DMF, 10 ml) were added. The flask was 
flushed with N 2 and then cooled to 0 °C in an ice bath. CBr2 F2 (lm l + 1ml + 0.5ml, 
27.17 mmol in total) was added slowly in portions by syringe, then the mixture was 
allowed to warm up to room temperature and stirred for an additional 30 min. The 
mixture was diluted with hexamethylphosphoramide (HMPA, 10 ml) and cooled to 
0 °C. CuBr (1.80 g, 12.6 mmol) was added and the mixture was stirred for 10 min.
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To the mixture containing CUCF3 , 2-trifluoromethyl-6-iodophenol (937.1 mg, 3.25 
mmol) was added and the mixture was heated over an oil bath (65 °C) with stirring 
for 2 h. The resulting mixture was cooled to room temperature, poured into a 
mixture o f HC1 (3 mol L"1, 30 ml) and diethyl ether (30 ml), and the precipitate was 
removed from the mixture by filtration. The aqueous phase was extracted with 
diethyl ether (25 ml * 5), and the combined extract was washed with saturated NaCl 
and then dried over MgSC>4 , filtered and evaporated over a rotary evaporator to leave 
a brown residue, which was subjected to short path distillation. The fraction (b.p. 
80 °C / 0.7 Torr), was collected to afford a colourless oil (283.4 mg) in 38% yield.
HO
7
c f 3
4
'HNM R (400 Hz, chloroform-d, 8 , ppm), 7.69 (2H, H3, H5, d, J = 8  Hz), 7.06 (1H, H4, 
t, J = 8  Hz), H] has not been found, because it was too broad.
I3CNMR (400 Hz, chloroform-d, 8 , ppm), 153.0 (C,), 131.0 (C 3/C 5), 123.8 (C7, q 
due to coupling to 3 F nuclei), 120.3 (C4 ), 120.0 (C2 /C 6 ).
MS (m/z), El: 230 ([M]+, 18%), 213 ([M-OH]+, 28%), 179 (23%), 163 ([M- 
CF3+2H]+, 30%), 135 (100%).
3.3.10.4 Synthesis of 2,6-bis(trifluoromethyI)phenyl acridine-9-carboxyIate 
(16e)4
In a flask (5ml) equipped with a stirrer bar, a condenser, and a CaCE drying tube, 
acridine-9-carboxylic acid chloride (131.6 mg, 0.544 mmol), 2,6-bis- 
(trifluoromethyl)phenol (130 mg, 0.565 mmol), and pyridine (3 ml), were stirred 
vigorously at 40 °C for 1 day. Then the volatiles were evaporated and the residue 
was extracted with DCM. The extract was subjected to column chromatography 
(silica, Tol + EtOAc 4:1). The fractions with R f = 0.49 were collected and 
evaporated to give an orange solid (137.5 mg, 58% yield), m.p. 171 °C.
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'HN M R (400 Hz, chloroform-d, 5, ppm), 8.51 (2H, H |, Hs, d, J = 9 Hz), 8.32 (2H, H4 , 
H5, d, J = 9 Hz), 7.96 (2H, H 13, H 13>, d, J = 8  Hz), 7.79 (2H, H3, H6, dd, J = 9, 7 Hz), 
7.61 (2H, H2, H 7, dd, J = 9, 7 Hz), 7.56 (1H, H 14, t, J = 8  Hz).
i3CNMR ((400 Hz, chloroform-d, 6 , ppm), 164.6 (C I0), 148.6 (C4 a/C4a-), 146.3 (C ,,), 
131.9 (C |3/C |3.), 131.1 (C4 /C 5 ), 130.0 (C3 /C6), 128.5 (C2 /C7), 127.8 (Q/Cg), 126.5 
(C9 ), 126.2 (C9 a/C9a0 , 125.8 (C 14), 123.8 (C 12/C 12O, 122.8 (C ]5, q due to coupling to 3 
F nuclei).
IR ((o, c m 1), 1758 (C =0).
MS (m/z), El: 435 ([M]+, 10%), 206 (82%), 178 (100%); Cl, m/z, 436 ([M + H f, 
39%), 180(100%).
3.3.10.5 Synthesis of 9-(2,6-bis(trifluoromethyl)phenoxycarbonyI)-10- 
methylacridinium trifluoromethanesulfonate (16)
To a flask (10ml), equipped with a stirrer bar, 2,6-bis(trifluoromethyl)phenyl 
acridine-9-carboxylate (110 mg, 0.252 mmol) was added. The flask was flushed with 
N 2, and then dry DCM (3 ml) and methyl triflate (160 ul, 1.42 mmol) were 
introduced with syringes respectively. No precipitate appeared apparently as 
expected after the mixture was stirred at room temperature for 2 h. The flask was 
immersed into an oil bath (30 °C). A few minutes later, precipitate appeared. The 
mixture was maintained at 30 °C overnight. The resulting mixture was filtered, the 
solid was washed with ether and the fdtrate was precipitated with diethyl ether. All
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the solids were combined, washed with diethyl ether ( 2  ml) and pumped overnight to 
give a yellow solid (67.8 mg, 46% yield), m.p. 231-232 °C.
14
'H N M R (400 Hz, acetonitrile-d3, 5, ppm), 8.78 (2H, 2H, H4, H5, d, J = 9 Hz), 8.76 
(2H, H ,, H8, d, J = 9 Hz), 8.53 (2H, H3, H6, dd, J = 9, 7 Hz), 8.28 (2H, H ,3, H 13-, d, J 
= 8  Hz), 8.15 (2H, H2, H7, dd, J = 9, 7 Hz), 7.91 (1H, H ]4, t, J = 8  Hz), 4.95 (3H, H )5, 
s).
13CNMR (400 Hz, acetonitrile-d3, 5, ppm), 161.7 (C 10), 144.1 (C9), 144.0 (C n ),
142.2 (C4 a/C4a'), 138.9 (Ci3/C l3-), 132.2, 129.4, 129.2, 127.0 (C3/C6, C4 /C5, Q/Cg, 
C2/C7), 124.5 (split into 2  lines, C ,2 /C ,r ), 123.7 (C9a/C9a’), 119.0 (C 14), 40.1 (C 15).
IR ((u, cm '1), 1769 (C=0).
MS (m/z), ES+: 450 ([M-CF3 S 0 3]+, 100%), 252 (22%), 224 (17%), 193 (15%); ES': 
149 ([CF3 S 0 3]-, 100%). Acc-MS: calculated mass: 450.0923 ([M-CF3 S 0 3]+); 
measured mass: 450.0928.
3.3.11 Synthesis of 9-(2,6-bis(trifluoromethyI)phenoxycarbonyl)-10-(10-
succimmidyloxycarbonyldecyl)acridinium trifluoromethanesulfonate (17)
To a flask (5 ml) previously flushed with nitrogen, 2,6-bis(trifluoromethyl)phenyl 
acridine-9-carboxylate (74.9 mg, 0.172 mmol), and succinimidyl 11- 
(trifluoromethanesulfonyloxy)undecanoate (74.8 mg, 0.174 mmol) were added. The 
flask was re-flushed with N2, and then dry DCE (1.6 ml) was introduced with a
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syringe. The mixture was refluxed for 21 h and then stripped o f solvents on a rotary 
evaporator to leave a yellow residue. The residue was extracted with DCM (1 ml), 
and the extract was subjected to column chromatography (silica gel), eluted with 
DCM + CH 3 CN (3:1). The fractions with R f = 0.19 was pooled and evaporated to 
give a yellow solid (15.9 mg, 11% yield), m.p. 164-165 °C.
14
'HNM R (400 Hz, chloroform-d, 6 , ppm), 8.78 (2H, H4, H5, d, J = 9 Hz), 8.71 (2H, Hi, 
H8, d, J = 9 Hz), 8.49 (2H, dd, H3, H6, J = 9, 7 Hz), 8.06 (2H, H ]3, His, d, J = 8  Hz), 
7.98 (2 H, H2, H7, dd, 9, 7 Hz), 7.12 ( 1 H, H 14, t ,  J = 8  Hz), 5.60 (2H, H ,7, t ,  J = 8  Hz), 
2.76 (4H, H30, H3 j, s ) ,  2.51 (2H, H26, t ,  J = 7 Hz), 2.29-2.18 (2H, m ) ,  1.84-1.69 (4H, 
m) and 1.51-1.26 (10H, m), (H]8, H 19, H2 o, H 2 i, H22, H23, H24, H 2 s).
13CNMR (400 Hz, chloroform-d, 5, ppm), 169.7 (C2 8 /C29), 169.1 (C27), 161.8 (C 10), 
145.0 (C9), 144.9 (C n), 141.7 (C4 a/C4 a0, 140.6 (C ,3/C i5), 132.4, 130.0, 129.0, 128.5, 
(C ,/C8, C3/C6, C4 /C5, C2 /C7), 125.9 (splitting into 2 peaks, C i2 /C 16), 124.3 (C9 a/C9 a0,
119.8 (C]4), 53.3 (C 17), 26.0 (C 3 0 /C31), 31.3, 30.1, 29.6, 29.5 (2 signals), 29.3, 29.0,
26.9, 24.9 (C ]8, C j9, C20, C2], C22, C23, C24, C25, C26), (the CF3 signals were not seen 
as the signal to noise ratio was too low).
I9FNMR (400 Hz, chloroform-d, 6 , ppm), -78.4 (CF3 S 0 3‘), -59.8 (CF3).
IR (o, cm '1), 1733 (C =0).
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MS (m/z), ES+: 717 ([M-CF3 S 0 3]+, 100%), 519 (17%), 505 (8 %), 491 (9%); ES': 
149 ([CF 3 SO 3 ]', 100%). Acc-MS, calculated: 717.2394 ([M-CF3 S 0 3]+); measured: 
717.2390.
3.3.12.1 Synthesis of 2,6-dinitrophenyl acridine-9-carboxylate (18a)
In a round bottom flask (5 ml) equipped with a stirrer bar, acridine-9-carboxylic acid 
chloride (1.08 mmol) and anhydrous 2,6-dinitrophenol (235 g, 1.28 mmol) were 
dissolved in pyridine. The flask was flushed with N 2 , and then DCC (250 mg, 1.23 
mmol) in THF (3 ml) was introduced with a syringe. The yellow colour o f the 
mixture faded slightly and some precipitate appeared. The mixture was stirred for 2 
days at room temperature. The resulting mixture was filtered to remove DCU and 
pyridinium chloride. The filtrate was evaporated on a rotary evaporator and the 
residue was re-dissolved in DCM for loading onto a silica column for 
chromatography. The column was eluted with DCM. The fractions with R f = 0 .1 9  
were pooled and evaporated under vacuum to give a yellow solid (93 mg, 22%
yield), m.p. 203-204 °C.
4
HNM R (400 Hz, chloroform-d, 5, ppm), 8.47 (2H, H], H8, d, J = 9 Hz), 8.31 (2H, 
Hi3, H i3-, d, J = 8  Hz), 8.26 (2H, H4, Hs, d, J = 9 Hz), 7.79 (2H, H3, H6, dd, J = 9, 7 
Hz), 7.68-7.57 (3H, H2, H7, H 14, m).
13CNMR (400 Hz, chloroform-d, 5, ppm), 163.9 (C 10), 149.1 (C4 a/C 4 a0, 144.6 (C n ),
138.2 (C ,2 /C ,r ), 131.8 (C9), 130.8, 130.6, 130.4 (C ,3/C 13’, C4 /C5, C3 /C6), 128.6 
(C2 /C 7), 127.9 (C14), 125.7 (C ,/C8), 123.5 (C9a/C 9 a0.
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IR (u , cm’1), 1775 (C=0).
M S (m/z), El: 389 ([M ]\ 17%); 206 (96%), 178 (100%); Cl: 390 ([M+H]+, 11%), 
180(100% ).
3.3.12.2 Synthesis of 9-(2,6-dinitrophenoxycarbonyl)-10-methyIacridinium  
trifluoromethanesulfonate (18)
To a flask (5 ml) equipped with a stirrer bar, 2,6-dinitrophenyl acridine-9- 
carboxylate (33 mg, 0.085 mmol) was added. The flask was flushed with N 2 , and 
then dry DCM (2 ml) and methyl triflate were introduced, respectively. The mixture 
wa:s stirred for 3 h. The resulting mixture was transferred into a vial (12 ml) and then 
diethyl ether (4 ml) was added. The precipitate was filtered and washed with diethyl 
ether until TLC gave only 1 yellow spot. The yellow solid was collected and pumped 
(2 1 .4 mg, 46% yield) overnight, m.p. 199-200 °C.
c h 3
N O ,
14
'H N M R  (400 Hz, acetonitrile-d3, 5, ppm), 8.83 (2H, H4, H5, d, J = 9 Hz), 8.74 (2H, 
H ], H8, d, J = 9 Hz), 8.60-8.48 (4H, H3, H6, H 13, H 13-, m), 8.14 (2H, H2, H7, apparent 
t), 7.94 (1H, H 14, t, J = 8  Hz), 4.96 (3H, H )5, s).
13CNMR (400 Hz, acetonitrile-d3, 5, ppm), 160.4 (C10), 143.9 (C9), 142.7 (Cn),
139.2 (C4a/C4 a0, 135.4 (C 12/C ]2’), 141.5, 130.4, 129.2, 128.9, 127.5, 118.6 (Cj/Cg, 
C 3/C 6, C2 /C7, C4/C5, C 13/C ]3’, C 14), 1 2 1 . 2  (C ]6), 123.0 (C9 a/C 9 a0, 42.0 (C ,5).
IR  (u, cm '1), 1767 (C=0).
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MS (m/z), ES+: 404 ([M-CF3 S 0 3]+, 100%), 252 (19%), 224 (29%), 193 (78%); ES': 
149 ([CF3 S 0 3]', 100%). Acc-MS: calculated mass: 404.0877 ([M-CF3 S 0 3]+); 
measured mass: 404.0882.
3.3.13 Synthesis of 9-(2,6-dinitrophenoxycarbonyl)-10-(10-
succinimidyloxycarbonyldecyl)acridinium trifluoromethanesulfonate (19)
To a flask (5 ml) equipped with a stirrer bar and a condenser, succinimidyl 11- 
(trifluoromethanesulfonyloxy)undecanoate (57 mg, 0.13 mmol) was added, followed 
by 2,6-dinitrophenyl acridine-9-carboxylate (52.6 mg, 0.13 mmol). The system was 
flushed with N 2 . Then DCE (2 ml) was introduced and the mixture was re fluxed for 
20 h. The resulting mixture was stripped o f solvent, taken up in DCM (1 ml), and 
subjected to chromatography on a silica column (0.8 g), eluted with DCM firstly and 
then DCM + CH3CN (3:1). The fractions with R f = 0.17 were pooled and evaporated 
under vacuum to leave a yellow compound (oil like, 15.8 mg, 14% yield).
9a'
N 0 2
14
]HNMR (400 Hz, chloroform-d, 8 , ppm), 8.71-8.60 (4H, Hi, H8, H4, H5, m), 8.41 
(2H, H3, H6, dd, J = 8 , 7 Hz), 8.34 (2H, H 13, H 15, d, J = 8  Hz), 7.92 (2H, H2, H7, dd, J 
= 9 ,1  Hz), 7.78 (1H, H]4 , t, J = 8  Hz), 5.48 (2H, H 17, t, J = 8  Hz), 2.69 (4H, H30, H31, 
s), 2.45 (2H, H26, t, J = 7 Hz), 2.08 (2H, m), 1.68-1.53 (4H, m) and 1.35-1.10 (10H, 
m) (Hig, H 19, H 2o, H 2 i, H22, H23, H2 4 , H2 s).
]3CNMR (400 Hz, chloroform-d, 6 , ppm), 169.7 (C2 8 /C29), 169.1 (C27), 161.1 (C ]0),
144.8 (C9), 143.9 (C n ), 141.6 (C4 a/C4 a0, 136.6 (C 12/C 16), 140.7, 131.1, 130.2, 129.7,
128.9, 119.6 (C]/C8, C2/C7, C3/C6, C4/C5, C 13/C 15, C 14), 124.1 (C9a/C9a0, 53.1 (C ]7),
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31.3, 30.1, 29.6, 29.5, 29.4, 29.2, 29.0, 26.9, 24.9 (C 18, C I9, C20, C21, C22, C23, C24, 
C2 5 , C2 6 ), 26.0 (C3 0 /C 3 1).
IR (u, cm '1), 1735 (C =0).
MS (m/z), ES+: 671 ([M-CF3 S 0 3]+, 100%), 519 (15%), 505 (23%), 491 (42%), 361 
(77%), 246 (44%), ES': 149 ([CF3 SO3 ]', 100%), 80 (41%). Acc-MS: calculated mass: 
671.2348 ([M-CF3 S 0 3]+); measured mass: 671.2352.
3.4 Conclusions
The targets in this chapter were synthesized in a similar synthetic pathway to the 
corresponding compounds in Chapter 2. 2,5-Dimethyl (electron-donating) AEs and 
unsubstituted AEs (model compounds) were synthesized successfully and all gave 
better yields compared with the 2,6-dibromo compounds (1-6). However, for the 
targets with the phenoxy moiety substituted with 2 ,6 -bis(trifluoromethyl) and 2 ,6 - 
dinitro groups (strongly electron-withdrawing), only 4 compounds were synthesized 
successfully (compounds 16-19) and another 4 compounds (23-26) could not be 
synthesized. The yield for synthesis o f 2,6-dibromo AEs in Chapter 2, was slightly 
lower compared with the model compounds, although the reaction conditions were 
already relatively harsh. This situation was exacerbated even more by the strongly 
electron-withdrawing nitro and trifluoromethyl groups.
For the simple AEs without a linker group, the yield for methylation o f the acridine 
is higher than dodecylation, and the reaction conditions are milder. This is consistent 
with the reference . 16
For syntheses o f AEs with the linker and spacer attached to the N atom, with the 
length o f the linkers increasing, the necessary reaction conditions became milder, and 
the yields were improved, due to the inductive effect from the ester group. Also as 
the length o f the linkers increased, the polarity o f the AEs decreased, so that for 
compounds with long linker groups, column chromatography proved to be a better 
purification method than that simple solvent washing, whereas for compounds with 
only three CH2 groups in the linker chain, chromatography doesn’t work so well. In
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this case, the product could be separated from the starting materials due to their 
different solubility in DCM, diethyl ether and EtOAc.
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Chapter 4
Synthesis of acridinium 
derivatives with substituents on 
the acridinium ring
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4. 1 Introduction
The only factor affecting the wavelength o f the emitted light involves changes made 
on the acridine ring. Substitutions on the acridinium ring (emitter) not only can 
change the wavelength o f the light emitted, but also can affect the kinetics as well as 
stability o f an acridine ester, in a similar way to modifications to the phenoxy ring . 1 
Compound 20 shown in figure 4.1, is a simple model compound to test synthetic 
methods that might be used for synthesis o f  a substituted acridine ring in an 
acridinium ester. If  such methods prove successful, compound 21 (figure 4.1), 
designed to have a spacer and a linker group on the acridine ring rather than have 
them linked with the phenoxy ring as in compound 22 (shown in figure 4.1) or with 
the N atom o f the acridinium ring (compounds 3, 4, 5, 6 , 9 ,1 0 ,1 1 , 1 3 ,1 4 ,1 5 ,1 7 ,1 9 ;  
see chapter 2 & 3), would be synthesized.
9-(4-(2-Benzyloxycarbonylethylphenoxycarbonyl)-2,7-dimethoxy-10-methyl- 
acridinium triflate (compound 22’, figure 4.1) had been synthesized by Dr. Li 
before, and gave a longer wavelength o f emitted light than that o f the AE with the 
acridinium ring unsubstituted, because the conjugation system is enlarged by an n-7r 
conjugation effect between the methoxy group and the acridinium ring. Therefore, 
this compound, together with a standard acridinium ester, could allow multi-analysis 
based on different wavelengths o f chemiluminescence. Consequently, Compound 22 
was also designed and was expected to have the same chemiluminescent wavelength 
as compound 2 2 ’, but the presence o f a linker group would enable it to be used as a 
label for oligonucleotides.
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Figure 4.1, targets in chapter 4
4. 2 Results and discussion
4.2.1 A simple model compound 2,6-dibromophenyl l,3-dim ethylacridine-9- 
carboxylate (2 0 )
Compound 20 would be synthesized in a synthetic pathway similar to that used for 
compound 7a, by converting l,3-dimethylacridine-9-carboxylic acid (20d) to its 
corresponding acid chloride 2 0 e, and then coupling 2 0 e with 2 ,6 -dibromophenol to 
afford the product 20 (figure 4.2). Formation o f the substituted acridine ring is a key 
stage in synthesis o f the product, and was expected to involve the following steps 
(figure 4.2): (i) coupling /?-bromoxylene and formanilide to give N-(3,5- 
dimethylphenyl)formanilide (20a); (ii) hydrolysis o f 20a to provide A-(3,5- 
dimethylphenyl)aniline (2 0 b); (iii) coupling 2 0 b with phosgene, (COCl)2 , followed 
by treating with a strong Lewis acid, AICI3 , to afford a substituted isatin, 3,5- 
dimethyl-A-phenylisatin (20c); (iv) rearrangement o f 20c in refluxing KOH solution 
to form 2 0 d; and (v) conversion o f compound 2 0 d into the desired compound 2 0 . 
Indeed, as described in the following sections, the synthesis was successful under the 
conditions recorded in figure 4.2.
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NHCHO
KOH, ethanol
(COCl)2, DCM , reflux, 0.5 h
AIC13, reflux, 1 h
SOCl2, reflux
COOH
pyridine, 2,6-dibromophenol
4-dimethylaminopyridine, r.t, 23 h
Figure 4.2, synthesis o f 2,6-dibromophenyl l,3-dim ethylacridine-9-carboxylate (20)
4.2.1.1 Synthesis of 7V-(3,5-dimethylphenyl)formanilide (20a)
Synthesis o f A^-(3,5-dimethylphenyl)formanilide (20a) was performed according to 
Ahmed . 1 p-Bromoxylene and formanilide were heated with K 2 CO 3 at 190 °C for 17 
h, using Cul as a catalyst. The resulting mixture was taken up in DCM and then 
filtered to remove the inorganic materials. The filtrate was evaporated to give a crude 
product, showing 2 components by TLC. The crude product was purified by 
chromatography (silica column), eluted with DCMihexane (1:1). The 1st component 
(R f = 0.73) was shown to be a side product (white crystals, m.p. 144°C, 20% yield).
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It was characterised by its 'HNM R spectrum (400 Hz, chloroform-d, 5, ppm), 7.15 
(2H, dd, J = 8 , 7 Hz), 6.96 (2H, d, J = 8  Hz), 6.89 (1H, t, J = 7 Hz), 6.63 (4H, s), 6.59 
(2H, s), 2.16 (12H, s); l3CNMR spectrum (400 Hz, chloroform-d, 6 , ppm), 148.7,
148.3, 139.1, 129.4, 125.0, 124.2, 122.7, 122.4, 21.7. The IR spectrum did not show 
any absorption from 1600 to l800  cm ' 1 (C =0) or absorption around 3400 cm ' 1 (N-H). 
The EI/CI mass spectrum showed the molecular ion peak at m/z 301 (M+), together 
with other ions at m/z 285 (46%) and 302 ([M+H]+; 100%). The spectra above 
suggested that the product had the structure shown in figure 4.3. This product could 
be understood as resulting from deformylation o f  2 0 a, followed by further reaction 
with a second mole o f /?-bromoxylene.
Figure 4.3, the structure o f  a side product formed during preparation o f 20a
The 2nd component o f the product mixture (Rf, 0.30) isolated in a 67% yield was 
shown to be the desired product. In the 1HNMR spectrum of 20a, peaks in the 
aromatic (including CHO) and aliphatic regions integrated in a ratio o f 9:6. Due to 
restricted rotation around the nitrogen-carbonyl bond, two sets o f signals were 
observed, including two aldehyde peaks at 8.59 ppm and 8.55 ppm. In the 13CNMR 
spectrum, the signals for each carbon atom in the aromatic region, were similarly 
split into two close lines, and a signal at 162 ppm attributed to the carbonyl group 
was found. The EI/CI mass spectrum showed ions at m/z 225 (M+), 243 ([M+NH4 ]+) 
and 226 ([M+H]+, 8 6 %). The successful usage o f the product in the next stage 
corroborated its structure.
Although the side product could be removed by chromatography, changing the 
reaction to employ slightly lower temperature, a 1 : 1  molar ratio o f the starting 
materials and control o f the amount o f the catalyst should allow improvement in the 
yield o f the desired product and decrease the amount o f the side product. However, a 
similar reaction had been performed by M cCapra’s group, using nitrobenzene as 
solvent. Therefore, the reaction was performed under M cCapra’s conditions, which
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were similar to those o f Ahmed, apart from the use o f the solvent. The resulting 
mixture was first evaporated to remove nitrobenzene, then purified by 
chromatography. A 65% yield o f the desired product was obtained. However, an 
additional side product (brown oil in 4% yield) was obtained. In the 'HNM  R 
spectrum o f the brown oil, it did not show any methyl group in the aliphatic region, 
and all peaks were in the low field, integrating in a ratio o f 1:1:1:1:2:4:4. The
i -)
CNMR spectrum showed the carbonyl group. The EI/CI mass spectrum showed 
molecular ion peaks at m/z 242 ([M]+, twice o f the formanilide), 121 (fromanilide), 
260 ([M+NH 4 ]+), 198, and 139. The accurate mass spectrum gave an ion at m/z at 
241.1087 while the M-H peak for a compound with twice the molecular mass is 
241.1084. It is thought to be the structure shown in figure 4.4, formed via a
# o
mechanism similar to the aldol condensation. The reaction being carried out at 
extremely high temperature 200 °C for 17 h might account for the formation o f this 
product. 'HNM R (400 Hz, chloroform-d, 8 , ppm), 8.84 (1H, s), 8.72 (1H, d), 8.34 
(1H, s), 7.97 (1H, s), 7.57 (2H, d, J = 8  Hz), 7.44-7.31 (4H, m), 7.25-7.10 (4H, m). 
13CNMR (400 Hz, chloroform-d, 8 , ppm), 163.4, 159.8, 137.4, 137.2, 130.2, 129.5,
125.7, 125.2, 120.5, 119.2. IR (u, cm '1), 3262 (-OH, -NH), 1669 (C=0).
NHCHO
Figure 4.4, a possible side reaction during preparation o f 20a.
4.2.1.2 Synthesis of A-(3,5-dimethyIphenyl)aniline (20b)
Compound 20a was refluxed in ethanol with KOH (10%) for 20 h, as shown in 
figure 4.2. The resulting mixture was evaporated, and DCM was added to take up the 
organic compounds. The crude product was purified by chromatography on a silica 
column, eluted with DCM. The fractions with R f = 0.78 were pooled and evaporated 
to give crystals with a dark brown colour on the surface and white in the core (6 8 % 
yield). In the 'HNM R spectrum o f the product 20b, there were 6  peaks in the 
aromatic region and a singlet in the aliphatic region, integrating in a ratio o f 8 :6 . The
I Tsinglet was attributed to the 2 CH 3 groups. In the CNMR spectrum, there were only
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7 peaks in the aromatic region, but it was believed that there were 8  different 
aromatic carbons, due to accidental overlaps. A peak at 21.8 ppm was attributed to 
the 2 CH 3 groups. As expected, no signal for carbonyl group was found, indicating 
loss o f the formyl group.. The IR spectrum showed a strong sharp absorption at 3400 
cm"1, attributed to Un-h; no absorption for a carbonyl group was found. The EI-CI 
mass spectrum showed pseudo molecular ion peaks at m/z 197 ([M+]) and 198 
([M+H]+), corroborating the structure o f the product.
4.2.1.3 Synthesis of 3,5-dimethyI-A^-phenylisatin (20c)
1 2In the literature o f  both F. M cCapra and Z. Ahmed, ’ CS2  was used as solvent. 
Because CS2 is toxic and has a poor solubility for the starting material 20b, therefore, 
DCM was used in place o f CS2 and worked well. To oxalyl chloride in DCM, N-(3,5- 
dimethylphenyl)aniline (20b) in DCM was added slowly and then the mixture was 
gently re fluxed for 0.5 h. The excess oxalyl chloride and solvent were removed by 
evaporation. DCM was added again, followed by aluminium chloride in portions. 
The mixture was then re fluxed for 1 h. The resulting mixture was evaporated. To the 
black residue, hydrochloric acid (1 mol L"1) was added carefully (a lot o f heat was 
generated) to destroy the reactive components. Then the product was extracted with 
EtOEt and purified by chromatography on silica column, eluted with DCM. The 
fractions with R f = 0.61 were pooled and evaporated to give an orange solid, 20c.
According to the accepted mechanism, the oxalyl chloride couples to the N atom first, 
and then the carboxylic acid chloride attacks the carbon ortho to the N atom (a 
Friedel-Crafts reaction involving intramolecular cyclisation). In the process o f 
cyclisation there are 2 carbons ortho to the N  atom, so the attack toward C atom can 
occur in two ways (figure 4.5). Therefore, 2 isomers (20c and 20c’) would be 
expected to form. However, this was not the case. The ]HNM R spectrum showed 2 
triplets or apparent triplets, 1 doublet and 2  singlets in the aromatic region, and 2  
singlets in the aliphatic region, integrating in a ratio o f  2:1:2:1:1:3:3. The 1HNMR 
and 13CNMR spectra suggested that the compound obtained should be isomer 20c 
(figure 4.5), which means that the attack occured only by one route (figure 4.5). The 
richer electron on the dimethylphenyl ring compared to the phenyl ring may account
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for this result. In the CNMR spectrum, there were 10 peaks in the aromatic region.
There were 2 signals at 182.9 and 158.4 ppm attributed to 2 carbonyl groups, and 
another 2 signals at 23.2 and 18.6 ppm attributed to 2 methyl groups. The IR 
spectrum showed absorptions at 1745 and 1721 cm '1, attributed to 2 carbonyl groups. 
The EI/CI mass spectrum gave ion peaks at m/z 251 (M+) and 269 ([M+NH 4 ]+).
Figure 4.5, the 2 possible attack directions in synthesis o f  isatin from diarylamine.
4.2.1.4 An attempt at synthesis of A^-^S-dimethylpheny^isatin (20c’)
Compound 20c and 20c’ would give the same product, compound 20d in the next 
stage. However, synthesis o f compound 20c’ by the route shown in figure 4.6, 
would save two steps (compared to sections 4.2.1.1 to 4.2.1.3), Furthermore, if  
successful, the experience gained might be useful for syntheses o f other precursors o f 
substituted acridine rings.
(COCI)2
20c’
O
20c'
Figure 4.6, an attempt to synthesize A/-(3,5-dimethyIphenyl)isatin
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The attempted synthesis o f A-(3,5-dimethylphenyl)isatin (20c’) was performed by 
using isatin (2.407 g, 13.9 mml) and /?-bromoxylene (3 g, 16.2 mmol) under 
conditions similar to those used for the cross-coupling reaction (section 4.2.1.1). 
After the starting materials were heated with Na2 CC>3 (2.558 g, 18.5 mmol) at 200 °C 
using Cul (0.753 g, 3.96 mmol) as a catalyst for 21 h, the mixture was extracted with 
DCM (100 ml), and the extract was concentrated and chromatographed. TLC showed 
5 components when developed with DCM or 6  components when developed in 
hexane : DCM (1:10). The 1st component with R f = 0.90 (DCM) was a white solid, 
m.p. 241-244 °C, (85 mg, 1% yield). The ]HNM R spectrum showed 6  peaks in the 
aromatic region and 1 singlet at 2.26 ppm in a ratio o f 1:1:2:1:1:1:6. ’HNMR (400 
Hz, chloroform-d, 8 , ppm), 7.43 (1H, d, J = 8  Hz), 7.36 (1H, s, broad), 7.16 (2H, s),
7.04 (1H, s, broad), 6.92 (1H, d, J = 7 Hz), 6 . 8 8  (1H, s), 2.26 (6 H, s). The 13CNMR 
spectrum showed 1 2  peaks in total but did not give any signal for a carbonyl group. 
13CNMR (400 Hz, chloroform-d, 8 , ppm), 141.3, 139.7, 139.1, 128.7, 127.0, 123.8,
122.8, 119.7, 118.9, 116.1, 111.4, 21.9. The EI/CI mass spectrum gave ions at m/z 
414 ([M+]), 415 ([M+H]+), and 309 further, which suggested the possible structure 
shown in figure 4.7 (several isomeric structures are possible, o f which the most 
likely is drawn). IR did not show any absorption for a carbonyl group, but showed a 
strong peak at 1590 cm -I . The 2nd, 3rd, and 4th spots were very close, and have not 
been separated. They have a slightly higher R f value than the simple isatin and one 
o f them could be the desired product, possibly. The 'HNM R spectrum o f the mixture 
of the 2nd, 3rd, and 4th components was too messy to give useful information. The 
Ullman methodology (C-N cross coupling conditions) is clearly not very suitable for 
the isatin analogues, possibly because the isatin is an amide and not an amine, 
leading to lower reactivity for the coupling. It has been reported in the literature , 4  
that isatin can react in DMSO in the presence o f NaH and benzene with dimethyl or 
diethyl sulphate, a variety o f alkyl halides, acyl halides and anhydrides to give N- 
alkyl and A-acylisatins . 5 However no reaction with aromatic halides has been 
reported.
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Figure 4.7, possible side product from the attempted synthesis o f  N-(3,5-
dimethylphenyl)isatin
Given the difficulties associated with this reaction, it was decided to continue with 
compound 2 0 c for the next stage o f the synthesis.
4.2.1.5 Synthesis o f l,3-dimethyIacridine-9-carboxylic acid (20d)'
3,5-Dimethyl-/'/-phenylisatin (20c) was refluxed in KOH aqueous solution (10%) for
39 h, as illustrated in figure 4.2. The resulting mixture was acidified with
concentrated HC1, and then filtered. The precipitate was re-dissolved in K 2 CO 3
aqueous solution ( 1 0 %), carefully re-precipitated by acidification with concentrated
HC1, filtered, and dried to give a yellow solid in 57% yield . 1 The ’HNMR spectrum
showed 1 doublet, 1 mutiplet, 2  singlets and 1 apparent triplet in the aromatic region,
and 2 singlets in the aliphatic region, integrating in a ratio o f 1:2:1:1:1:3:3. Due to
1 ^the poor solubility in DMSO, signals in the CNMR spectrum were too weak to 
betray any useful information. The IR spectrum gave a broad strong peak around 
3127 cm ' 1 (OH/NH)and a peak at 1714 cm ' 1 (C =0). Pseudo molecular ion peaks at 
m/z 251 ([M]+) and 252 ([M+H]+) in the EI/CI mass spectrum and its successful 
usage in the next step further corroborated the structure o f the product.
4.2.1.6 Synthesis of 2,6-dibromophenyl l,3-dimethy!acridine-9-carboxylate (20)
Synthesis o f 2,6-dibromophenyl l,3-dimethylacridine-9-carboxylate (20) was first 
attempted in a synthetic pathway similar to that used for lc , 7a, 12a and 16e (see
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chapter 3). However, the product was obtained in a yield o f only 3%, due to steric 
hindrance from the methyl group at position 1 on the acridine ring. The formation o f 
the acid chloride appeared to have been straightforward, but the reaction o f the acid 
chloride with 2,6-dibromophenol had not proceeded well. 4-Dimethylaminopyridine 
(DMAP) is a frequently used catalyst when the esterification reaction involves 
sterically hindered alcohols or phenols . 5 Owing to the electron-donating effect, 
DMAP possesses greater nucleophilicity than pyridine. It could attack the carbonyl 
carbon atom, displace C1‘ anion and form the reactive intermediate more quickly and 
effectively. Furthermore it acts as a good leaving group during the attack o f  a phenol 
with the reactive intermediate. Synthesis o f 20 was therefore performed by using 
DMAP as a catalyst and stirring l,3-dimethylacridine-9-carboxylic acid chloride 
(20e) and 2,6-dibromophenol in pyridine at room temperature for 23 h, as illustrated 
in figure 4.2. The resulting mixture was evaporated under vacuum to remove 
pyridine. The product was separated by chromatography (silica column), eluted with 
DCM. The first component, with R f = 0.57 (TLC in DCM) was obtained in 11% 
yield and proved to be the desired product.
In the 'HNM R spectrum o f 20, there were 3 doublets, 2 singlets and 3 triplets or 
apparent triplets in the aromatic region, and 2  singlets in the aliphatic region, 
integrating in a ratio o f  1:1:1:1:2:1:1:1:3:3. The signal integrating for 2 protons was a 
doublet. In the 13CNMR spectrum, a signal at 164.2 ppm was attributed to the 
carbonyl group and 2 peaks at 24.5 and 22.2 ppm were attributed to the 2 methyl 
groups. Another 17 aromatic peaks attributed to 17 different aromatic carbons were 
found. The IR spectrum showed an absorption at 1760 cm ' 1 for the carbonyl group. 
The Cl-mass spectrum gave a pseudo molecular ion peak at m/z 486 ([M + H f ,  
13%).
The successful synthesis o f compound 20 having been achieved, attention was next 
turned to the synthesis o f compound 21.
4.2.2 Synthesis of compound 21
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ROOC(H2C)2' ROOC(H2C)2
21e
O
+
COOH
COOH 
2 Id
21c l
Br
21b (21b’)
21 b, R = CH3; 21 b \  R = H
21a (21a')
21a, R = CH3; 21a1, R = H
Figure 4.8, the retrosynthetic route for compound 21
Compound 21 would be synthesized by the route shown in figure 4.8. Compound 
21b and compound 21d would be the important intermediates. The synthesis of 
compound 21b or 21b’ would involve a cross-coupling reaction. Conversion o f 21b 
or 2 1 b’ to 2 1 c followed by conversion to 2 1 d would accomplish the desired
i ^
substituted acridine ring. According to the literature, ’ the carbon-nitrogen cross 
coupling reaction could be carried out by using Cul as a catalyst, in the presence o f 
K2 CO 3 at high temperature as shown in section 4.2.2.1. However, in the recent
f \  7literature, ’ similar cross-coupling reactions were catalyzed by a palladium complex 
at lower temperature with a higher yield. Because the catalyst Cul is cheap and easily 
available, the coupling reaction was be first attempted by using Cul as a catalyst.
4.2.2.1 Synthesis of ./V-phenyl-4-(2-carbonylethyI)aniline catalysed by Cul (21b’)
The synthesis o f compound 21b’ (figure 4.8) was attempted by a cross coupling 
reaction o f 3-(4-bromophenyl)propionic acid and formanilide , 1 catalysed by Cul in
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the presence o f K 2 CO 3 at 200 °C for 24 h. The resulting mixture showed 3 spots in 
addition to the starting materials on a TLC plate. After tedious column 
chromatography (silica, several hundred times o f the sample weight), the product 
was obtained in a 12% yield. Then, according to the literature, synthesis o f N- 
phenyl-4-(2-carbonylethyl)aniline (21b’) was conducted by heating 3-(4- 
bromophenyl)propionic acid and formanilide at reflux in nitrobenzene and catalysed 
by Cul in the presence o f K 2 CO 3 powder for 2 days. The resulting mixture was 
stripped o f solvent under vacuum and then refluxed in concentrated HC1 and acetic 
acid (1:1) for 3 h. After cooling, the mixture was extracted with EtOEt. The extract 
was dried over M gS 0 4 , filtered and evaporated to give a dark green oil, which 
solidified on standing. This was subjected to chromatography on a silica column. The 
product was obtained in only 11% yield. The IR spectrum gave absorptions 
consistent with what F. McCapra had reported, 3401 cm for Un-h- However, the 
’HNMR spectrum showed that the integral o f  protons in the aromatic region was 1.5 
times that in the aliphatic region for the 2 CH 2 groups (the ideal ratio should be 9:4). 
This suggested the presence o f impurities, possibly the starting material, 3-(4- 
bromophenyl)propionic acid. This coupling reaction differs from that used for 
synthesis o f 20a only in that the starting material, 3-(4-bromophenyl)propionic acid 
has a functional group, the carboxylic acid. 3-(4-Bromophenyl)propionic acid was 
then protected by conversion to an ester, before the synthesis o f 2 1 b was attempted 
under similar coupling conditions. However, a similar result was obtained. So the 
coupling reaction for synthesis o f 2 1 b would be catalyzed by PdfDPPFjCb instead o f 
Cul, as described in section 4.2.2.2,
4.2.2.2 Synthesis of A-phenyl-4-(2-methoxycarbonyIethyl)aniline (21b) catalysed 
by Pd[DPPF]Cl2
Palladium-catalyzed cross-coupling reactions (C-C or C-N coupling) o f aryl halides 
are now common synthetic procedures. Indeed, (DPPF)PdCl2  has proved to be an 
effective catalyst for the amination o f aryl bromides and iodides with both aryl and 
alkyl primary amines. The efficient reaction o f aryl iodides, as well as aryl bromides, 
extends the scope o f amination reactions to a wide range o f electrophiles. Aryl 
halides with either electron-donating or electron-withdrawing substituents, as well as
Chapter 4 158
6 8ones bearing ortho substituents, react with anilines within only 3 h. ’ Before the 
cross-coupling reaction, 3-(4-bromophenyl)propionic acid was first esterified, as 
illustrated in figure 4.9.
H O O C (H 2C )2'
Br
S O C l2, M eO H  
reflux, 3 h
H3C O O C (H 2C )2'
21a
P d(D P PF )C l2 5%, D PPF 15%, N 2 
t-B uO K , to luene, reflux, 3 h
N H ,
(C H 2)2C O O C H 3
N
H
21b
Figure 4.9, synthesis o f  A/r-phenyl-4-(2-methoxycarbonylethyl)aniline
The 3-(4-bromophenyl)propionic acid was re fluxed in S O C f for 3 h. The excess 
SOCI2 was evaporated under vacuum. Pyridine and methanol were added and the 
mixture was stirred overnight. Afterwards, the excess methanol and pyridine were 
evaporated to leave a pale yellow oil, which was then purified by column 
chromatography on a silica column, eluted with DCM, to give an oil (21a) in 87% 
yield . 9 ' 10 In the 'HNM R spectrum, there were 2 peaks in the aromatic region, and 3 
peaks in the aliphatic region, integrating in a ratio o f  2:2:3:2:2. A singlet at 3.69 ppm 
was attributed to the methoxy group and signals at 2.92 and 2.63 ppm were attributed
1 Tto the 2 CH 2 groups. In the CNMR spectrum, there were 1 signal at 173.4 ppm for 
the carbonyl group, another 4 signals in the aromatic region for the 4 different 
aromatic carbons, and another 3 signals in the aliphatic region. The EI/CI mass 
spectrum showed pseudo molecular ions at m/z 262, 260 ([M+NH 4 ]+, for 79Br & 81Br 
isotope peaks 100% respectively) and 242, 244 ([M]+, 6 %), corroborating the 
successful synthesis o f 2 1 a.
The cross-coupling reaction was performed by refluxing methyl 3-(4- 
bromophenyl)propionoate (21a), aniline, DPPF, (DPPF)PdCl2 and sodium t- 
butoxide (100:120:15:5:140 approximately) in redistilled toluene under argon for 3 
h . 6  The volatiles were removed from the resulting mixture under vacuum. The 
residue was loaded onto a silica column for chromatography, eluted with DCM. The
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fractions with R f = 0.84 were evaporated to leave a yellow solid, m.p 185-186 °C, 
which proved to be a side product. 1HNMR (CDCI3 , 5, ppm), 7.27 (s), 4.15 (s), 3.88 
(s), integrating in a ratio o f 4:1:1. It possibly resulted from decomposition o f  the 
catalyst. The fractions with R f = 0.24 were pooled and evaporated to afford the 
desired product, 2 1 b.
In the 'HNM R spectrum o f 21b, there were 4 signals in the aromatic region (signals 
for two sets o f protons overlapped accidentally) and 4 other signals, integrating in a 
ratio o f 2:2:4:1:1:3:2:2. A broad singlet at 5.61 ppm was attributed to the proton 
linked with the N atom; a singlet at 3.49 ppm was attributed to the methoxy group; 2 
triplets at 2.72 and 2.43 ppm were attributed to the 2 CH 2 groups. In the l3CNMR 
spectrum, a peak at 173.9 ppm was attributed to the carbonyl group; another 8  peaks 
in the aromatic region and 3 peaks in the aliphatic region were found. The IR 
spectrum gave a strong absorptions at 3383 (N-H) and 1723 cm ' 1 (C =0). In the EI/CI 
mass spectrum, the ion peaks at m/z 255 ([M]+), 273 ([M+NH 4 ]+ and 256 ([M+H]+) 
further proved the structure o f compound 2 1 b.
4.2.2.3 Synthesis of 5-(2-methoxycarbonyIethyI)-/V-phenylisatin (21cl) and N-(4- 
(2 -methoxycarbonylethyl)phenyl)isatin (2 1 c2 )
The syntheses o f o f 5-(2-methoxycarbonylethyl)-/V-phenylisatin (21cl) and N-(4-(2- 
methoxycarboxylethyl)phenyl)isatin (2 1 c2 ) were performed by a procedure similar 
to that used for compound 20c in section 4.2.I.3. The retrosynthesis is illustrated in 
figure 4.8. The crude product was subjected to chromatography, eluted with DCM. 
The 1st fraction proved to be a mixture o f compound 21cl and 21c2. TLC developed 
in several solvent systems showed no evidence o f significant separation o f the 
isomers (compound 21cl and 21c2). However, after column chromatography, the 
ratio o f the isomers was different in different eluted fractions, becoming 3:1 in the 
last fraction. It was expected the isomer with the lower R f value should be 
compound 2 1 c2  and it was hoped to get one pure isomer by efficient crystallization. 
However, the amount o f the mixture was not enough for an efficient crystallisation. 
Because both o f the isomers would give the same product in the next stage, no 
further effort was made for the separation.
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4.2.2.4 Synthesis of 2-(2-carbonylethyI)acridine-9-carboxylic acid (21d)
The mixture o f 2 isatin isomers, 5-(2-methoxycarbonylethyl)-AA-phenylisatin (21 c l)  
and A-(4-(2-methoxycarbonylethyl)phenyl)isatin (21c2), was refluxed in NaOH 
aqueous solution (10%) for 20 h (figure 4.8). The resulting mixture was cooled to 
room temperature and acidified with concentrated HC1 to pH 2. A copious amount o f 
yellow solid precipitated. The precipitate was filtered, washed with distilled H2 O, 
DCM and methanol, and then dried under vacuum to give a yellow solid in 84% 
yield. The product did not melt even up to 290 °C, but at that point, the compound 
turned black. In the ]HNM R spectrum, there were 3 doublets, 1 multiplet (an 
apparent triplet overlapped with a doublet), a singlet and an apparent triplet in the 
aromatic region and 2  triplets in the aliphatic region, integrating in a ratio o f 
1:1:1:2:1:1:2:2. In the 13CNMR spectrum, peaks at 174.4 and 169.1 ppm were 
attributed to the 2  carboxylic groups; there were another 1 1  peaks in the aromatic 
region for 13 different aromatic carbons (2 pairs o f them overlapped); 2 signals at
35.4 and 31.5 ppm were attributed to the 2 CH2  groups. The mass spectra showed 
m/z at 296 ([M+H]+) in Cl mode and 294 ([M -H]') in ES' mode, corroborating the 
structure o f the product.
4.2.2.5 Synthesis of 2 ,6 -dibromophenyl 2-(2-
succinimidyloxycarbonylethyI)acridine-9-carboxylate (21e)
Compound 21e was synthesized according to McCapra. 2-(2-Carbonylethyl)- 
acridine-9-carboxylic acid (2 Id) was refluxed in SOCI2  for 3 h. The excess SOCI2  
was evaporated under vacuum. To the residue, pyridine and A-hydroxysuccinimide 
were added. After the mixture was stirred for 4 h under argon, it was cooled in an ice 
bath, / 7-toluenesulfonyl chloride was added and the mixture was stirred for 15 min. 
Then the ice bath was removed, 2,6-dibromophenol was added and the mixture was 
stirred for a further 2.5 h at room temperature. The resulting mixture was evaporated 
to remove pyridine. The residue was washed with diluted HC1 (0.1 mol L’1) and then 
dried under vacuum. The crude product was purified by chromatography, eluted with 
DCM, and the fractions with R f = 0.22 were pooled and evaporated under vacuum to 
give a pale yellow powder (49.1 mg, 22%), which proved to be succinimidyl p- 
toluenesulfonate, m.p. 145-146 °C. Its structure is shown in figure 4.10. 'h n m r ,
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(chloroform-d, 6 , ppm), 7.85 (2H, d, J -  8  Hz), 7.33 (2H, d, J = 8  Hz), 2.74 (4H, s),
2.41 (3H, s). MS (m/z), El: 269 ([M+], 2%), 155 (56%), 91.3 (100%); Cl: 287 
([M+NH 4 ]+, 100%). The fractions with R f = 0.11 were pooled and evaporated under 
vacuum to give a pale yellow solid, proved to be the desired product (33 mg, 6 % 
yield). The mechanism for the esterification with /?-toluenesulfonic acid chloride was 
shown in figure 4.11. A slight modification was carried out to the procedure in order 
to improve the yield to 29%. Firstly, A-hydroxysuccinimide (NHS) was added at an 
earlier stage, i.e. during refluxing o f  the 2 1  d and SOCI2 , to drive the NHS 
esterification fully . 9 Secondly, the reaction time for the esterification with 2,6- 
dibromophenol was prolonged to 24 h, as illustrated in figure 4.12.
Figure 4.10, a side product, succinim idyl/M oluenesulfonate
R
O
H
TsC l
O O
Figure 4.11, mechanism o f  the esterification with / 7-toluenesulfonyl chloride.
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HO
2 Id
COOH
SOCI2, jV-hydroxysuccinimide Pyridine
reflux, 3 h r.t, overnight
O
TsCl, argon
r.t, 2,6-dibromophenoI, 24 h
Br-
2 1 e
Figure 4.12, synthesis o f 2,6-dibromophenyl 2-(2-succinimidyIoxycarbonylethyl)acridine-9-
carboxylate (2 1 e)
regions were in a ratio o f 10: 8 . Two triplets at 3.37 and 3.20 ppm were attributed to 
the 2 CH 2 groups, and a singlet at 2.97 ppm integrating for 4 protons was attributed
1 3to the 2 CH 2 groups o f the succinimidyl moiety. In the CNMR spectrum, 3 signals 
for the 4 CH 2 groups (2 o f them are identical) in the aliphatic region, and another 12 
peaks in the aromatic region, for 17 different aromatic carbons (5 pairs o f them 
presumably overlapping), were found; peaks at 169.3 (a pair o f them overlapped 
presumably) and 163.7 ppm were attributed to the 3 different carbonyl groups. The 
EI/CI mass spectrum gave ion peaks at m/z 626 ([M]+) and 627 ([M+H]+), 512 and 
260 (figure 4.13).
In the 'HNM R spectrum o f 21e, the proton integrals in the aromatic and aliphatic
m /z, 512
Figure 4.13, MS fragments for compound 21e
4.2.2.6 Synthesis o f 9-(2,6-dibromophenoxycarbonyl)-2-(2-
succinimidyloxycarbonylethyl)-1 0 -methylacridinium trifluoromethanesulfonate 
(21)
Chapter 4 163
Compound 21 was synthesized in a synthetic pathway similar to those used for 
compounds 2, 7, 12, 16, and 18, by stirring 2,6-dibromophenyl 2-(2- 
succinimidyloxycarbonylethyl)acridine-9-carboxylate (21e) and methyl triflate in dry 
DCM under argon (figure 4.14). After the mixture was stirred at room temperature 
for 3 h, the expected precipitate had not appeared, therefore, the mixture was stirred 
for a further 20 h, but there was still no precipitate. The resulting mixture was 
evaporated to give a red brown residue. The residue was re-dissolved in DCM and 
the product was precipitated with EtOEt in a way similar to that used for purifying 
LiAE. But TLC showed that the starting material was not removed completely. 
Possibly, this is due to the difference o f the solubility between 21 and 21 e not being 
so great as those o f other corresponding pairs, e.g. 2 /la , 7/7a, 12/12a, 16/16e and 
18/18a. Therefore, the crude product was subjected to chromatography on a silica 
column, eluted with DCM +CH 3 CN (4:1, and then 3:1). The fractions with R f = 0.19 
(developed in DCM+CH 3 CN, 3:1) were combined and evaporated to give a brown 
yellow oil, which solidified on standing, in 54% yield.
o - n
•O -N
r.t, 23 h, N 2
21
Figure 4.14, synthesis o f  9-(2,6-dibromophenoxycarbonyl)-2-(2- 
succinimidyloxycarbonylethyl)-l O-methylacridinium trifluoromethanesulfonate (21)
In the 'HNM R spectrum o f 21, there were 7 peaks in the aromatic region for 9 
different protons (2 pairs o f them overlapped accidentally), and 4 peaks in the 
aliphatic region, integrating in a ratio o f 2:2:1:1:1:2:1:3:2:2:4. A singlet at 5.08 ppm 
was attributed to the methyl group, 2  triplets were attributed to the 2  different CH 2  
groups and a singlet at 3.07 ppm was attributed to the 4 protons o f the succinimidyl
1 3moiety. In the CNMR spectrum, there were peaks at 170.2, 169.0 and 161.8 ppm, 
accounting for the 3 carbonyl groups, and another 17 peaks in the aromatic region 
accounting for the 17 different aromatic carbons. A signal at 40.4 ppm was 
attributed to the methyl group; signals at 33.4 and 30.3 ppm were attributed to the 2
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different CH 2  groups, and a peak at 26.3 ppm was attributed to the 2 identical CH 2 
groups o f the succinimidyl moiety. The ES mass spectrum showed cations at m/z 641 
([M-CF3 S0 3 ]+) and 544, and an anion at m/z 149 ([CF3 SO3 ]'), corroborating the 
structure o f the compound 21 (figure 4.15).
.0 —n OH
m/z, 544m/z, 641
Figure 4.15, MS fragments for compound 21
4.2.3 Synthesis of 9-(4-(2-succinimidyloxycarbonylethyl)phenoxycarbonyl)-2,7-
11 11dimethoxy-10-methylacridinium trifluoromethansulfonate (22) ’
The structure o f compound 22’, synthesized before by Li in the Smith group, is 
12shown in figure 4.1. Its precursor (compound 22a) shown in figure 4.16, available 
generously from Dr. Li, is an important intermediate for the synthesis o f 22. 
Selective hydrolysis o f the benzyl group o f compound 22a would give the 
corresponding carboxylic acid (22b). Compound 22b would be esterified with N- 
hydroxysuccinimide to afford compound 22c, which would be methylated to provide 
the final product 2 2 .
4.2.3.1 Synthesis o f 4-(2-carbonyIethyl)phenyl 2,7-dimethoxyacridine-9- 
carboxylate (22b)
Compound 22b was synthesized by selectively hydrolysing 4-(2- 
benzyloxycarbonylethyl)phenyl 2,7-dimethoxyacridine-9-carboxylate (22a) in 
HBr+HOAc (1:4) at 100 °C for 3 h, as illustrated in figure 4.16. The resulting 
mixture after cooling, was poured into water and extracted with MeOH (20%) + 
CHCI3 . The organic extracts were dried over MgSC>4 , filtered, and evaporated on a 
rotary evaporator to leave a yellow solid, which was taken up in hot DCM. Hexane
Chapter 4 165
was then added until the solution became cloudy. The mixture was left to stand 
overnight at room temperature. The precipitate that formed was collected by 
filtration and dried under vacuum to yield the desired product.
HBr/HOAc
reflux, 3 h, N 2
OH
22a 22b
Figure 4.16, Synthesis o f 4-(2-carbonylethyl)phenyl 2,7-dimethoxyacridine-9-carboxylate
(2 2 b)
In the 'HNM R spectrum o f 22b, there were 5 peaks in the aromatic region and 3 
peaks in the aliphatic region, integrating in a ratio o f 2:2:2:2:2:6:2:2. A singlet at 
3.78 ppm was attributed to the 2 methoxy groups, and 2 triplets at 2.69 and 2.38 ppm 
were attributed to the 2 CH 2 groups. Due to its poor solubility in DMSO, the signals
1 Tof the CNMR spectrum were too weak to be clear. The IR spectrum showed 
absorptions at 1745 (C =0 o f ester bond) and 1704 cm ' 1 (C = 0  o f carboxylic acid). 
The mass spectrum gave a pseudo molecular ion peak at m/z 432 ([M+H]+).
4.2.3.2 Synthesis o f 4-(2-succinimidylyoxycarbonylethyl)phenyl 2,7- 
dimethoxyacridine-9-carboxylate (22c)
Compound 22c was synthesized by using 4-(2-carbonylethyl)phenyl 2,7- 
dimethoxyacridine-9-carboxylate (22b) and A-hydroxysuccinimide. Compound 22b 
was heated in SOCI2 at 65 °C for 3 h. The excess SOCI2  was evaporated under 
vacuum, and pyridine was then added, followed by A-hydroxysuccinimide. The 
mixture was stirred overnight at room temperature. The synthesis is illustrated in 
figure 4.17. The resulting mixture was stripped o f  pyridine under vacuum to leave a 
brown residue. DCM was added to take up the product. The extract was loaded onto 
a silica column for chromatography, eluted with DCM + EtOAc (30%). The fractions
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(R f = 0.25) were pooled and evaporated to give a bright yellow solid. However, the 
'HNM R spectrum showed impurities, which had the same R f value as the product 
2 2 c, possibly resulting from hydrolysis o f the phenyl ester bond during the process of 
heating 22b with thionyl chloride. The reaction was slightly modified, by heating 
22b in thionyl chloride for a shorter time (0.5 h) in the first stage. A pure product 
was achieved in 33% yield.
In the 'HN M R spectrum o f 22c, there were 2 signals in the aromatic region for 5 
different aromatic protons (4 o f them overlapped accidentally), and 4 signals in the 
aliphatic region, integrating in a ratio o f 2:8:6:2:2:4. A singlet at 3.95 ppm was 
attributed to the 2 methoxy groups and 2 triplets at 3.13 and 2.98 ppm were attributed 
to the 2 CH2  groups linked with the phenoxy ring. A singlet at 2.83 ppm was
i ^attributed to the 2 identical CH 2 groups o f the succinimidyl moiety. In the CNMR 
spectrum, there were 3 peaks at 169.5, 168.2 and 167.0 ppm attributed to the 3 
carbonyl groups and another 1 1  signals in the aromatic region for the 1 1  different 
aromatic carbons. A signal at 56.0 ppm was attributed to the 2 methoxy carbons, 
peaks at 32.9 and 30.3 ppm were attributed to the 2 different CH2 groups linked with 
the phenoxy ring, and a peak at 26.0 ppm was attributed to the 2  identical CH2 
groups o f the succinimidyl moiety. The EI-CI mass spectrum showed ions at m/z 528 
([M]+), 414 and 266 (figure 4.18); the accurate molecular mass was found at 
528.1525, against 528.1527 by calculation.
° CH3 h o — n
SOCl2
Pyridine, r.t., overnight65 °C
OH
O2 2 b 22c
Figure 4.17, synthesis o f 4-(2-succinimidyloxycarbonylethyl)phenyl 2,7-dimethoxyacridine-
9-carboxylate (22c)
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m/z, 414
H-.CO'
m/z. 266
OCH3
Figure 4.18, MS fragments for compound 22c
4.2.3.3 Synthesis o f 9-(4-(2-succinimidyIoxycarbonylethyl)phenoxycarbonyl)-2,7- 
dimethoxy-1 0 -methylacridinium trifluoromethansulfonate (2 2 )
Compound 22 was synthesized by stirring 4-(2- 
succinimidyloxycarbonylethyl)phenyl 2,7-dimethoxyacridine-9-carboxylate (22c) 
and methyl triflate in dry DCM, as illustrated in figure 4.19. The starting materials 
were stirred at room temperature overnight in dry DCM under argon. The excess 
triflate and solvent were evaporated under vacuum. The crude product was purified 
by chromatography over a silica column, eluted with DCM+CH 3CN (3:1), the 
fractions with R f = 0.16 being pooled and evaporated under vacuum gave an orange- 
yellow solid. In the 'HNM R spectrum, there were 2 doublets and 1 multiplet (3 
signals overlapped accidentally) in the aromatic region, and 5 signals in the aliphatic 
region, integrating in a ratio o f 2:2:6:3:6:2:2:4. A singlet at 5.02 ppm was attributed 
to the methyl group next to the N atom o f the acridinium ring, a singlet at 4.06 ppm 
was attributed to the 2 methoxy groups, 2 triplets at 3.02 and 2.92 ppm were 
attributed to the 2 different CH 2 groups and a singlet at 2.76 ppm was attributed to
13the 2 identical CH 2  groups o f the succinimidyl moiety. In the CNMR spectrum, 
there were 3 lines at 170.0, 168.6 and 164.2 ppm attributed to the 3 carbonyl groups, 
and another 11 lines attributed to the 11 different aromatic carbons. A peak at 56.6 
ppm was attributed to the 2 methoxy groups; a signal at 40.5 ppm was attributed to 
the /V-methyl group; 2 peaks at 32.4 and 29.3 ppm were attributed to the 2 different 
CH2  groups; and a peak at 25.8 ppm was attributed to the 2 identical CH 2 groups on 
the NHS moiety. The mass spectrum showed a cation at m/z 543 ([M-CF3 SC>3 ]+) and 
an anion at m/z 149 ([CF3 SC>3 ]‘), corroborating the successful synthesis o f 22.
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CF3S 0 3CH3,N 2 H3C0
DCM, r.t, overnight
22c O22
Figure 4.19, Synthesis o f  9-(4-(2-succinimidyIoxycarbonylethyl)phenoxycarbonyl)-2,7- 
dimethoxy-10-methylacridiniurn trifluoromethansulfonate (22)
4.3 Experimental details and characterization
4.3.1.1 Synthesis of 7V-(3,5-dimethyIphenyl)formanilide (20a)
In a round bottom flask (25 ml), equipped with an air condenser and a stirrer bar, 
formanilide (3.274 g, 27.1 mmol), 5-bromo-m-xylene (7.028 g, 38.2 mmol), 
potassium carbonate (3.724 g, 27.0 mmol) and copper iodide (5.163 g, 27.2 mmol) 
were mixed and heated at reflux for 18 h. The resulting mixture was extracted with 
DCM (90 ml). The extract was dried over MgSCU, filtered, and evaporated on a 
rotary evaporator to give a yellow oil. The oil (9.142 g) was subjected to 
chromatography over a silica column, eluted with hexane firstly, then DCM. The 
fractions (R f = 0.73 in DCM) were pooled and evaporated to give a white solid 
(1.126g, 20 % yield), m.p. 144 °C, which proved to be a side product N,N-(bis(3,5- 
dimethylphenyl)aniline. The fractions with R f = 0.30 were combined and evaporated 
to provide a pale yellow oil (4.118 g, 67% yield), which solidified on standing, m.p. 
54-55 °C, and which proved to be the desired product.
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'HNM R (400 Hz, chloroform-d, 5, ppm), 8.59, 8.55, (1H, Hjo splitting into 2 singlets, 
because o f  restricted rotation about the N-CO bond), 7.32 (2H, H 7 , Hy, m), 7.16-7.25 
(2 H, Hg, H 6 or H6>, m), 7.08 (1H, H6or H6-, d, J = 7 Hz), 6.85 (2H, H2, Hr , s), 6.71 
( 1 H, H4, s), 2.23 (6 H, H9, H9*, s).
i3CNMR (400 Hz, chloroform-d, 5, ppm), 162.0 (C 10), 142.4 and 142.0, (C 5 , splitting 
into 2 peaks, because o f restricted rotation about the N-CO bond), 140.2 and 139.7 
(Ci, splitting into 2  lines), 139.7 and 139.4 (C3 /C 3 ’, splitting into 2  lines), 129.8 
(C 7/C 7 0, 129.3 (C4), 126.8 (C8), 124.3 ( C ^ ) ,  123.5 (C2 /Cr ), 21.7 (C9 /C9>).
IR (o , cm '1), 1682 (C =0).
MS (m/z), El: 225 (M+, 100%), 197 ([M -C H O +H f, 79%), 77 (49%); CI: 243 
([M+NH4]+, 100%), 226, ([M +H]+, 8 6 %).
4.3.1.2 Synthesis of vV-(3,5-dimethylphenyl)aniline (20b)
In a round bottom flask (50 ml), equipped with a condenser and a stirrer bar, 
com pound 20a (1.95 g, 8.67 mmol) was gently refluxed in ethanol (15 ml) with 
KOH (1.95g, 34.8 mmol) for 20 h. Then the solvent was removed on a rotary 
evaporator. To the residue, DCM (100 ml) was added. The mixture was filtered, and 
the filtrate was concentrated on a rotary evaporator, and then loaded onto a silica 
column for chromatography, eluted with DCM. The fractions with R f = 0.78 were 
combined and evaporated to give a brown solid (1.168g, 6 8 % yield), m.p. 51-52 °C.
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'HNM R (400 Hz, chloroform-d, 5, ppm), 7.20 (2H, H7, H7’, dd, J = 8 , 7 Hz,), 7.02 (d, 
H6, H6’, d, J = 8  Hz), 6.87 (1H, Hg, t, J = 7 Hz), 6.67 (2H, H2, Hr , s), 6.54 (1H, H4, s), 
2.20 (6 H, H9, H9’, s ) ,  H io was not found, presumably because it was very broad.
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l3CNMR (400 Hz, chloroform-d, 5, ppm), 142.8 (C5), 139.5 (C ,, C3 /C 3 .), 129.7 
(C7/C 7 O, 123.8 (C4), 1 2 2 . 0  (C8), 118.7 (C(/C6-), 116.4 (C2 /C2-), 21.8 (C9 /C 9 0-
IR (o, cm’1), 3382 (N-H).
MS (m/z), El: 197 (M +, 54%), 77 (43%); CI: 198 ([M + H f, 100%).
4.3.1.3 Synthesis o f 4,6-dimethyk/V-(phenyI)isatin (20c)
To oxalyl chloride (1.162g, 8.20 mmol) in DCM (5 ml) in a round bottom flask (25 
ml), equipped with a stirrer, 77-(3,5-dimethylphenyl)aniline (20b) (1.168g, 5.93 
mmol) in DCM (6 . 8  ml) was added slowly. The flask was equipped with a condenser 
and refluxed for 0.5 h. The resulting mixture was allowed to cool, and the excess 
oxalyl chloride and DCM were evaporated on a rotary evaporator. To the brown 
residue, DCM (10 ml) was added again, followed by AICI3 (2.77 g, 20.8 mmol) in 
portions carefully. The mixture was refluxed for a further 1 h. Then after cooling and 
removal o f the solvent from the resulting mixture under vacuum, any remaining 
reactive species were destroyed with ice and dilute HC1 (1 mol L"1, 10 ml) carefully. 
The mixture was extracted with DCM (20 ml x 3). The extract was dried over 
MgSC>4 , filtered and evaporated. The crude product was purified by column 
chromatography (silica), eluted with DCM. The fractions with R f = 0.61 were 
combined and evaporated to afford an orange solid (0.991 g, 67% yield), m.p. 157-
158 °C.
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HNMR (400 Hz, chloroform-d, 8 , ppm), 7.39 (2H, H9 , H9 ’, apparent t, J = 8  Hz,), 
7.29 (1H, H 10, t, J = 8  Hz), 7.23 (2H, H8, Hg-, d, J = 8  Hz), 6.58 (1H, H,, s ) , 6.32 (1H, 
H3, s), 2.43 (3H, H ,, or Hn , s), 2.16 (3H, H „ or H 12, s).
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13CNMR (400 Hz, chloroform-d, 8, ppm), 182.9 (C n ), 158.4 (C I2), 152.5 (C2), 150.2 
(C6), 141.9 (C7), 133.6 (C4), 130.3 (C9 /C 9 O, 129.1 (C3), 127.5 (C 10), 126.7 (Cg/C8-),
114.1 (C5), 109.8 (C,), 23.2 (C „), 18.6 (C 12).
IR (u, cm '1), 1746 (A r-C =0), 1721 (-N C=0).
MS (m/z), El: 251 (M+, 19%), 223 ([M-2CH3+2H]+, 78%), 77 (100%); CI: 269 
([M+NH4]+, 100%), 238 (17%).
4.3.1.4 Synthesis o f l,3-dimethylacridine-9-carboxyIic acid (20d)
To a round bottom flask (25 ml), equipped with a stirrer and a condenser, 4,6- 
dimethyl- 7/-(phenyl)isatin (20c) (0.739 g, 2.94 mmol) and KOH (1.414 g, 25.2 
mmol) in H20  (13 ml) were added. The mixture was refluxed for 39 h. After the 
mixture was cooled, it was acidified with concentrated HC1 to pH = 2. The yellow 
precipitate was filtered, re-dissolved in K2C 0 3 (10%) aqueous solution, and then re­
precipitated with concentrated HC1 carefully. The precipitate was collected by 
filtration, washed with DCM (10 ml) and methanol (10 ml), and pumped overnight. 
The product (0.419 g) was obtained in 57% yield, m.p. > 280 °C.
c o o h  19
'HNM R (400 Hz, DMSO-d6, 8, ppm), 8.24 (1H, H8, d, J = 8 Hz), 8.08-7.97 (2H, Hs, 
H6, m), 7.93 (1H, H4, s), 7.78 (1H, H7, apparent t, J = 8 Hz), 7.49 (1H, H2, s), 2.84
(3H, H9  or Hio, s), 2.57 (3H, H 9 or Hjo, s). Hn was not found, presumably because 
the chemical shift was more than 11.5 ppm or because the peak was too broad.
IR (u, cm-1), 1714 (C =0).
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MS (m/z), El: 251 (M+, 11%), 207 ([M-COOH]+ or [M-2CH3 -OH+3H]+, 27%), 44 
(100%); CI: 252 ([M+H]+, 17%), 210 (100%). MS/ACC, 252.1019 ([M+H]+) for 
theoretical mass o f C]6Hi4N 0 2; 252.1022 found.
4.3.1.5 Synthesis of 2,6-dibromophenyI l,3-dimethylacridine-9-carboxylate (20e)
l,3-Dimethylacridine-9-carboxylic acid (20d) (226 mg, 0.900 mmol) was refluxed in 
thionyl chloride (15 ml) in a round bottom flask (25 ml) for 23 h. Excess thionyl 
chloride was removed on a rotary evaporator to leave a brown solid. Then pyridine 
(10 ml), DMAP (87 mg, 0.707 mmol) and 2,6-dibromophenol (208 mg, 0.826 mmol) 
were added respectively. The flask was flushed with N 2  and the mixture was stirred 
at room temperature overnight. The resulting mixture was stripped o f  pyridine under 
vacuum. The residue was taken in DCM for chromatography over a silica column, 
eluted with DCM, The fractions with R f = 0.57 were pooled and evaporated to give a 
yellow solid (44 mg, 11% yield), which turned purple later.
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'HNM R (400 Hz, chloroform-d, 6 , ppm), 8.62 (1H, Hg, broad d, J = 9 Hz), 8.08 (1H, 
Hs, broad d, J = 9 Hz), 7.78 (1H, H4, s), 7.63 (1H, H6, ddd, J = 9, 7, 1 Hz), 7.51 (2H, 
d, H 13, H 15, J = 8  Hz), 7.43 (1H, H7, ddd, J = 9, 7, 1 Hz), 7.13 (1H, H2, s), 6.92 (1H, 
Hm, t, J = 8  Hz), 2.67 (3H, H ] 7  or H ]8, s), 2.38 (3H, H J7 or H ]8, s).
13CNMR (400 Hz, chloroform-d, 6 , ppm), 164.2 (C ]0), 150.6 (C n ), 148.2 (C5a), 146.7 
(C4a), 140.7 (C3), 136.2 (C9), 134.5 (C,), 133.9 (C 13/C ]5), 133.5 (C ,4), 130.6 (C2), 
129.9 (C5), 129.0 (C6), 127.6 (C7), 127.1 (C4), 126.6 (C8), 123.1 (C9a’), 121.6.(C9a),
118.1 (C ,2/C ,6), 24.5 (C ,8), 22.2 (C ,7).
IR (u, cm '1), 1760 (C =0).
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MS (m/z), El: 485 ([M]+, 1%), 234 (100%), 206 (69%); CI: 486 ([M+H]+, 13%), 
236 (30%), 208 (100%).
4.3.2.1 Synthesis o f methyl 3-(4-bromophenyl)propionoate (21a)
In a round bottom flask (100 ml), equipped with a condenser and a CaCh drying tube,
3-(4-bromophenyl)propionic acid (1.130g, 4.93 mmol) was refluxed in SOCI2 (10 ml) 
for 2 h. The resulting mixture was evaporated to leave an oil, to which, methanol (3 
ml) and pyridine (10 ml) were added and the whole mixture was then stirred 
overnight at room temperature. The resulting mixture was evaporated on a rotary 
evaporator to leave a pale yellow oil, which was chromatographed on a silica column, 
eluted with DCM. The fractions with R f = 0.83 were pooled and evaporated to give a 
pale yellow oil (1.045g) in 87% yield, (lit. I0, b.p. 154-155 °C /16mmHg).
J
'HNM R (400 Hz, chloroform-d, 5, ppm), 7.42 (2H, H3, H3-, d, J = 8 Hz), 7.10 (2H, 
H2, Hr , d, J = 8 Hz), 3.69 (3H, H8, s), 2.92 (2H, H5, t, J = 8 Hz), 2.63 (2H, H6, t, J =
8 Hz).
13CNMR (400 Hz, chloroform-d, 6, ppm), 173.4 (C7), 139.8 (C,), 132.0 (C3/C3>),
130.5 (C2/C 2 O, 120.5 (C4), 52.1 (C8), 35.8 (C6), 30.7 (C5).
IR (u, cm '1), 1733 cm '1.
MS (m/z), El: 244, 242 ([M]+), 6%), 184, 182 (100%), 171, 169 (52%); CI: 262, 260 
([M+NH4]+, 100%), 182 (27%).
4.3.2.2 Synthesis of 4-(2-methoxycarbonyIethyl)-/V-phenylaniline (21b)
To a two-neck round bottom flask (100 ml), methyl 3-(4-bromophenyl)propionoate 
(21a) (2.181 g, 8.97 mmol), aniline (1.074g, 11.54 mmol), DPPF (0.756g, 1.36
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mmol), (DPPF)PdCl2 (0.367g, 0.449 mmol) and sodium t-butoxide (1.237g, 12.9 
mmol) were added. The flask was equipped with a condenser and a stirrer bar, and 
flushed with nitrogen. Then, re-distilled toluene (20 ml) was introduced with a 
syringe. The mixture was heated at 100 °C for 3 h. After the reaction was cooled to 
room temperature, the volatiles were removed over a rotary evaporator. The residue 
was loaded onto a silica column for chromatography, eluted with DCM. The 
fractions with R f = 0.24 were pooled and evaporated to give a pale yellow oil (1.33 g, 
58% yield).
'HNM R (400 Hz, chloroform-d, 8 , ppm), 7.07 (2H, H 7 , H 7 ’, apparent t, J = 8  Hz), 
6.92 (2 H, H3, H3’, d, J = 8  Hz), 6.89-6.78 (4H, H2, Hr , H6, H6-, m), 6.72 (1H, H8, t, J 
-  8  Hz), 5.61 ( 1 H, H 13, broad s), 3.49 (3H, H 12, s), 2.72 (2H, H9, t, J = 8  Hz), 2.43 
(2 H ,H ]0, t, J = 8 Hz).
13CNMR (400 Hz, chloroform-d, 5, ppm), 173.9 (C n ), 143.9 (C5), 141.7 (Ci), 133.7 
(C4), 129.7 (C 7/C 7 O, 129.6 (C3/C 3 O, 1 2 1 . 1  (C8), 118.8 (C6/C 6 0, 117.7 (C 2 /Cr ), 52.0 
(C 12), 36.3 (C10), 30.7 (C9).
IR (o, cm '1), 3383 (N-H), 1723 (C=0).
MS (m/z), El: 255 ([M]+, 23%), 240 (7%), 195 (13%), 182 (100%), 167 (18%); CI: 
273 ([M+NH4]+, 15%), 256 ([M+H]+, 100%), 182 (16%).
4.3.2.3 Synthesis of 5-(2-methoxycarbonylethyl)-/V-phenyIisatin (21cl) and 7V-(4- 
(2 -methoxycarbonylethyl)phenyl)isatin (2 1 c2 )
4-(2-Methoxycarbonylethyl)-/V-phenylaniline (1.30g, 5.21 mmol) in DCM ( 6  ml) 
was added to stirred oxalyl chloride (1.017g, 8.01 mmol) in DCM (9 ml) slowly. The 
flask (50 ml) was equipped with a condenser and a CaCl2 drying tube. The mixture 
was refluxed for 30 min and then the excess (COCl) 2 and solvent were removed. The
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black brown residue was dissolved DCM (12 ml), and then anhydrous AICI3 (2.2g,
16.5 mmol) was added in portions carefully. The mixture was refluxed for 50 min. 
The solvent was removed under vacuum, and then remaining reactive material was 
destroyed with HC1 (1 mol L '1, 10 ml). The mixture was filtered, and the filtrate was 
extracted with EtOEt (5X 15 ml). The extract was combined with the precipitate and 
the solvent was removed under vacuum. The crude product was purified by 
chromatography over a silica column, eluted with DCM. The fractions with R f =
0.17 were pooled and evaporated to leave a red oil (solidifying on standing, 978 mg, 
61% yield). The 'H N M R spectrum showed that it was a mixture o f two isomers, both 
o f them giving the same product in the next stage. The mixture was characterized 
with MS and IR. MS (m/z), El: 309 ([M]+, 22%) and 207 (100%); CI: 327 
([M+NH4]+, 100%), 313 ([M+NH 4 -CH 3+H]+, 48%), 296 (46%). IR (o, cm-1), 1732, 
1705, 1669 (C =0). Compound 21c2 could be characterized by its 'HNM R spectrum.
CH2CH2COOCH3 
13 14 15
'HNM R (400 Hz, chloroform-d, 6 , ppm), 7.62 (1H, H8, dd, J = 8 , 1 Hz), 7.47 (1H, H7, 
apparent td, J = 8 , 1 Hz), 7.32 (2H, H 10, Hjo-, d, J = 8  Hz), 7.27 (2H, H n , H i r , d, J = 
8  Hz), 7.10 (1H, H6, apparent td, J = 8 , 1 Hz), 6.82 (1H, H5, dd, J = 8 , 1 Hz), 3.63 
(3H, H]5 , s), 2.96 (2H, H 13, t, J = 8  Hz), 2.62 (2H, H 14, t, J = 8  Hz).
4.3.2.4 Synthesis of 2-(carbonylethyI)acridine-9-carboxylic acid (21d)
In a round bottom flask (50 ml), the mixture o f 2 isatin isomers 21cl and 21c2 (779.7 
mg, 2.52 mmol) was refluxed in NaOH aqueous solution (10%, 15 ml) for 20 h. The 
resulting mixture was cooled and acidified with concentrated HC1 to pH 2.0. A 
copious quantity o f yellow compound precipitated, and was collected by filtration, 
washed with H 2 O (30 ml), methanol (20 ml) and DCM (30 ml), and then evaporated 
under vacuum. A yellow solid (629 mg, 84% yield) was obtained, m.p. > 290 °C.
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‘COOH
13COOH
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'HNM R (400 Hz, DMSO-d6, 6 , ppm), 8.21 (1H, H8, broad d, J = 8  Hz), 8.17 (1H, H 5, 
broad d, J = 9 Hz), 8.06 (1H, H4, d, J = 8  Hz), 7.91 (1H, H6, ddd, J = 9, 7, 1 Hz), 7.86 
(1H, H3, d, J = 8 Hz), 7.85 (1H, H ,, s), 7.72 (1H, H7, ddd, J = 8 , 7, 1 Hz), 3.10 (2H, 
H ii, t, J = 8  Hz), 2.70 (2H, H 12, t, J = 8  Hz); H 10 and H 13 were not found, presumably 
because the chemical shifts were more than 11.5 ppm or because the peaks were too 
broad.
13CNMR (400 Hz, DMSO-d6, 6 , ppm), 174.4 (C 13), 169.1 (Cio), 148.2 (C5a), 147.9 
(C4a), 141.1 (C2, C9), 133.7 (C3), 131.5 (C5), 129.9 (C4, C6), 128.2 (C7), 126.1 (C,),
123.7 (C8), 122.0 (C9a>), 121.8 (C9a), 35.4 (C 12), 31.5 (C „).
IR (u, cm '1), 1709 cm '1.
MS (m/z), CI: 296 ([M+H]+, 100%), 252 (62%), 208 (39%); ES': 294 ([M -H ]\ 
100%), 240 (96%).
4.3.2.5 Synthesis of 2,6-dibromophenyl 2-(2-succinimidyloxycarbonyIethyl)- 
acridine-9-carboxyIate (21e)
In a round bottom flask (25 ml), equipped with a stirrer bar, a condenser and a CaCl2  
drying tube, 2-(2-carbonylethyl)acridine-9-carboxylic acid (250 mg, 0.84 mmol) was 
refluxed in SOCl2 ( 6  ml) with /V-hydroxysuccinimide (184 mg, 1.60 mmol) for 3 h. 
The excess SOCl2  was evaporated under vacuum. To the residue, pyridine (7 ml) was 
added. After the mixture was stirred overnight under argon, it was cooled in an ice 
bath. p-Tolenesulfonyl chloride (279 mg, 1.47 mmol) was added, the mixture was 
stirred for 15 min, and then the ice bath was removed. 2,6-Dibromophenol (230 mg,
0.92 mmol) was added and the mixture was stirred for a further 1 day. The resulting 
mixture was evaporated under vaccum. The residue was washed with HC1 (0.1 mol 
L '1, 8  ml) and then dried under vacuum to provide the crude product, which was
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purified by chromatography, eluted with DCM. The fractions with R f = 0.11 were 
pooled and evaporated under vacuum to give a pale yellow solid, m.p. 207-208 °C, 
(154 mg, 29% yield).
9a’
14
'HNM R (400 Hz, chloroform-d, 5, ppm), 8.28-8.17 (3H, H ,, H s, H8, m), 8.19 (1H, 
H4, d, J = 9 Hz), 7.78 (1H, H6, ddd, J = 9, 7, 1 Hz), 7.75 (1H, H3, d, J = 9, 1 Hz), 7.63 
( 1 H, H7, ddd, J = 9, 7, 1 Hz), 7.46 (2H, H 13, H 13-, d, J = 8  Hz), 6.92 (1H, H 14, t, J = 8  
Hz), 3.37 (2H, H 15, t, J = 8  Hz), 3.20 (2H, H ]6, t, J = 8  Hz), 2.97 (4H, H 19, H 19’, s).
13CNMR (400 Hz, chloroform-d, 5, ppm), 169.3 (C 17, C 18/C , 8 ), 163.7 (C 10), 148.5 
(C5a), 148.1 (C4a), 140 .7(C n ), 133.1 (C2, C9), 132.8 (C3, C 13/C 13.), 131.0 (C 14), 130.4 
(C4, C5), 128.7 (CW, C9a), 128.6 (C6), 125.2 (C7), 123.2 (C,, C8), 118.2 (C 12/C i r ),
34.5 (C 16), 31.3 (C 15), 26.3 (C 19/C l9.).
IR (o, cm"1), 1739 cm '1.
MS (m/z), El: 626 ([M]+, 3%), 512 (9%), 347 (5%), 333 (11%), 260 (100%), 251.9 
(49%); CI: 627 ([M+H]+, 17%), 583 (23%), 486 (100%).
4.3.2.6 Synthesis o f 9-(2,6-dibromophenoxycarbonyl)-2-(2-succinimidyloxy- 
carbonylethyl)-1 0 -methylacridinium trifluoromethanesulfonate (2 1 )
To a round bottom flask (5 ml), 2,6-dibromophenyl 2-(2- 
succinimidyloxycarbonylethyl)acridine-9-carboxylate (21e) (47 mg, 0.075 mmol) 
was added. The flask was flushed with argon, and then dry DCM (3 ml) and methyl 
triflate (110 pi, 0.97 mmol) were introduced with syringe, respectively. The mixture 
was stirred at room temperature for 23 h. The resulting mixture was evaporated to
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give a red brown residue, which was loaded onto a silica column for chromatography, 
eluted with DCM + CH 3 CN (4:1, and then 3:1), the fractions (R f = 0.19 with solvent 
DCM + CH3 CN, 3:1) were combined and evaporated to give a brown yellow oil, 
which solidified on standing, m.p. 86-87 °C (32 mg, 54% yield).
_ 20
14
'HNM R (400 Hz, acetone-d6, 6 , ppm), 8.98-8.90 (2H, H5, H8, m), 8.59-8.53 (2H, H 1# 
H4, m), 8.49 (1H, H6or H 7, apparent t, J = 8  Hz), 8.42 (1H, H3, d, J = 8  Hz), 8.14 (1H, 
H 6 or H7, apparent t, J = 8  Hz), 7.52 (2H, H 13, H ,3’, d, J = 8  Hz), 7.03 (1H, H )4, t, J = 
8  Hz), 5.08 (3H, H20, s), 3.44 (2H, H 15, t, J = 7 Hz), 3.33 (2H, H l6, t, J = 7 Hz), 3.07 
(4H, H 19, H i9’, s ) .
13CNMR (400 Hz, acetone-d6, 6 , ppm), 170.2 (C 18/C ]8’), 169.0 (C 17), 161.8 (C 10),
146.5 (C „), 143.7 (C9), 143.1 (C5a), 142.4 (C4a), 142.2 (C 13/C 13’), 142.0 (C2), 139.9 
(C5), 133.0 (C 14), 130.7, 129.4, 127.2, 125.5 (C4, C6, C7, C8), 124.1, 124.0 (C9a, C9 a0, 
120.4, 120.3 (Ci, C3), 117.8 (C ]2 /C ,r ), 40.4 (C20), 33.4 (C 16), 30.3 (C 15), 26.3
( C 19/ C  ] 9’) .
IR (u, cm '1), 1738 cm '1.
MS (m/z), ES+: 641 ([M-CF3 S 0 3]+, 100%), 558 (76%), 544 (78%), 530 (48%), 420 
(29%), 344 (48%), 248 (31%), 209 (42%), 196 (49%); ES‘: 149 ([CF3 SO3]', 100%),
80 (58%). Acc-MS: calculated mass: 638.9761 ([M-CF3 S0 3 ]+); measured mass: 
638.9758.
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4.3.3.1 Synthesis of 4-(2-carbonylethyl)phenyl 2,7-dimethoxyacridine-9- 
carboxylate (2 2 b)
To a solution o f HBr (48%) + HOAc (1:4) (10 ml), 4-(2-
benzyloxycarbonylethyl)phenyl 2,7-dimethoxyacridine-9-carboxylate (22a) (0.517 
mg, 0.991 mmol) was added, and the mixture was heated at 100 °C for 3 h. After the 
resulting mixture was cooled, it was poured into water ( 1 0 0  ml) and extracted with 
MeOH (20%) + CHCI3 (5 x 100 ml). The organic extracts were combined, dried over 
MgSC>4 , filtered and evaporated on a rotary evaporator. The residue was dissolved in 
hot DCM, and then hexane was added until the solution became cloudy. The mixture 
was left to stand overnight at room temperature. The solid that formed was collected 
by filtration and pumped overnight to yield the desired product (378 mg, 8 8 %), m.p. 
308-309 °C.
'HNM R (400 Hz, DMSO-d6, 5, ppm), 7.95 (2H, H4, H5, d, J = 9 Hz), 7.38 (2H, H3, 
H6, d, J = 9 Hz), 7.28 (2H, H 13, H 13’, d, J = 8  Hz), 7.22 (2H, H 12, H 12’, d, J = 8  Hz), 
7.15 (2H, Hj, H8, s), 3.78 (6 H, H 17, H I7’, s), 2.68 (2H, H ]4, t, J = 7 Hz), 2.38 (2H, H 15, 
t, J = 7 Hz). H i6 was not found, presumably because the chemical shift was more 
than 11.5 ppm or because the peak was too broad.
IR (u, cm '1), 1745 (C = 0 o f ester bond), 1704 (C = 0  o f carboxylic acid) and a broad 
band for OH/NH group at 2600-3600 cm '1.
MS (m/z), CI: 432 ([M+H]+, 29%), 240 (89%).
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4.3.3.2 Synthesis of 4-(2-succinimidyloxycarbonylethyl)phenyl 2,7- 
dimethoxyacridine-9-carboxylate (22c)
In a round bottom flask (25 ml), equipped with a stirrer and a condenser, 4-(2- 
carbonylethyl)phenyl 2,7-dimethoxyacridine-9-carboxylate (22b) (286 mg) was 
heated in SOCI2 at 65 °C for 0.5 h. The resulting mixture was evaporated under 
vacuum to remove SOCI2 , then pyridine (5 ml) and 7V-hydroxysuccinimide (119 mg,
1.03 mmol) were added and the mixture was stirred overnight at room temperature. 
The resulting mixture was evaporated under vacuum to leave a brown residue, which 
was taken up in DCM and loaded onto a silica column for chromatography, eluted 
with DCM + EtOAc (30%). The fractions with R f = 0.25 were pooled and 
evaporated to give a bright yellow solid (130 mg, 33% yield), m.p. 193-194 °C.
4a' NL ■4a
'HNM R (400 Hz, chloroform-d, 6, ppm), 8.12 (2H, H4 , H 5 , d, J = 9 Hz), 7.45-7.33 
(8H, H3, H6, H ,, H8, H 12, H ,2 ’, H j3, H ,3 ’, m), 3.95 (6H, H20, H20-, s), 3.13 (2H, H I5, t, 
J = 7 Hz), 2.98 (2H, H 16, t, J = 7 Hz), 2.83 (4H, H 19, H 19’, s).
13CNMR (400 Hz, chloroform-d, 6, ppm), 169.5 (C i8/C 18’), 168.2 (C I7), 167.0 (C I0), 
159.0 (C2/C 7), 149.8 (C n ), 144.4 (C4a/C4a’), 138.0 (C 14), 132.0 (C4/C 5), 130.5 (C9 or 
C9a/C9a’), 130.2 (C 13/ c 130, 130.1 (C9 o r C 9a/C9a0, 124.6 (C3/C6), 1 2 2 . 0  (C12/C 12’),
100.4 (C ,/C8), 56.0 (C2 0 /C 2 0 O, 32.9 (C 16), 30.3 (C 15), 26.0 (C 19/C ,9.).
IR (u, cm '1), 1731 (C =0).
MS (m/z), El: 528 ([M]+, 1%), 414 (2%), 266 (78%); CI: 432 (2%), 240 (100%); 
MS/ Acc: measured 528.1525; calculated for C29H24N208, 528.1527.
Chapter 4 181
4.3.3.3 Synthesis of 9-(4-(2-succinimidyIoxycarbonyIethyl)phenoxycarbonyI)-2,7- 
dimethoxy-1 0 -methylacridinium trifluoromethanesulfonate (2 2 )
To a round bottom flask (5 ml), 4-(2-succinimidyloxycarbonylethyl)phenyl 2,7- 
dimethoxyacridine-9-carboxylate (22c) (51.9 mg, 0.095 mmol) was added. The flask 
was flushed with N 2 , and then dry DCM (2.5 ml) and methyl triflate (200 pi, 1.77 
mmol) were introduced with syringe respectively. The mixture was stirred overnight, 
and then the volatiles were evaporated under vacuum. The crude product was 
purified by chromatography over a silica column, eluted with DCM +CH 3 CN (3:1). 
The fractions with R f = 0.16 were pooled and evaporated under vacuum to give an 
orange solid (31.2 mg, 46% yield), m.p. 94-96 °C.
_ 20
4a^N . 4a
'HNM R (400 Hz, acetone-d6 , 6 , ppm), 8.81 (2H, H4, H 5, d, J = 9 Hz), 7.98 (2H, H 13, 
H i3-, d, J = 8  Hz), 7.55-7.40 (6 H, H 12, H i r , H3, H6, H ,, Hg, m), 5.02 (3H, H20, s), 4.06 
(6 H, H21, H21’, s ) ,  3.02 (2H, H l5, t, J = 7 Hz), 2.92 (2H, H 16, t, J = 7 Hz), 2.76 (4H, 
H 1 9 , H |9 ’, s ) .
13CNMR (400 Hz, acetone-d6, 5, ppm), 170.0 (Cig/Cjg-), 168.6 (C 17), 164.2 (C I0), 
159.8 (C2/C7), 149.1 (C „), 142.0 (C9), 139.5 (C 14), 137.9 (C4a/C4a0, 132.3 (C4/C5),
130.7 (C 13/C 130, 125.7 (C9a/C9aO, 122.1 (C12/C i r ), 121.9 (C ,/C8), 102.5 (C3/C6), 56.6 
(C2|/C2r), 40.5 (C20), 32.4 (C 16), 29.3 (C 15), 25.8 (CI9/C 19’).
IR (o, cm '1), 1732 (C =0).
MS (m/z), ES+: 543 ([M-CF3 S 0 3]+, 100%), 446 (10%), 253 (6 %); ES': 149 
([CF3 SO3 ]', 100%). Acc-MS: calculated mass: 543.1762 ([M-CF3 S0 3 ]+); measured 
mass: 543.1756.
Chapter 4 182
References for chapter 4
1. Z. Ahmed. P h D  Thesis, University o f Wales Swansea, 1996.
2. F. McCapra. Pat (No. US 5284951; No. US 5283334), 1994.
3. A. Streitwieser and J.C.H. Heathcock. Introduction to Organic Chemistry, 2nd 
edition, MacmillanPublishing Co., Inc., 1981, p392.
4. A.R. Katritzky and A. J. Boulton. Advances in Heterocyclic Chemistry, Academic
press, 1975, 18, p l2 , 45, 52.
5. R.O.C. Norman and J. M. Coxon. Principles o f  Organic Synthesis, Blackie 
Academic & Professional, 3rd edition, 1993, p i 17.
6 . Michael Driver and J. F. Hartwig. J. Am. Chem. Soc., 1996, 118, 7217.
7. F. Berthiol, H. Doucet and M. Santelli. Tetrahedron Lett., 2003, 44, 1221.
8 . L. Xu, D. Zhu, F. Wu, R. Wang and B. Wan. J. Molecular Catalys. A: Chem.,
2005,237,210-214.
9. M. Zaidlewicz and A. Wolan. J. organometal. Chem., 2002, 657, 129.
10. E. Bergmann. J. Chem. Soc., 1936, 402.
I L L .  Chen. P h D  Thesis, University o f  Wales Swansea, 2000.
12. Z. Li. P hD  Thesis, University o f Wales Swansea, 1998.
Chapter 5 183
Chapter 5
Chemiluminescence tests
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There are 22 target compounds in total that have been synthesized. Except for 
compounds 3 (LiAE) and 20, their chemiluminescent kinetics and storage stabilities 
have been tested. Compound 3, was expected to have the same chemiluminescent 
properties as compound 4; therefore, only compound 4 was tested. Compound 20 
is not in an acridinium format, the kinetics o f its chemiluminescence would be so 
slow as to prevent it being tested properly; therefore, its chemiluminescence was not 
intended to be tested.
1 25.1 Chemiluminescence measurements and initiating reagents ’
Samples were tested in a Luminometer (Ciba-Coming Magic Lite Analyzer). The 
procedure used was as follows.
The previously prepared sample solution (10 pi) was introduced to a test tube 
manually and the test tube was placed in the luminometer. The light triggering 
solution (reagent 1 ) was first injected to the test tube, followed by the light 
triggering solution (reagent 2), automatically. Firstly, the kinetics curve (light output 
versus time) was plotted by the machine automatically, and then the light output 
(efficiency) o f each sample solution was measured for a suitable time (15s). The light 
output was expressed in relative light units (RLU).
Reagent 1 and Reagent 2 solutions were kindly provided by MLT (Molecular Light 
Technology Research Ltd, Cardiff).
Reagent 1 (in 1 liter): nitric acid (6.3 ml, 70%), hydrogen peroxide (16.5 ml, 30%), 
and distilled water (977 ml).
Reagent 2 (in 1 liter): sodium hydroxide (10 g) and cetyltrimethylammonium 
chloride (7.5 ml, 25%) and distilled water (983 ml).
Sample solutions
The stock solutions o f  acridinium esters were prepared by dissolving the pure sample 
(1 mg or so, weighed accurately) in acetonitrile (1 ml). The stock solutions were
'y
firstly diluted with acetonitrile to 1 ><1 0 ' mg/ml, and further dilutions were made
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with acetonitrile or fixed phosphate pH buffers to yield ready-to use solutions (ca. 1 
ng/m l).
5.2 Results and discussion
5.2.1 The kinetics
The kinetics curves (chemiluminescence versus time, Relative Light Units against 
seconds) were plotted by the machine automatically, but the length o f the 
chemiluminescent time was controlled manually via the control panel. The results are 
displayed in figure 5.1. The compound number is shown in the top o f each picture. 
The structures o f  compounds 1, 2, 3, 4 ,5 and 6  are referred to in figure 3.2 and 
table 5.1; compounds 7, 8 , 9 ,1 0 ,1 1 ,1 2 ,1 3 , 14, 15,16, 17 ,18  and 19 are referred to 
in figure 3.2 and table 3.1; compounds 21 and 22 are referred to in figure 4.1.
Table 5.1, the specific compounds, numbering 1, 2, 4, 5 and 6, synthesized in chapter 2.a
Compound
number
Type a or b n Ri r 2 r 3
1 a 11 Br H Br
2 a 0 Br H Br
4 b 3 Br H Br
5 b 5 Br H Br
6 b 10 Br H Br
a: The substituents shown are referred to in figure 3.1 (Y = CF3 SO3).
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Figure 5.1, chemiluminescent kinetics o f the novel AEs.
The electronic natures o f substituents on the leaving group affect the 
chemiluminescent kinetics, due to the ease or difficulty o f expelling the leaving 
group during the chemiluminescent process, as shown in the mechanism o f 
chemiluminescence (figure 1.7). AEs having electron-withdrawing groups on the 
phenoxy moiety should react to provide chemiluminescence quickly. By contrast, 
AEs having electron-donating groups on the phenoxy moiety should glow slowly. 
However, substituents on the acridinium moiety would be expected to have relatively
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little effect. From the pictures in figure 5.1, it is clear that the nature o f the alkyl 
substituent at the 10 position does not affect the kinetics; and that neither the 
2-succinimidyloxycarbonylethyl group substituted at the side o f the acridinium ring 
in compound 21, nor the 2,7-dimethoxy groups substituted at the side o f the 
acridinium ring in compound 22, have significant effects on chemiluminescent 
kinetics. However, substituents on the leaving group do indeed affect the kinetics. 
AEs with a 2,6-dibromophenoxy leaving group (compounds 1, 2, 4, 5, 6  and 21), a
2.6-bis(trifluoromethyl)phenoxy leaving group (compounds 16 and 17), a
2.6-dinitrophenoxy leaving group (compounds 18 and 19), or an unsubstituented 
phenoxy group (compounds 7, 8 , 9, 10, 11 and 22), all showed similar kinetics 
because they all flashed quickly and the differences in their kinetics were too small to 
be significant. For AEs with a 2,5-dimethylphenoxy leaving group, (compounds 12, 
13, 14 and 15), the chemiluminescent kinetics were significantly slower. Therefore, 
AEs with electron-donating substituents on the leaving group, together with those 
AEs with electron withdrawing substituents or unsubstitued AEs, could be used to 
establish a multi-analysis pattern based on different chemiluminescent kinetics, but a 
combination o f  AEs with electron-withdrawing groups and ones with unsubstituted 
AEs will not be suitable for such a propose.
5.2.2 Storage stability
The stock solutions o f the acridinium esters were first diluted to lx  10‘4 mg/ml with 
acetonitrile. Further dilution was carried out with buffers o f pH = 6, 7 and 8, to yield 
the ready-to-use solutions (ca. 1 ng/ml). Each o f the sample solutions was divided 
into three portions, and incubated at 8 °C, 25 °C and 37 °C, respectively. The values 
o f measured relative light units for the 1 ng/ml ready to use samples were adjusted to 
their corresponding RLU values calculated for a concentration o f 1 nmol L"1. Sample 
solutions incubated at 37 °C were monitored over 1 week; and those at 8 °C and 25 
°C were monitored over 2 weeks. In each case, the total emission (in RLUs) over 15 
seconds was measured at intervals. The results are shown in figure 5.2.
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Figure 5.2. storage stabilities for AEs 1, 2 , 4 , 4 , 6 , 7 , 8 , 9 , 10, 11, 12, 13, 14, 15, 16, 17, 18,
19, 21 and 22 stored in pH 6 (blue curves). 7 (red curves) and 8 (yellow curves) buffer 
solutions at different temperatures (A: at 8 °C, B: 24 °C, C: 37 °C).
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The stabilities o f  acridinium esters could be tested by monitoring chemiluminescent 
decay during storage, because hydrolysis o f the acridinium ester group would cause 
decrease in chemiluminescence. Generally, The AEs stored at 8 °C (plots labelled A) 
showed stronger intensities o f  chemiluminescence than the same AEs stored at higher 
temperatures, 24 °C (plots labelled B) or 37 °C (plots labelled C) over the same 
period. AEs stored at 37 °C showed the weakest chemiluminescence, and after 1 
week or so at this temperature, the chemiluminescence for most AEs diminished by 
more than 90% per cent, so the samples were monitored for only 1 week. The results 
shows that AEs stored at 8 °C are more stable than at 24 °C or 37 °C, which is in 
accord with expectation.
By comparing the A-methylated AEs (compounds 2 and 7) with the TV-dodecylated 
AEs (compounds 1 and 8 ), the methylated ones showed reasonable plots in line with 
expectations, i.e: as the length o f the storage time increased, the intensity o f 
chemiluminescence decreased slowly, due to hydrolysis o f the sample during storage. 
For the dodecylated AEs, the chemiluminescence decreased sharply within 1 day 
even at 8 °C at pH 6, 7 and 8, as shown for compound 1 and compound 8  in figure 
5.2. No previous report has been found for the chemiluminescent properties o f AEs 
with a log-chain alkyl group attached to the nitrogen atom. The reason why AEs 
possessing a long alkyl chain linked to the N atom are so unstable is not clear. 
Possibly the pseudo-base for a compound with a bulkier substituent at the nitrogen 
atom is favoured (figure 5.3). The leaving group may be more easily expelled due to 
steric expulsion at C9 position in a pseudo-base than that in an acridinium salt. It 
may also have something to do with the different solubilities o f the compounds, 
which might cause them to disperse differently in the aqueous media. For example, 
the long alkyl chains encourage micelle formation, with the polar acridinium ester 
portions o f the molecules being on the outside o f  the micelle, where they are exposed 
to the aqueous medium.
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R
Figure 5.3, the equilibrium o f acridinim salt and pseudobase
For AEs having a linker group with a 10 CFE spacer (i.e. compounds 6 , 11, 15, 17 
and 19), the chemiluminescence also decreased abruptly within 1 day during storage. 
This is a similar case to the dodecylated AEs. The poor solubility in water, leading to 
aggregation o f micelles o f AE, probably account also for the fluctuation o f 
chemiluminescence with duration o f storage. 9-(2,5-Dimethylphenoxycarbonyl)AEs 
(compounds 13, 14 and 15) also showed fluctuations o f chemiluminescence during 
storage, perhaps for the same reason.
Generally, AEs stored in pH 6 and 7 buffer solutions showed relatively good 
stabilities. This is consistent with what Dr. Chen reported. The peudobase is favoured 
in a basic buffer solution while an acridinium salt is favoured in an acidic buffer 
solution. Therefore, AEs display better stability in weakly acidic or neutral aqueous 
solutions than in basic solutions.
It has been reported that the substitution ortho to the phenoxy leaving group could 
provide protection o f  the compound from hydrolysis, irrespective o f the electronic 
nature o f the substituents. This is the case for 9-(2,6-dibromophenoxy)AEs and 
9-(2,5-dimethylphenoxy)AEs, but it is not the case for 9-(2,6-dinitrophenoxy)AEs. 
The ready hydrolysis caused by the strongly electron-withdrawing nature o f the nitro 
groups predominates over any protection against hydrolysis due to ortho steric 
hindrance. The 9-(2,6-dinitrophenoxy)AEs (compounds 18 and 19), showed terribly 
poor stability in pH 6, 7 or 8 buffer solutions, and also poor efficiency in basic buffer
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solution (pH = 8). However, the 9-(2,6-bis(trifluoromethyl)phenoxy)AEs
(compounds 16 and 17), have much better stabilities than the
9-(2,6-dinitrophenoxy)AEs (18 and 19), despite the similar electron-withdrawing 
nature o f the substituents. Perhaps the bulkier trifluoromethyl groups provide some 
protection against hydrolysis because o f  steric hindrance.
Considering the stability, kinetics and the overall output o f chemiluminescence, 
9-(2,6-dibromophenoxycarbonyl)-10-(3-succinimidyloxycarbonylpropyl)acridinium 
triflate (LiAE’, compound 4) and 9-(2,6-dibromophenoxycarbonyl)-2-
(2-succinimidyloxycarbonylethyl)-10-methylacridinium triflate (compound 21) 
showed potentially good properties for application in labelling oligonucleotides and 
in immunoassays.
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